
<html lang="en"     class="pb-page"  data-request-id="e17195f7-6b25-4782-b22c-650dcce84c4e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2017.60.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b00994;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for Obesity" /></meta><meta name="dc.Creator" content="Javier  García-Cárceles" /></meta><meta name="dc.Creator" content="Juan M.  Decara" /></meta><meta name="dc.Creator" content="Henar  Vázquez-Villa" /></meta><meta name="dc.Creator" content="Ramón  Rodríguez" /></meta><meta name="dc.Creator" content="Eva  Codesido" /></meta><meta name="dc.Creator" content="Jacobo  Cruces" /></meta><meta name="dc.Creator" content="José  Brea" /></meta><meta name="dc.Creator" content="María I.  Loza" /></meta><meta name="dc.Creator" content="Francisco  Alén" /></meta><meta name="dc.Creator" content="Joaquin  Botta" /></meta><meta name="dc.Creator" content="Peter J.  McCormick" /></meta><meta name="dc.Creator" content="Juan A.  Ballesteros" /></meta><meta name="dc.Creator" content="Bellinda  Benhamú" /></meta><meta name="dc.Creator" content="Fernando  Rodríguez de Fonseca" /></meta><meta name="dc.Creator" content="María L.  López-Rodríguez" /></meta><meta name="dc.Description" content="The 5-HT2CR agonist lorcaserin, clinically approved for the treatment of obesity, causes important side effects mainly related to subtype selectivity. In the search for 5-HT2CR allosteric modulator..." /></meta><meta name="Description" content="The 5-HT2CR agonist lorcaserin, clinically approved for the treatment of obesity, causes important side effects mainly related to subtype selectivity. In the search for 5-HT2CR allosteric modulator..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 17, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00994" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00994" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00994" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00994" /></link>
        
    
    

<title>A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for Obesity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00994" /></meta><meta property="og:title" content="A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for Obesity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0012.jpeg" /></meta><meta property="og:description" content="The 5-HT2CR agonist lorcaserin, clinically approved for the treatment of obesity, causes important side effects mainly related to subtype selectivity. In the search for 5-HT2CR allosteric modulators as safer antiobesity drugs, a chemical library from Vivia Biotech was screened using ExviTech platform. Structural modifications of identified hit VA240 in synthesized analogues 6–41 afforded compound 11 (N-[(1-benzyl-1H-indol-3-yl)methyl]pyridin-3-amine, VA012), which exhibited dose-dependent enhancement of serotonin efficacy, no significant off-target activities, and low binding competition with serotonin or other orthosteric ligands. PAM 11 was very active in feeding inhibition in rodents, an effect that was not related to the activation of 5-HT2AR. A combination of 11 with the SSRI sertraline increased the anorectic effect. Subchronic administration of 11 reduced food intake and body weight gain without causing CNS-related malaise. The behavior of compound 11 identified in this work supports the interest of a serotonin 5-HT2CR PAM as a promising therapeutic approach for obesity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00994"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00994">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00994&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00994&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00994&amp;href=/doi/10.1021/acs.jmedchem.7b00994" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 9575-9584</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00953" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01001" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A Positive Allosteric Modulator of the Serotonin 5-HT<sub>2C</sub> Receptor for Obesity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Javier++Garc%C3%ADa-C%C3%A1rceles">Javier García-Cárceles</a></span><span class="author-xref-symbol "><sup>○</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-4614-9639" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juan+M.++Decara">Juan M. Decara</a></span><span class="author-xref-symbol "><sup>○</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henar++V%C3%A1zquez-Villa">Henar Vázquez-Villa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-7911-3160" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ram%C3%B3n++Rodr%C3%ADguez">Ramón Rodríguez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eva++Codesido">Eva Codesido</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacobo++Cruces">Jacobo Cruces</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9++Brea">José Brea</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+I.++Loza">María I. Loza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francisco++Al%C3%A9n">Francisco Alén</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joaquin++Botta">Joaquin Botta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+J.++McCormick">Peter J. McCormick</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juan+A.++Ballesteros">Juan A. Ballesteros</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bellinda++Benham%C3%BA">Bellinda Benhamú</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-0864-026X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fernando++Rodr%C3%ADguez+de+Fonseca">Fernando Rodríguez de Fonseca</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+L.++L%C3%B3pez-Rodr%C3%ADguez">María L. López-Rodríguez</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-8607-1085" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Departamento de Química Orgánica I, Universidad Complutense de Madrid, E-28040 Madrid, Spain</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Unidad de Gestión Clínica de Salud Mental, Instituto IBIMA, Hospital Regional Universitario, E-29010 Málaga, Spain</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Galchimia, E-15823 O Pino, A Coruña, Spain</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Biofarma Research Group, USEF Screening Platform, CIMUS, USC, E-15782 Santiago de Compostela, Spain</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">School of Pharmacy, University of East Anglia, NR4 7TJ Norwich, U.K.</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">School of Veterinary Medicine, University of Surrey, GU2 7XH Guildford, U.K.</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∇</span> <span class="aff-text">Vivia Biotech S.L., Parque Científico de Madrid, E-28760 Madrid, Spain</span></div><div class="corresp-info"><strong>*</strong>For M.L.L.-R.: phone, 34-91-3944239; fax 34-91-3944103; e-mail, <a href="/cdn-cgi/l/email-protection#2c41405956405e6c594f4102495f"><span class="__cf_email__" data-cfemail="5e33322b24322c1e2b3d33703b2d">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For F.R.F.: phone, 34-952-614-012; e-mail, <a href="/cdn-cgi/l/email-protection#751310071b141b111a5b071a11071c1200100f351c171c18145b1000"><span class="__cf_email__" data-cfemail="ddbbb8afb3bcb3b9b2f3afb2b9afb4baa8b8a79db4bfb4b0bcf3b8a8">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00994&amp;href=/doi/10.1021%2Facs.jmedchem.7b00994" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 9575–9584</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 8, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 July 2017</li><li><span class="item_label"><b>Published</b> online</span>17 November 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 December 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00994" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00994</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9575%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJavier%2BGarc%25C3%25ADa-C%25C3%25A1rceles%252C%2BJuan%2BM.%2BDecara%252C%2BHenar%2BV%25C3%25A1zquez-Villa%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D23%26contentID%3Dacs.jmedchem.7b00994%26title%3DA%2BPositive%2BAllosteric%2BModulator%2Bof%2Bthe%2BSerotonin%2B5-HT2C%2BReceptor%2Bfor%2BObesity%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9584%26publicationDate%3DDecember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00994"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1963</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00994" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for Obesity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Javier&quot;,&quot;last_name&quot;:&quot;García-Cárceles&quot;},{&quot;first_name&quot;:&quot;Juan&quot;,&quot;last_name&quot;:&quot;M. Decara&quot;},{&quot;first_name&quot;:&quot;Henar&quot;,&quot;last_name&quot;:&quot;Vázquez-Villa&quot;},{&quot;first_name&quot;:&quot;Ramón&quot;,&quot;last_name&quot;:&quot;Rodríguez&quot;},{&quot;first_name&quot;:&quot;Eva&quot;,&quot;last_name&quot;:&quot;Codesido&quot;},{&quot;first_name&quot;:&quot;Jacobo&quot;,&quot;last_name&quot;:&quot;Cruces&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Brea&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;I. Loza&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;Alén&quot;},{&quot;first_name&quot;:&quot;Joaquin&quot;,&quot;last_name&quot;:&quot;Botta&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;J. McCormick&quot;},{&quot;first_name&quot;:&quot;Juan&quot;,&quot;last_name&quot;:&quot;A. Ballesteros&quot;},{&quot;first_name&quot;:&quot;Bellinda&quot;,&quot;last_name&quot;:&quot;Benhamú&quot;},{&quot;first_name&quot;:&quot;Fernando&quot;,&quot;last_name&quot;:&quot;Rodríguez de Fonseca&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;L. López-Rodríguez&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;9575-9584&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00994&quot;},&quot;abstract&quot;:&quot;The 5-HT2CR agonist lorcaserin, clinically approved for the treatment of obesity, causes important side effects mainly related to subtype selectivity. In the search for 5-HT2CR allosteric modulators as safer antiobesity drugs, a chemical library from Vivia Biotech was screened using ExviTech platform. Structural modifications of identified hit VA240 in synthesized analogues 6–41 afforded compound 11 (N-[(1-benzyl-1H-indol-3-yl)methyl]pyridin-3-amine, VA012), which exhibited dose-dependent enhancement of serotonin efficacy, no significant off-target activities, and low binding competition with serotonin or other orthosteric ligands. PAM 11 was very active in feeding inhibition in rodents, an effect that was not related to the activation of 5-HT2AR. A combination of 11 with the SSRI sertraline increased the anorectic effect. Subchronic administration of 11 reduced food intake and body weight gain without causing CNS-related malaise. The behavior of compound 11 identified in this work supports the interest of a &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00994&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00994" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00994&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00994" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00994&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00994" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00994&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00994&amp;href=/doi/10.1021/acs.jmedchem.7b00994" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00994" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00994" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00994%26sid%3Dliteratum%253Aachs%26pmid%3D29116785%26genre%3Darticle%26aulast%3DGarc%25C3%25ADa-C%25C3%25A1rceles%26date%3D2017%26atitle%3DA%2BPositive%2BAllosteric%2BModulator%2Bof%2Bthe%2BSerotonin%2B5-HT2C%2BReceptor%2Bfor%2BObesity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D23%26spage%3D9575%26epage%3D9584%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290869" title="Food">Food</a>,</li><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a>,</li><li><a href="/action/doSearch?ConceptID=291803" title="Obesity">Obesity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/jmcmar.2017.60.issue-23/20171214/jmcmar.2017.60.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The 5-HT<sub>2C</sub>R agonist lorcaserin, clinically approved for the treatment of obesity, causes important side effects mainly related to subtype selectivity. In the search for 5-HT<sub>2C</sub>R allosteric modulators as safer antiobesity drugs, a chemical library from Vivia Biotech was screened using ExviTech platform. Structural modifications of identified hit VA240 in synthesized analogues <b>6</b>–<b>41</b> afforded compound <b>11</b> (<i>N</i>-[(1-benzyl-1<i>H</i>-indol-3-yl)methyl]pyridin-3-amine, VA012), which exhibited dose-dependent enhancement of serotonin efficacy, no significant off-target activities, and low binding competition with serotonin or other orthosteric ligands. PAM <b>11</b> was very active in feeding inhibition in rodents, an effect that was not related to the activation of 5-HT<sub>2A</sub>R. A combination of <b>11</b> with the SSRI sertraline increased the anorectic effect. Subchronic administration of <b>11</b> reduced food intake and body weight gain without causing CNS-related malaise. The behavior of compound <b>11</b> identified in this work supports the interest of a serotonin 5-HT<sub>2C</sub>R PAM as a promising therapeutic approach for obesity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Obesity, defined as having a body mass index (weight [kg]/height [m<sup>2</sup>]) equal to or greater than 30 kg/m<sup>2</sup>, is a major global health issue affecting nearly one billion adults worldwide and this number continues to rise.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Obesity is a major risk factor for chronic diseases, such as diabetes, cardiovascular pathology, and certain cancers.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Hence, it is widely believed that obesity will become one of the leading causes of morbidity and mortality for this and future generations. Although a number of strategies have been used to tackle obesity, most of the marketed medicines have been withdrawn mainly due to safety issues,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> including CNS-related adverse effects, and the pharmaceutical options available to obese patients are currently limited.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Therefore, there is a major need for new agents that can provide a safe and effective mechanism for inducing weight loss.</div><div class="NLM_p">Among the variety of pharmacological approaches that can be used to control body weight, the serotonin (5-hydroxytryptamine, 5-HT) system has long been known to be involved in the modulation of food intake.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> Accordingly, classical antiobesity medicines such as sibutramine (<b>1</b>) and (dex)fenfluramine (<b>2</b>) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A) act by increasing the level of serotonin.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> The current classification of the serotonin receptor family, which has essentially remained unchanged since 1994,<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> includes 14 receptor subtypes classified into seven major classes (5-HT<sub>1–7</sub>). The 5-HT<sub>2</sub> class comprises three GPCR members (5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, 5-HT<sub>2C</sub>) characterized by close sequence homology and coupling primarily via G<sub>q</sub> proteins to intracellular signaling pathways such as phospholipase C and phospholipase A.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In particular, serotonin 2C receptors are predominantly expressed in the CNS, where they are widely distributed in different brain regions. There is substantial evidence supporting that their modulation may offer therapeutic benefit in various pathological conditions, including schizophrenia, substance addiction, and obesity.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> In this regard, the 5-HT<sub>2C</sub> receptor (5-HT<sub>2C</sub>R) is critical for the anorectic effect of serotoninergic activation,<a onclick="showRef(event, 'ref7 ref13'); return false;" href="javascript:void(0);" class="ref ref7 ref13">(7, 13)</a> and the satiating effects of <b>2</b> have thus been demonstrated to be attenuated in 5-HT<sub>2C</sub>R knockout mice as well as by selective 5-HT<sub>2C</sub>R antagonists.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Classical serotoninergic antiobesity agents. (B) 5-HT<sub>2C</sub>R ligands: agonist <b>3</b> clinically used for obesity and positive allosteric modulator <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Stimulation of 5-HT<sub>2C</sub>Rs is the most advanced approach toward serotonin mediated control of food intake and associated reduction in body weight, and multiple research efforts have identified several promising 5-HT<sub>2C</sub>R ligands.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> In 2012, the 5-HT<sub>2C</sub>R agonist lorcaserin (<b>3</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B) was approved by the FDA as a first-in-class antiobesity drug.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Therefore, the activation of 5-HT<sub>2C</sub>Rs has been validated in the search of therapeutic strategies for the treatment of obesity. However, selectivity is critical because of the detrimental effects of 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> receptor activation that are respectively associated with potential hallucinogenic effects<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and cardiac valvulopathy.<a onclick="showRef(event, 'ref12 ref24'); return false;" href="javascript:void(0);" class="ref ref12 ref24">(12, 24)</a> Indeed, increased risk of cardiovascular and cardiopulmonary diseases has led to the withdrawal of nonselective serotoninergic drugs <b>1</b> and <b>2</b> from the EU and the USA markets, respectively,<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> and certain restrictions apply to the use of compound <b>3</b> as its moderate 5-HT<sub>2B</sub>R activity might induce major cardiac side effects.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Clearly, further efficacy and safety data are needed to prove the clinical utility of 5-HT<sub>2C</sub>R ligands as antiobesity agents.</div><div class="NLM_p">In this context, the development of 5-HT<sub>2C</sub>R agonists with better selectivity profiles for this worldwide disease would be of great value. This represents a significant challenge, as the molecular determinants involved in ligand recognition by 5-HT<sub>2</sub>R subtypes are highly conserved.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> More opportunities may emerge from targeting an allosteric binding site as opposed to the orthosteric site of the 5-HT<sub>2C</sub>R protein. Positive allosteric modulators (PAMs) should elicit a more physiologically relevant enhancement of target function compared to an orthosteric agonist.<a onclick="showRef(event, 'ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31">(28-31)</a> To date, PNU-69176E (<b>4</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B) is the only 5-HT<sub>2C</sub>R PAM described, which was identified via screening of a chemical library of Pharmacia (now Pfizer).<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> A derivative of this modulator (CYD-1-79, undisclosed structure) has recently been reported to potentiate 5-HT<sub>2C</sub>R signaling in vivo in a drug discrimination assay,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> although no antiobesity properties have been described to our knowledge.</div><div class="NLM_p">In the present work, we contribute to the quest for selectively acting 5-HT<sub>2C</sub>R modulators. In the screening of a chemical library from Vivia Biotech company using a proprietary platform, compound <b>5</b> (VA240, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) was identified and validated as a moderate PAM of the 5-HT<sub>2C</sub>R. Further structural modification in synthetic analogues <b>6</b>–<b>41</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) has led to compound <b>11</b> (VA012, <i>N</i>-[(1-benzyl-1<i>H</i>-indol-3-yl)methyl]pyridin-3-amine) with enhanced allosteric efficacy that was found to be very active in feeding models in rodents, reducing both food intake and body weight gain without inducing CNS-related malaise.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. High-throughput screening of Vivia Biotech chemical library and subsequent functional validation allowed to identify hit compound <b>5</b>, which entered a medicinal chemistry program for the search of allosteric modulators of the 5-HT<sub>2C</sub>R.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15811" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15811" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Hit Identification: High-Throughput Screening</h3><div class="NLM_p">The proprietary ExviTech platform developed by Vivia Biotech is a highly sensitive method based on flow cytometry to assess activation of GPCRs. A functional whole cell assay was used to access activity by measuring calcium mobilization in response to receptor activation. For screening, the tested compounds were added to HEK-293 cells stably expressing 5-HT<sub>2C</sub>R, and after 10 min, a 25% of the maximal effective concentration (EC<sub>25</sub>) of serotonin was added. The resulting percentage of cells that respond was then determined. The response for each well (i.e., compound) was compared to control, receiving only an EC<sub>25</sub> concentration of serotonin, any response above this level indicating a potential modulator. Specificity was simultaneously analyzed by screening cell lines expressing close family members, 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> subtypes, using multiparametric flow cytometry and cell tracking dyes. A Vivia Biotech chemical library of approximately 1600 compounds was screened on ExviTech platform at a concentration of 10 μM (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Three compounds enhanced at ∼20% the effect produced by serotonin in cells expressing the 5-HT<sub>2C</sub>R, whereas no potentiation of serotonin effect was observed for 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> receptors.</div><div class="NLM_p last">The three putative modulators identified in the ExviTech platform were validated for their ability to stimulate the 5-HT<sub>2C</sub>R in a functional assay by determining inositol monophosphate (IP) levels in cells, a well characterized signaling pathway of receptor activation. Biological analyses were conducted in HeLa cells stably expressing physiological levels of the human 5-HT<sub>2C</sub>R. Cells were treated with a fixed concentration of the tested compounds (10 μM) and increasing concentrations of serotonin. The accumulation of IP was quantified by homogeneous time-resolved fluorescence energy transfer (HTRF). A 5-HT dose–response curve was obtained in the presence of each compound, and potentiation of the 5-HT maximal effect (<i>E</i><sub>max</sub>) was measured. Using this assay, compound <b>5</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) enhanced the IP release induced by 5-HT, with a 20% potentiation of 5-HT <i>E</i><sub>max</sub>, which supports the allosteric activity at the 5-HT<sub>2C</sub>R. Hence, <b>5</b> was selected as a starting hit for the search of new synthetic modulators of the 5-HT<sub>2C</sub>R with enhanced allosteric efficacy.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Optimization of Compound <b>5</b></h3><div class="NLM_p">Starting from the validated hit <b>5</b>, two series of analogues, <b>6</b>–<b>14</b> and <b>15</b>–<b>41</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> and <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), were generated by modification of the pyrimidine or the phenyl ring attached to the indole scaffold, respectively, to examine the effect on functional activity and allosteric modulation at the 5-HT<sub>2C</sub>R. In compounds <b>6</b>–<b>14</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), the phenyl ring was maintained and different nitrogen-containing heterocycles were introduced. These compounds were synthesized by reductive amination starting from 1-benzyl-1<i>H</i>-indole-3-carbaldehyde (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Derivatives <b>6</b>–<b>9</b> and <b>13</b> were prepared via one-pot reaction of the aldehyde with the corresponding pyrimidin-, pyrazin-, pyridazin-, or pyridinamine in 1,2-dichloroethane using sodium triacetoxyborohydride as reducing agent. For compounds <b>10</b>–<b>12</b> and <b>14</b>, a two-step procedure was carried out. In this case, condensation of 1-benzyl-1<i>H</i>-indole-3-carbaldehyde with pyridazin-4-amine or the appropriate pyridinamine, catalyzed by <i>p</i>-toluenesulfonic acid in refluxing toluene, afforded the corresponding imine, which was isolated and subsequently reduced with sodium borohydride in methanol.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Compounds <b>6</b>–<b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amino <i>N</i>-heterocycle, NaBH(OAc)<sub>3</sub>, 1,2-dichloroethane, Δ, 8–15 h, 11–21% (<b>6</b>–<b>9</b>, <b>13</b>); (b) (i) amino <i>N</i>-heterocycle, <i>p</i>-TSA, toluene, Δ, 5–18 h, (ii) NaBH<sub>4</sub>, MeOH, 0 °C to rt, 1–2 h, 33–73% (<b>10</b>–<b>12</b>, <b>14</b>).</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Identified Hit <b>5</b> and New Compounds <b>6-14</b> in 5-HT-Induced IP Production in 5-HT<sub>2C</sub>R-HeLa Cells</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Potentiation of 5-HT <i>E</i><sub>max</sub> at a fixed concentration of compound = 10 μM; values are the mean ± SEM of three independent experiments with duplicate determinations.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect of Selected Compound <b>11</b> and New Compounds <b>15</b>–<b>41</b> in 5-HT-Induced IP Production in 5-HT<sub>2C</sub>R-HeLa Cells</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0010.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0011.gif" alt="" id="GRAPHIC-d128e953-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Potentiation of 5-HT <i>E</i><sub>max</sub> at a fixed concentration of compound = 10 μM; values are the mean ± SEM of three independent experiments with duplicate determinations.</p></div></div><div></div></div><div class="NLM_p">Synthesized compounds <b>6</b>–<b>14</b> were assessed for their effect on 5-HT-induced IP release in 5-HT<sub>2C</sub>R-HeLa cells. From the data in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, most compounds resulted in being inactive although in general pyridyl derivatives showed potentiation of the endogenous agonist effect. In particular, 3-pyridyl analogue <b>11</b> exhibited the highest potentiation (35% at 10 μM).</div><div class="NLM_p">We next approached the synthesis of the second series of proposed compounds <b>15</b>–<b>41</b>, where the 3-pyridyl moiety of compound <b>11</b> was maintained as <i>N</i>-heterocycle and the phenyl ring was modified. In analogues <b>15</b>–<b>37</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) substituents of different size and electronic effects (F, Cl, Br, Me, OMe, CF<sub>3</sub>, CN) were introduced in the benzene ring. These compounds were obtained by <i>N</i>-alkylation of the indole intermediate <b>42</b> with the appropriate benzyl bromide derivative using sodium hydride as base (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Intermediate <b>42</b> was prepared by reductive amination of 1<i>H</i>-indole-3-carbaldehyde with pyridin-3-amine, following the two-step procedure described above.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Target Compounds <b>15</b>–<b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) pyridin-3-amine, <i>p</i>-TSA, toluene, Δ, 1–6 h, (ii) NaBH<sub>4</sub>, MeOH, 0 °C to rt, 15–60 min, 26–91%; (b) benzyl bromide derivative, NaH, DMF, rt, 15 min, 30–87%; (c) 2-, 3-, or 4-(bromomethyl)pyridine hydrobromide, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 2 h, 86–94%; (d) (bromomethyl)cyclopropane, NaH, DMF, rt, 1 h, 97%.</p></p></figure><div class="NLM_p">In addition, replacement of the benzene ring with a pyridine was considered in compounds <b>38</b>–<b>40</b>, as well as that with a cyclopropane ring in compound <b>41</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), to explore the requirement of aromaticity at the 1-position of the indole scaffold. In the case of pyridine-containing derivatives <b>38</b>–<b>40</b>, alkylation reaction of <b>42</b> with the corresponding (bromomethyl)pyridines failed, and an alternative <i>N</i>-alkylation-reductive amination sequence was followed (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Thus, treatment of 1<i>H</i>-indole-3-carbaldehyde with the appropriate bromide derivative in the presence of cesium carbonate yielded intermediates <b>43</b>–<b>45</b>, which after reductive amination with pyridin-3-amine afforded final compounds <b>38</b>–<b>40</b>. Similarly, cyclopropyl derivative <b>41</b> was synthesized by reductive amination of intermediate <b>46</b>, obtained by alkylation of 1<i>H</i>-indole-3-carbaldehyde with (bromomethyl)cyclopropane using sodium hydride as base (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><div class="NLM_p last">The new set of compounds <b>15</b>–<b>41</b> was tested in the IP functional assay, and the data are shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. No substantial improvement of the allosteric potentiation was observed for any of the aryl derivatives, which exhibited lower values than unsubstituted analogue <b>11</b>. The presence of heterocyclic pyridine or nonaromatic cyclopropane in analogues <b>38</b>–<b>41</b> was also less favorable than that of a phenyl ring (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Hence, compound <b>11</b> was selected for further pharmacological characterization as an allosteric modulator of the 5-HT<sub>2C</sub>R.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> In Vitro Characterization of Compound <b>11</b></h3><div class="NLM_p">Compound <b>11</b> was evaluated in the 5-HT-induced IP assay at different concentrations in CHO cells stably expressing 5-HT<sub>2C</sub>R. As shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A, results revealed an increase of 5-HT <i>E</i><sub>max</sub>, reaching 35% of potentiation at 10 μM. It should be noted that a lower concentration of 1 μM enhanced the maximal effect of 5-HT by 28%. In the concentration–response curve of the compound over 5-HT EC<sub>70</sub>, a dose-dependent potentiation of 5-HT effect was obtained, with a high potency for compound <b>11</b> (EC<sub>50</sub> = 16 ± 2 nM). The compound did not induce IP release in the 5-HT<sub>2C</sub>R-CHO cells in the absence of 5-HT (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B), so it does not present intrinsic agonist activity. Importantly, this profile for compound <b>11</b> was distinguished from that seen in 5-HT<sub>2A</sub>R-CHO (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C,D) and 5-HT<sub>2B</sub>R-CHO (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>E,F) cells, in which neither the compound in the presence of 5-HT nor alone altered IP release.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vitro characterization of compound <b>11</b>. (A) 5-HT curves in the presence of increasing concentrations of the compound. (B) Effect of the compound in the absence of serotonin. (C) Allosteric effect of the compound at the 5-HT<sub>2A</sub>R. (D) Agonist effect of the compound at the 5-HT<sub>2A</sub>R. (E) Allosteric effect of the compound at the 5-HT<sub>2B</sub>R. (F) Agonist effect of the compound at the 5-HT<sub>2B</sub>R. (G) Binding displacements of orthosteric ligands of the 5-HT<sub>2C</sub>R by 10 μM <b>11</b>. Points represent the mean ± SD (vertical bars) of triplicate measurements.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the selectivity exhibited over 5-HT<sub>2</sub> subtypes, no significant off-target agonist or antagonist activities were observed in a CEREP cellular GPCR profile of the compound (no effect over 20% at 10 μM was observed in either agonist or antagonist assays), which discarded important safety issues.</div><div class="NLM_p">In radioligand binding competition assays, 10 μM <b>11</b> showed low displacement of the endogenous agonist (5-HT) or other orthosteric ligands (mesulergine and clozapine), suggesting its binding to a different site of the receptor (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>G). The moderate affinity observed for compound <b>11</b> in the presence of LSD may be due to the location of this orthosteric ligand close to the extracellular domain of the receptor, where allosteric modulators of aminergic GPCRs bind.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This is in agreement with the recently reported crystal structure of the closely related 5-HT<sub>2B</sub>R bound to LSD.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p last">Overall, the in vitro characterization of compound <b>11</b> proves its pharmacological profile as a specific and safe PAM of the 5-HT<sub>2C</sub>R, which supports the exploration of its activity in vivo.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vivo Behavior of the New 5-HT<sub>2C</sub>R PAM <b>11</b></h3><div class="NLM_p">Prior to the evaluation of the new 5-HT<sub>2C</sub>R PAM <b>11</b> in animal models, the in vivo brain permeability was studied (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00994/suppl_file/jm7b00994_si_001.pdf" class="ext-link">Figure S1</a>). Results showed a ratio of concentrations of the compound in brain and plasma of 3.8 after 120 min when administered intraperitoneally (ip) at a dose of 10 mg/kg. Importantly, this ratio was constant up to 6 h. These data prompted us to assess the behavior of <b>11</b> in animal models of obesity.</div><div class="NLM_p">In a first experiment, food intake was monitored upon acute administration of studied compound or the 5-HT<sub>2C</sub>R agonist <b>47</b> (WAY 161503)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> assayed as a reference compound of 5-HT<sub>2C</sub>R activation (<a class="ref internalNav" href="#fig4" aria-label="Figures 4">Figures 4</a>A,B). Both compounds induced a reduction in feeding when they were acutely administered at 2 mg/kg (ip). Agonist <b>47</b> produced a reduction in food intake that was more intense at the earlier times and almost vanished after 4 h (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A, dose effect <i>F</i> (2.80) = 51.9, <i>P</i> < 0.01). Notably, the newly identified allosteric modulator <b>11</b> reduced feeding with a higher efficacy (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B, dose effect <i>F</i> (3.82) = 256, <i>P</i> < 0.001) and with a more prolonged action (time × dose interaction <i>F</i> (3.82) = 5.3, <i>P</i> < 0.01), reaching almost 50% reduction after 4 h at the dose of 10 mg/kg. The effects of <b>11</b> were not related to the activation of serotonin 5-HT<sub>2A</sub>R, as revealed by the persistence of food intake inhibition despite pretreatment with the 5-HT<sub>2A</sub>R antagonist ketanserin (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00994/suppl_file/jm7b00994_si_001.pdf" class="ext-link">Figure S2A</a>). In addition, the effect of <b>11</b> was not eliminated after pretreatment with the 5-HT<sub>2C</sub>R antagonist <b>48</b> (SB-242084, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00994/suppl_file/jm7b00994_si_001.pdf" class="ext-link">Figure S2B</a>),<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> whereas the antagonist did reduce the inhibition produced by the 5-HT<sub>2C</sub>R agonist <b>47</b> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00994/suppl_file/jm7b00994_si_001.pdf" class="ext-link">Figure S2C</a>). These results suggest no direct action of PAM <b>11</b> at the orthosteric site of the receptor.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo behavior of the new 5-HT<sub>2C</sub>R PAM <b>11</b>. (A) The 5-HT<sub>2C</sub>R agonist <b>47</b> reduced feeding in food deprived animals. (B) In a similar model, compound <b>11</b> has a more potent and prolonged action. (C) When administered in animals with restricted food access (4 h/day), <b>11</b> reduced daily feeding. (D) This effect was also observed when the compound was given to animals with continuous access to food. (E,F) In both models, food restriction and continuous access, repeated administration of <b>11</b> reduced net body weight gain. (G) Compound <b>11</b> induced hypolocomotion in the elevated plus maze. (H) Compound <b>11</b> did not result in conditioned taste aversion. * denotes statistical significance (<i>P</i> < 0.01) when compared to control. <i>N</i> = at least 8 animals per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">When compound <b>11</b> was administered in a restricted food access model, it reduced both food intake (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C, <i>F</i> (6.98) = 7.9, <i>P</i> < 0.001) and body weight gain (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>E, <i>F</i> (6.98) = 10.7, <i>P</i> < 0.001). Similar results were observed after 7 days of repeated administration of the compound in a continuous food access model, where both daily food intake (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>D, <i>F</i> (6.98) = 6.2, <i>P</i> < 0.001) and body weight gain (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>F, <i>F</i> (6.98) = 3.9, <i>P</i> < 0.01) decreased.</div><div class="NLM_p">To establish whether the new PAM induced side effects, we explored the appearance of hypolocomotion, anxiety, and conditioned taste aversion. The compound induced hypolocomotion in the elevated plus maze (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>G, <i>F</i> (2.21) = 12, <i>P</i> < 0.01). Anxiety cannot be discarded (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00994/suppl_file/jm7b00994_si_001.pdf" class="ext-link">Figure S3A</a>) although the hypolocomotion made very difficult the evaluation of this response. The hypolocomotion was also observed in the open field test (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00994/suppl_file/jm7b00994_si_001.pdf" class="ext-link">Figure S3B</a>). The hypolocomotor profile of PAM <b>11</b> appears as a side effect that might limit its therapeutic utility at certain doses, as it has also been described for 5-HT<sub>2C</sub>R agonists such as lorcaserin in animal models of obesity or nicotine addiction.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> On the other hand, administration of compound <b>11</b> (2 mg/kg, ip) did not result in conditioned taste aversion (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>H, treatment per saccharin interaction, <i>F</i> (2.58) = 26.5, <i>P</i> < 0.01), indicating that the compound did not cause malaise, in contrast to LiCl used as positive control.</div><div class="NLM_p">As a way of demonstrating allosteric potentiation of serotonin-induced feeding suppression by compound <b>11</b>, we tested the effects of coadministration with the selective serotonin reuptake inhibitor (SSRI) sertraline. This antidepressant drug is known to induce a mild feeding suppression, as shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A (<i>F</i> (3.112) = 29.1, <i>P</i> < 0.01) when administered in a wide range of doses (0.4–10 mg/kg). In this experiment, two different combinations of both compounds were used: 0.5 mg/kg <b>11</b> with 2 mg/kg sertraline (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B) and 2 mg/kg <b>11</b> with 5 mg/kg sertraline (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C). When the extracellular concentration of serotonin increased upon administration of sertraline, the anorectic effect of <b>11</b> was potentiated, as expected for a positive modulator of the receptor activity (interaction <b>11</b>–sertraline <i>F</i> (9.111) = 4.6 <i>P</i> < 0.001). This is a very remarkable action because the prevalence of depression associated with obesity is very high, i.e., 19% in severe obesity.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> This combination might offer a new strategy for feeding reduction in depressed obese people.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo allosteric modulation of serotonin-induced feeding suppression by compound <b>11</b>. (A) Selective serotonin reuptake inhibitor sertraline induced a mild feeding suppression in rats. (B,C) When the extracellular concentration of serotonin increased upon administration of sertraline, the anorectic effect of <b>11</b> was potentiated. * denotes statistical significance (<i>P</i> < 0.01) when compared to control. <i>N</i> = at least 8 animals per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this work, we have developed compound <b>11</b> (<i>N</i>-[(1-benzyl-1<i>H</i>-indol-3-yl)methyl]pyridin-3-amine) as an allosteric modulator of the serotonin 5-HT<sub>2C</sub>R that exhibits enhanced efficacy dose-dependently, no significant off-target activities, and low competition with the endogenous agonist or other orthosteric ligands. The compound was found to be very active in feeding models in rodents, reducing both food intake and body weight gain without causing CNS-related malaise when administered subchronically. The effects were not related to 5-HT<sub>2A</sub>R activation, and a potentiation of the anorectic action of <b>11</b> was observed when administered in combination with sertraline, which suggests an allosteric modulation of serotonin effect in vivo. These results support the interest of a 5-HT<sub>2C</sub>R PAM as a promising therapeutic approach for obesity.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31344" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31344" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Synthesis</h3><div class="NLM_p last">Unless otherwise stated, the starting materials, reagents, and solvents were purchased as high-grade commercial products from Sigma-Aldrich, Acros, ABCR, Fluorochem, Scharlab, or Panreac. Analytical thin-layer chromatography (TLC) was run on Merck silica gel plates (Kieselgel 60 F-254), with detection by UV light (λ = 254 nm), 5% ninhydrin solution in ethanol, or 10% phosphomolybdic acid solution in ethanol. Unless otherwise stated, products were purified by flash chromatography using a Varian 971-FP system with cartridges of silica gel (Varian, particle size 50 μm). All compounds were obtained as oils, except for those whose melting points (mp) are indicated, which were solids. Melting points (uncorrected) were determined on a Stuart Scientific electrothermal apparatus. Infrared (IR) spectra were measured on a Bruker Tensor 27 instrument equipped with a Specac ATR accessory of 5200–650 cm<sup>–1</sup> transmission range; frequencies (ν) are expressed in cm<sup>–1</sup>. <sup>1</sup>H, <sup>13</sup>C, and <sup>19</sup>F NMR spectra were recorded on a Bruker Avance 500 MHz (<sup>1</sup>H, 500 MHz; <sup>13</sup>C, 125 MHz) or Bruker DPX 300 MHz (<sup>1</sup>H, 300 MHz; <sup>13</sup>C, 75 MHz; <sup>19</sup>F, 300 MHz) instrument at room temperature (rt) at the Universidad Complutense de Madrid (UCM) NMR core facility. Bruker DPX 300 MHz equipment was used unless otherwise stated. Chemical shifts (δ) are expressed in parts per million relative to the residual solvent peak for <sup>1</sup>H and <sup>13</sup>C nucleus (CDCl<sub>3</sub>: δ<sub>H</sub> = 7.26, δ<sub>C</sub> = 77.16; DMSO-<i>d</i><sub>6</sub>: δ<sub>H</sub> = 2.50, δ<sub>C</sub> = 39.52) and to internal (trifluoromethyl)benzene for <sup>19</sup>F nucleus; coupling constants (<i>J</i>) are in hertz (Hz). The following abbreviations are used to describe peak patterns when appropriate: s (singlet), d (doublet), t (triplet), q (quartet), qt (quintet), m (multiplet), app (apparent), and br (broad). 2D NMR experiments, homonuclear correlation spectroscopy (H,H–COSY), heteronuclear multiple quantum correlation (HMQC), and heteronuclear multiple bond correlation (HMBC) of representative compounds were acquired to assign protons and carbons of new structures. For all final compounds, purity was determined by high-performance liquid chromatography (HPLC) coupled to mass spectrometry (MS) using an Agilent 1200LC-MSD VL instrument, and satisfactory chromatograms confirmed a purity of at least 95% for all tested compounds. LC separation was achieved with a SunFire C18 column (3.5 μm, 2.1 mm × 100 mm), together with a guard column (5 μm, 4.6 mm × 12.5 mm). The mobile phase consisted of A (1:1 ACN/methanol) and B (5 mM NH<sub>4</sub>OH pH 7). MS analysis was performed with an ESI source. Spectra were acquired in positive or negative ionization mode from 80 to 800 <i>m</i>/<i>z</i> and in UV mode in the wavelength range 210–400 nm.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Procedure for One-Pot Reductive Amination</h3><div class="NLM_p">To a suspension of 1-benzyl-1<i>H</i>-indole-3-carbaldehyde (1.0 equiv) and NaBH(OAc)<sub>3</sub> (3.0 equiv) in anhydrous 1,2-dichloroethane (10 mL/mmol), the corresponding amino <i>N</i>-heterocycle (2.5 equiv) was added under an argon atmosphere, and the reaction was refluxed for 8–15 h. After this time, the mixture was allowed to reach rt, and it was diluted with DCM and washed with water. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated. The crude was purified by flash chromatography (some of them were slurred with hexane afterward) to afford the final compounds <b>6</b>–<b>9</b> and <b>13</b>.</div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> <i>N</i>-[(1-Benzyl-1<i>H</i>-indol-3-yl)methyl]pyridazin-3-amine (<b>9</b>)</h4><div class="NLM_p last">Following the general procedure for one-pot reductive amination, compound <b>9</b> was obtained from 1-benzyl-1<i>H</i>-indole-3-carbaldehyde (390 mg, 1.66 mmol) and pyridazin-3-amine (316 mg, 3.32 mmol) as an off-white solid (63 mg, 12%). Chromatography, DCM/methanol 96:4; mp, 152–153 °C; <i>R</i><sub>f</sub>, 0.27 (DCM/methanol 95:5). IR (ATR): ν 3248 (NH), 1598, 1509, 1467 (Ar). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 4.69 (d, <i>J</i> = 4.4, 2H, C<u class="uu">H</u><sub>2</sub>NH), 5.19 (br s, 1H, NH), 5.30 (s, 2H, NCH<sub>2</sub>), 6.35 (d, <i>J</i> = 5.8, 1H, H<sub>4</sub>), 7.09–7.16 (m, 4H, H<sub>2′</sub>, H<sub>5′</sub>, H<sub>2″</sub>, H<sub>6″</sub>), 7.19–7.25 (m, 1H, H<sub>6′</sub>), 7.29–7.35 (m, 4H, H<sub>7′</sub>, 3CH<sub>Ph</sub>), 7.63 (d, <i>J</i> = 7.7, 1H, H<sub>4′</sub>), 8.16 (d, <i>J</i> = 4.9, 1H, H<sub>5</sub>), 8.60 (app s, 1H, H<sub>6</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 37.2 (CH<sub>2</sub>NH), 50.2 (NCH<sub>2</sub>), 110.2 (C<sub>7′</sub>), 111.5 (C<sub>3′</sub>), 119.1 (C<sub>4′</sub>), 119.9 (C<sub>5′</sub>), 122.5 (C<sub>6′</sub>), 127.0 (C<sub>2″</sub>, C<sub>6″</sub>), 127.1 (C<sub>2′</sub>), 127.2 (C<sub>3a</sub>), 127.9 (C<sub>4″</sub>), 129.0 (C<sub>3″</sub>, C<sub>5″</sub>), 137.0 (C<sub>7a</sub>), 137.3 (C<sub>1″</sub>), 155.3 (C<sub>5</sub>), 158.8 (C<sub>6</sub>), 161.8 (C<sub>3</sub>), C<sub>4</sub> not observed. HPLC (<i>t</i><sub>R</sub>, min): 17.70. MS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>20</sub>H<sub>19</sub>N<sub>4</sub> ([M + H]<sup>+</sup>) 315.2, found 315.2.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Procedure for Two-Step Reductive Amination</h3><div class="NLM_p"><i>p</i>-Toluenesulfonic acid (0.1 equiv) was added to a solution of 1<i>H</i>-indole-3-carbaldehyde, 1-benzyl-1<i>H</i>-indole-3-carbaldehyde, or intermediates <b>43</b>–<b>46</b> (1.0 equiv) and the corresponding amino <i>N</i>-heterocycle (1.2 equiv) in anhydrous toluene (8 mL/mmol) under an argon atmosphere. The reaction mixture was refluxed for 1–18 h using a Dean–Stark equipment to remove water from the reaction medium. Solvent was concentrated off to afford the corresponding imine, which was used in the next step without further purification.</div><div class="NLM_p">NaBH<sub>4</sub> (2.5 equiv) was added portionwise to a 0 °C cooled solution of the previous imine in methanol (8 mL/mmol). The reaction was allowed to warm up to rt and stirred for 0.25–2 h. Then, the mixture was poured into brine, extracted with DCM (×2), and washed with water. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude was purified by flash chromatography (some of them were slurred with hexane afterward) to afford intermediate <b>42</b> or final compounds <b>10</b>–<b>12</b>, <b>14</b>, and <b>38</b>–<b>41</b>.</div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> <i>N</i>-[(1-Benzyl-1<i>H</i>-indol-3-yl)methyl]pyridin-3-amine (<b>11</b>)</h4><div class="NLM_p last">Following the general procedure for two-step reductive amination, compound <b>11</b> was obtained from 1-benzyl-1<i>H</i>-indole-3-carbaldehyde (500 mg, 2.12 mmol) and pyridin-3-amine (239 mg, 2.54 mmol) as a white solid (488 mg, 73%). Chromatography, hexane/EtOAc from 1:1 to 3:7; mp, 159–160 °C; <i>R</i><sub>f</sub>, 0.31 (hexane/EtOAc 2:8). IR (ATR): ν 3398 (NH), 1585, 1471, 1332 (Ar). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 3.96 (br s, 1H, NH), 4.48 (d, <i>J</i> = 4.1, 2H, CH<sub>2</sub>NH), 5.30 (s, 2H, NCH<sub>2</sub>), 6.96 (ddd, <i>J</i> = 8.2, 2.7, 1.2, 1H, H<sub>4</sub>), 7.08–7.33 (m, 10H, H<sub>5</sub>, 4CH<sub>indole</sub>, 5CH<sub>Ph</sub>), 7.67 (d, <i>J</i> = 7.7, 1H, H<sub>4′</sub>), 7.99 (d, <i>J</i> = 4.5, 1H, H<sub>6</sub>), 8.10 (d, <i>J</i> = 2.5, 1H, H<sub>2</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 39.8 (CH<sub>2</sub>NH), 50.2 (NCH<sub>2</sub>), 110.1 (C<sub>7′</sub>), 112.3 (C<sub>3′</sub>), 118.7 (C<sub>4</sub>), 119.2 (C<sub>4′</sub>), 119.8 (C<sub>5′</sub>), 122.4 (C<sub>6′</sub>), 123.8 (C<sub>5</sub>), 127.0 (C<sub>2″</sub>,C<sub>6″</sub>), 127.1 (C<sub>2′</sub>), 127.4 (C<sub>3a</sub>), 127.9 (C<sub>4″</sub>), 128.9 (C<sub>3″</sub>, C<sub>5″</sub>), 136.3 (C<sub>2</sub>), 137.0 (C<sub>7a</sub>), 137.4 (C<sub>1″</sub>), 138.9 (C<sub>6</sub>), 144.4 (C<sub>3</sub>). HPLC (<i>t</i><sub>R</sub>, min): 19.67. MS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>21</sub>H<sub>20</sub>N<sub>3</sub> ([M + H]<sup>+</sup>) 314.2, found 314.4.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Procedure for N-Alkylation Reaction</h3><div class="NLM_p">To a solution of 1<i>H</i>-indole-3-carbaldehyde or <b>42</b> (1.0 equiv) in anhydrous DMF (15 mL/mmol) under an argon atmosphere, sodium hydride (60% suspension in mineral oil, 1.2 equiv), or Cs<sub>2</sub>CO<sub>3</sub> (3.0 equiv) was added. The mixture was stirred at rt for 15 min, and the corresponding bromoderivative (1.2 equiv) was added. The reaction was stirred at rt for 0.25–2 h, and then it was poured into brine and extracted with Et<sub>2</sub>O or DCM (×2). The combined organic layers were washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. DMF was removed under high vacuum, and the residue was used in the next step without further purification in the case of intermediates <b>43</b>–<b>46</b> or purified by flash chromatography (some of them were slurred with hexane afterward) to afford final compounds <b>15</b>–<b>37</b>.</div><div id="sec4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-{[1-(3-Chlorobenzyl)-1<i>H</i>-indol-3-yl]methyl}pyridin-3-amine (<b>19</b>)</h4><div class="NLM_p last">Following the general procedure for <i>N</i>-alkylation reaction, compound <b>19</b> was obtained from <b>42</b> (260 mg, 1.16 mmol) and 1-(bromomethyl)-3-chlorobenzene (288 mg, 1.40 mmol), using sodium hydride, as a white solid (247 mg, 61%). Chromatography, hexane/EtOAc from 7:3 to 3:7; mp, 136–137 °C; <i>R</i><sub>f</sub>, 0.26 (hexane/EtOAc 2:8). IR (ATR): ν 3398 (NH), 1588, 1481, 1466 (Ar). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 3.99 (br s, 1H, NH), 4.50 (d, <i>J</i> = 2.7, 2H, C<u class="uu">H</u><sub>2</sub>NH), 5.26 (s, 2H, NCH<sub>2</sub>), 6.94–6.98 (m, 2H, H<sub>4</sub>, H<sub>6″</sub>), 7.08–7.29 (m, 8H, H<sub>5</sub>, 4CH<sub>indole</sub>, 3CH<sub>Ph</sub>), 7.67 (d, <i>J</i> = 7.7, 1H, H<sub>4′</sub>), 7.99 (dd, <i>J</i> = 4.6, 0.8, 1H, H<sub>6</sub>), 8.11 (d, <i>J</i> = 2.8, 1H, H<sub>2</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 39.8 (CH<sub>2</sub>NH), 49.6 (NCH<sub>2</sub>), 110.0 (C<sub>7′</sub>), 112.8 (C<sub>3′</sub>), 118.7 (C<sub>4</sub>), 119.3 (C<sub>4′</sub>), 120.0 (C<sub>5′</sub>), 122.6 (C<sub>6′</sub>), 123.9 (C<sub>5</sub>), 125.0 (C<sub>6″</sub>), 126.9, 127.0 (C<sub>2′</sub>, C<sub>2″</sub>), 127.4 (C<sub>3a</sub>), 128.1 (C<sub>5″</sub>), 130.3 (C<sub>4″</sub>), 134.9 (C<sub>3″</sub>), 136.2 (C<sub>2</sub>), 136.9 (C<sub>7a</sub>), 139.0 (C<sub>6</sub>), 139.5 (C<sub>1″</sub>), 144.4 (C<sub>3</sub>). HPLC (<i>t</i><sub>R</sub>, min): 19.77. MS (ESI, <i>m</i>/<i>z</i>): calcd for C<sub>21</sub>H<sub>19</sub>ClN<sub>3</sub>, 348.1 ([M(<sup>35</sup>Cl) + H]<sup>+</sup>), 350.1 ([M(<sup>37</sup>Cl) + H]<sup>+</sup>): found 348.2, 350.2.</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Functional Activity at 5-HT<sub>2</sub> Receptors</h3><div class="NLM_p">IP formation was measured by using the HTRF IP-One assay kit (CisBio, France). Assays were carried out in human 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, and 5-HT<sub>2C</sub> receptors expressed in CHO-K1 (5-HT<sub>2A</sub> and 5-HT<sub>2B</sub>) and HeLa-K1 (5-HT<sub>2C</sub>) cell lines. Cells were seeded (20000 cells/well for 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> and 30000 cells/well for 5-HT<sub>2B</sub>) in a 96-well plate in 100 μL of culture medium (DMEM, 10% FBS, 4 mM <span class="smallcaps smallerCapital">l</span>-glutamine) and maintained at 37 °C in a 5% CO<sub>2</sub> atmosphere for 24 h. After this time, medium was replaced by 50 μL of kit stimulation buffer and compounds (test compound and/or 5-HT) were added to the wells. Cells were incubated for 20 min at 37 °C, and then the IP accumulation was measured by using the kit reagents. HTRF was quantified in an ultraevolution multilabel reader (Tecan M1000 Genius Pro).</div><div class="NLM_p last">Data were normalized to 5-HT maximum effect, and nonlinear regression fitting was performed by using Prism v2.1 (GraphPad software).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Radioligand Binding Assays at 5-HT<sub>2C</sub>R</h3><div class="NLM_p last">Competition radioligand binding assays were carried out by using four different radioligands: [<sup>3</sup>H]mesulergine, [<sup>3</sup>H]serotonin, [<sup>3</sup>H]LSD, and [<sup>3</sup>H]clozapine. 5-HT<sub>2C</sub>–HeLa membrane suspensions (15 μg/well for [<sup>3</sup>H]mesulergine and [<sup>3</sup>H]LSD, 60 μg/well for [<sup>3</sup>H]serotonin and 20 μg/well for [<sup>3</sup>H]clozapine) were incubated with the test compound (10 μM) and radioligand (4 nM [<sup>3</sup>H]mesulergine, 2 nM [<sup>3</sup>H]serotonin, 2 nM [<sup>3</sup>H]LSD, and 15 nM [<sup>3</sup>H]clozapine) in assay buffer (50 mM Tris-HCl, pH = 7.4). The incubation conditions were 60 min at 27 °C for [<sup>3</sup>H]mesulergine, [<sup>3</sup>H]LSD, and [<sup>3</sup>H]clozapine and 180 min at 4 °C for [<sup>3</sup>H]serotonin. Nonspecific binding was determined in the presence of 10 μM mianserin. After the incubation, time samples were filtered through Multiscreen FC 96-well plates (Millipore) and washed four times with wash buffer (50 mM Tris-HCl, pH = 6.6). Radioactivity was detected in a Microbeta Trilux reader (PerkinElmer).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> In Vivo Experiments</h3><div class="NLM_p">For acute experiments, male Wistar rats (Charles Rivers Laboratories, Barcelona, Spain) weighing 200–250 g and aged 10–12 weeks at the beginning of the experiments were used. For subchronic experiments, male Wistar animals were made obese after 8 weeks of treatment with a high fat diet (HFD, 60% fat diet-D12492, Brogaarden, Gentofke, Denmark) containing 5.24 kcal/g (20% of the metabolizable energy content was protein, 20% carbohydrates and 60% fat). When tested for subchronic effects of compound <b>11</b>, animals had an average weight of 548 ± 20 g (see Crespillo et al. for further details).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Animals were housed in groups of two in a humidity- and temperature-controlled (22 °C) vivarium on a 12:12 h light–dark cycle (lights off at 8 PM). Water and standard laboratory chow were available ad libitum throughout the course of the studies unless otherwise indicated (e.g., in the diet-induced obesity procedure). All procedures were conducted in adherence to the European Communities Council Directive (86/609/ECC) and Spanish regulations (BOE 252/34367-91, 2005) for the use of laboratory animals. They were reviewed and approved by the Comisión de Ética e Investigación, Hospital Carlos Haya, Málaga (Spain). Procedures can be found in Gomez et al.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> All data are shown as mean ± SEM of at least eight determinations per experimental group. Kolmogorov–Smirnov normality tests indicated that all data followed a Gaussian distribution (<i>P</i> > 0.1), so we selected a parametric statistical test. Differences between the treatments and time of testing (along 7-day testing) were analyzed by two-way ANOVA for repeated measures, followed by Bonferroni post hoc test for multiple comparisons. The level of statistical significance was set at <i>P</i> < 0.05. Details on the methodology can be found on Crespillo et al.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div id="sec4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Acute Feeding Suppression</h4><div class="NLM_p last">Adult rats were food deprived for 16 h prior to refeeding to habituate the animals to the procedure. On the testing day, and after food deprivation, compound <b>11</b> was ip injected at the doses of 0.5, 2, and 10 mg/kg dissolved in sterile saline. Food and water intake were then measured at 30, 60, 120, and 240 min after the presentation of food. The 5-HT<sub>2C</sub>R agonist <b>47</b> (doses of 0.2 and 2 mg/kg, ip) was also tested for comparison of the acute suppression effect. In additional experiments, animals were pretreated with the inhibitor of the serotonin reuptake system sertraline (doses of 0.4, 2, 5, and 10 mg/kg), the 5-HT<sub>2A</sub>R antagonist ketanserin (2 mg/kg), or the 5-HT<sub>2C</sub>R antagonist <b>48</b> (3 mg/kg), all purchased from Tocris Cookson (Bristol, UK), that were ip injected 30 min prior to <b>11</b>, and the suppression effect was also analyzed.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Repeated Administration under Continuous Food Access</h4><div class="NLM_p last">To assess the subchronic (7-day treatment) effect of <b>11</b>, free-feeding rats were injected daily with the compound (2 mg/kg, ip) or vehicle. The amount of standard laboratory chow (3.02 kcal/g with 30 kcal% proteins, 55 kcal% carbohydrates, and 15 kcal% fat) eaten (kcal/kg body weight) and the body weight gain (g) were registered daily.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Repeated Administration under Food Restriction Schedule</h4><div class="NLM_p last">Animals were presented with food for 4 h a day. Once the 4 h period was over, food was retired until the next day. When a stable baseline of feeding was achieved, <b>11</b> (2 mg/kg, ip) or vehicle was injected 30 min prior to food presentation, and food and water intakes were measured at the end of the 4 h period. The procedure was repeated for 7 consecutive days, and total food intake and body weight were monitored.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Elevated Plus Maze</h4><div class="NLM_p last">Animals naïve to the maze were manipulated for 7 days before testing. The day of the experiment, 30 min after the ip injection of <b>11</b>, animals were placed in the center of the maze, facing an open arm. The number of entries and the % of time spent in the exposed arms of the maze were measured. Test length was 5 min, and animals were not retested (for details see Rodriguez de Fonseca et al. 2001).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Open Field</h4><div class="NLM_p last">Animals naïve to the open field were manipulated for 7 days before testing. The day of the experiment, 30 min after the injection of <b>11</b> (2 mg/kg, ip), animals were placed in the center of the maze and the distance walked registered through an automated procedure.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Test length was 10 min, and animals were not retested.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Conditioned Taste Aversion</h4><div class="NLM_p last">Rats were deprived of water for 24 h and then accustomed to drinking from a graded bottle during a 30 min test period for 4 days. On day 5, water was replaced with a 0.1% saccharin solution, and 30 min later the animals received ip injections of vehicle, <b>11</b> (2 mg/kg), or lithium chloride (0.4 M, 7.5 mL/kg). During the following 2 days, water consumption was recorded over 30 min test periods. The animals were then presented with water or saccharin, and drinking was finally measured.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00994">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00994" class="ext-link">10.1021/acs.jmedchem.7b00994</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthesis and characterization data of compounds <b>6</b>–<b>8</b>, <b>10</b>, <b>12</b>–<b>18</b>, and <b>20</b>–<b>42</b>; HPLC-MS purity analyses of final compounds <b>6</b>–<b>41</b>; molecular formula strings for compounds <b>1</b>–<b>48</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00994/suppl_file/jm7b00994_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00994/suppl_file/jm7b00994_si_001.pdf">jm7b00994_si_001.pdf (649.38 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00994" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41431" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41431" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernando Rodríguez de Fonseca</span> - <span class="hlFld-Affiliation affiliation">Unidad
de Gestión Clínica de Salud Mental, Instituto IBIMA, Hospital Regional Universitario, E-29010 Málaga, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#422427302c232c262d6c302d26302b25372738022b202b2f236c2737"><span class="__cf_email__" data-cfemail="fa9c9f88949b949e95d488959e88939d8f9f80ba939893979bd49f8f">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María L. López-Rodríguez</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Universidad
Complutense de Madrid, E-28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8607-1085" title="Orcid link">http://orcid.org/0000-0001-8607-1085</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e48988919e8896a4918789ca8197"><span class="__cf_email__" data-cfemail="711c1d040b1d033104121c5f1402">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Javier García-Cárceles</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Universidad
Complutense de Madrid, E-28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4614-9639" title="Orcid link">http://orcid.org/0000-0003-4614-9639</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juan M. Decara</span> - <span class="hlFld-Affiliation affiliation">Unidad
de Gestión Clínica de Salud Mental, Instituto IBIMA, Hospital Regional Universitario, E-29010 Málaga, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henar Vázquez-Villa</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Universidad
Complutense de Madrid, E-28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7911-3160" title="Orcid link">http://orcid.org/0000-0001-7911-3160</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramón Rodríguez</span> - <span class="hlFld-Affiliation affiliation">Galchimia, E-15823 O Pino, A Coruña, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eva Codesido</span> - <span class="hlFld-Affiliation affiliation">Galchimia, E-15823 O Pino, A Coruña, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacobo Cruces</span> - <span class="hlFld-Affiliation affiliation">Galchimia, E-15823 O Pino, A Coruña, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Brea</span> - <span class="hlFld-Affiliation affiliation">Biofarma
Research Group, USEF Screening Platform, CIMUS, USC, E-15782 Santiago de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María I. Loza</span> - <span class="hlFld-Affiliation affiliation">Biofarma
Research Group, USEF Screening Platform, CIMUS, USC, E-15782 Santiago de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco Alén</span> - <span class="hlFld-Affiliation affiliation">Unidad
de Gestión Clínica de Salud Mental, Instituto IBIMA, Hospital Regional Universitario, E-29010 Málaga, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joaquin Botta</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, University of East Anglia, NR4 7TJ Norwich, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter J. McCormick</span> - <span class="hlFld-Affiliation affiliation">School of
Veterinary Medicine, University of Surrey, GU2 7XH Guildford, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juan A. Ballesteros</span> - <span class="hlFld-Affiliation affiliation">Vivia
Biotech S.L., Parque
Científico de Madrid, E-28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bellinda Benhamú</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Química Orgánica I, Universidad
Complutense de Madrid, E-28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0864-026X" title="Orcid link">http://orcid.org/0000-0002-0864-026X</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.G.-C. and J.M.D. share first authorship of this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d128e2603-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants from MINECO (SAF2013-48271-C2, SAF2014-57138-C2-2-R, SAF2016-78792-R, and INNPACTO 01/12-CL-0-12-09), CAM (S2010/BMD2353), Xunta de Galicia (GRC2014/011), Junta de Andalucía (CTS-8221 and CTS-433), and European Regional Development Fund (ERDF). J.G.-C. is grateful to MINECO for a predoctoral fellowship. We thank the NMR Core Facilities from Universidad Complutense de Madrid.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i32" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i32"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i33" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i33"> Abbreviations Used</h2><tr><td class="NLM_term">5-HT<sub>2A</sub>R</td><td class="NLM_def"><p class="first last">5-HT<sub>2B</sub> receptor</p></td></tr><tr><td class="NLM_term">5-HT<sub>2B</sub>R</td><td class="NLM_def"><p class="first last">5-HT<sub>2B</sub> receptor</p></td></tr><tr><td class="NLM_term">5-HT<sub>2C</sub>R</td><td class="NLM_def"><p class="first last">5-HT<sub>2C</sub> receptor</p></td></tr><tr><td class="NLM_term">EC<sub>25</sub></td><td class="NLM_def"><p class="first last">25% of the maximal effective concentration</p></td></tr><tr><td class="NLM_term"><i>E</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximal effect</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence energy transfer</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">inositol monophosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span> </span><span class="NLM_article-title">Overweight and obesity</span>. Global Health Observatory (GHO) Data; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span><a href="http://www.who.int/gho/ncd/risk_factors/overweight_text/en/" class="extLink">http://www.who.int/gho/ncd/risk_factors/overweight_text/en/</a> (Sep 25, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Overweight+and+obesity.+Global+Health+Observatory+%28GHO%29+Data%3B+World+Health+Organization%3A+Geneva%2C+2017%3B+http%3A%2F%2Fwww.who.int%2Fgho%2Fncd%2Frisk_factors%2Foverweight_text%2Fen%2F+%28Sep+25%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DOverweight%2520and%2520obesity%26jtitle%3DGlobal%2520Health%2520Observatory%2520%2528GHO%2529%2520Data%26pub%3DWorld%2520Health%2520Organization%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Marseglia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Angelo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicotera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Rosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigo, T.</span><span> </span><span class="NLM_article-title">Oxidative Stress in Obesity: A critical component in human diseases</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.3390/ijms16010378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.3390%2Fijms16010378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlKiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=378-400&author=L.+Marsegliaauthor=S.+Mantiauthor=G.+D%E2%80%99Angeloauthor=A.+Nicoteraauthor=E.+Parisiauthor=G.+Di+Rosaauthor=E.+Gittoauthor=T.+Arrigo&title=Oxidative+Stress+in+Obesity%3A+A+critical+component+in+human+diseases&doi=10.3390%2Fijms16010378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress in obesity: a critical component in human diseases</span></div><div class="casAuthors">Marseglia, Lucia; Manti, Sara; D'Angelo, Gabriella; Nicotera, Antonio; Parisi, Eleonora; Di Rosa, Gabriella; Gitto, Eloisa; Arrigo, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">378-400, 23 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Obesity, a social problem worldwide, is characterized by an increase in body wt. that results in excessive fat accumulation.  Obesity is a major cause of morbidity and mortality and leads to several diseases, including metabolic syndrome, diabetes mellitus, cardiovascular, fatty liver diseases, and cancer.  Growing evidence allows us to understand the crit. role of adipose tissue in controlling the physic-pathol. mechanisms of obesity and related comorbidities.  Recently, adipose tissue, esp. in the visceral compartment, has been considered not only as a simple energy depository tissue, but also as an active endocrine organ releasing a variety of biol. active mols. known as adipocytokines or adipokines.  Based on the complex interplay between adipokines, obesity is also characterized by chronic low grade inflammation with permanently increased oxidative stress (OS).  Over-expression of oxidative stress damages cellular structures together with under-prodn. of anti-oxidant mechanisms, leading to the development of obesity-related complications.  The aim of this review is to summarize what is known in the relationship between OS in obesity and obesity-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSjsR0zOPwTLVg90H21EOLACvtfcHk0li_v4kEApiaUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlKiug%253D%253D&md5=47a74f93ffd527c3f910745104a69937</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3390%2Fijms16010378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms16010378%26sid%3Dliteratum%253Aachs%26aulast%3DMarseglia%26aufirst%3DL.%26aulast%3DManti%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DG.%26aulast%3DNicotera%26aufirst%3DA.%26aulast%3DParisi%26aufirst%3DE.%26aulast%3DDi%2BRosa%26aufirst%3DG.%26aulast%3DGitto%26aufirst%3DE.%26aulast%3DArrigo%26aufirst%3DT.%26atitle%3DOxidative%2520Stress%2520in%2520Obesity%253A%2520A%2520critical%2520component%2520in%2520human%2520diseases%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2015%26volume%3D16%26spage%3D378%26epage%3D400%26doi%3D10.3390%2Fijms16010378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Colman, E.</span><span> </span><span class="NLM_article-title">Food and Drug Administration’s obesity drug guidance document: a short history</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">2156</span><span class="NLM_x">–</span> <span class="NLM_lpage">2164</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.111.028381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1161%2FCIRCULATIONAHA.111.028381" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=2156-2164&author=E.+Colman&title=Food+and+Drug+Administration%E2%80%99s+obesity+drug+guidance+document%3A+a+short+history&doi=10.1161%2FCIRCULATIONAHA.111.028381"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.111.028381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.111.028381%26sid%3Dliteratum%253Aachs%26aulast%3DColman%26aufirst%3DE.%26atitle%3DFood%2520and%2520Drug%2520Administration%25E2%2580%2599s%2520obesity%2520drug%2520guidance%2520document%253A%2520a%2520short%2520history%26jtitle%3DCirculation%26date%3D2012%26volume%3D125%26spage%3D2156%26epage%3D2164%26doi%3D10.1161%2FCIRCULATIONAHA.111.028381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Rodríguez, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, K. M.</span><span> </span><span class="NLM_article-title">Past, present, and future of pharmacologic therapy in obesity</span> <span class="citation_source-journal">Prim. Care Clin. Office Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1016/j.pop.2015.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.pop.2015.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=26896200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A280%3ADC%252BC28jis12qtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2016&pages=61-67&author=J.+E.+Rodr%C3%ADguezauthor=K.+M.+Campbell&title=Past%2C+present%2C+and+future+of+pharmacologic+therapy+in+obesity&doi=10.1016%2Fj.pop.2015.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Past, Present, and Future of Pharmacologic Therapy in Obesity</span></div><div class="casAuthors">Rodriguez Jose E; Campbell Kendall M</div><div class="citationInfo"><span class="NLM_cas:title">Primary care</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-7, viii</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Medications for obesity management can be divided into 4 groups: antidepressants (naltrexone/bupropion), stimulants (phentermine, phendimetrazine, diethylpropion, phentermine/topiramate), fat blockers (orlistat), and diabetes medications (liraglutide).  Each group has specific therapeutic effects, adverse effects, and costs.  Two medications are indicated for long-term use in obesity: lorcaserin and orlistat.  Other available medications are for short-term use.  High cost makes many of these medications inaccessible for underserved and poor patients.  Because of misuse potential, many obesity medications are also classified as controlled substances.  There are no medications currently approved for use in pregnant or lactating women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFDeXC2zSiSENHe_gFldTbfW6udTcc2eYuaPkmRvJMQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jis12qtQ%253D%253D&md5=8cea992350a28916c2f2e31fc24eb535</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pop.2015.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pop.2015.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DJ.%2BE.%26aulast%3DCampbell%26aufirst%3DK.%2BM.%26atitle%3DPast%252C%2520present%252C%2520and%2520future%2520of%2520pharmacologic%2520therapy%2520in%2520obesity%26jtitle%3DPrim.%2520Care%2520Clin.%2520Office%2520Pract.%26date%3D2016%26volume%3D43%26spage%3D61%26epage%3D67%26doi%3D10.1016%2Fj.pop.2015.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Narayanaswami, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwoskin, L. P.</span><span> </span><span class="NLM_article-title">Obesity: Current and potential pharmacotherapeutics and targets</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.pharmthera.2016.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=27773782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslelsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2017&pages=116-147&author=V.+Narayanaswamiauthor=L.+P.+Dwoskin&title=Obesity%3A+Current+and+potential+pharmacotherapeutics+and+targets&doi=10.1016%2Fj.pharmthera.2016.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Obesity: Current and potential pharmacotherapeutics and targets</span></div><div class="casAuthors">Narayanaswami, Vidya; Dwoskin, Linda P.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">116-147</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Obesity is a global epidemic that contributes to a no. of health complications including cardiovascular disease, type 2 diabetes, cancer and neuropsychiatric disorders.  Pharmacotherapeutic strategies to treat obesity are urgently needed.  Research over the past two decades has increased substantially our knowledge of central and peripheral mechanisms underlying homeostatic energy balance.  Homeostatic mechanisms involve multiple components including neuronal circuits, some originating in hypothalamus and brain stem, as well as peripherally-derived satiety, hunger and adiposity signals that modulate neural activity and regulate eating behavior.  Dysregulation of one or more of these homeostatic components results in obesity.  Coincident with obesity, reward mechanisms that regulate hedonic aspects of food intake override the homeostatic regulation of eating.  In addn. to functional interactions between homeostatic and reward systems in the regulation of food intake, homeostatic signals have the ability to alter vulnerability to drug abuse.  Regarding the treatment of obesity, pharmacol. monotherapies primarily focus on a single protein target.  FDA-approved monotherapy options include phentermine (Adipex-P), orlistat (Xenical), lorcaserin (Belviq) and liraglutide (Saxenda).  However, monotherapies have limited efficacy, in part due to the recruitment of alternate and counter-regulatory pathways.  Consequently, a multi-target approach may provide greater benefit.  Recently, two combination products have been approved by the FDA to treat obesity, including phentermine/topiramate (Qsymia) and naltrexone/bupropion (Contrave).  The current review provides an overview of homeostatic and reward mechanisms that regulate energy balance, potential therapeutic targets for obesity and current treatment options, including some candidate therapeutics in clin. development.  Finally, challenges in anti-obesity drug development are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpId6VccvHlSrVg90H21EOLACvtfcHk0liO8Oz0jq7p5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslelsL7M&md5=f634c2c8f018cdbbcbf5c016221ef751</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DNarayanaswami%26aufirst%3DV.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DObesity%253A%2520Current%2520and%2520potential%2520pharmacotherapeutics%2520and%2520targets%26jtitle%3DPharmacol.%2520Ther.%26date%3D2017%26volume%3D170%26spage%3D116%26epage%3D147%26doi%3D10.1016%2Fj.pharmthera.2016.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Halford, J. C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrold, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, J. E.</span><span> </span><span class="NLM_article-title">Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.2174/1389450053174550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.2174%2F1389450053174550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=15777190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVSqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=201-213&author=J.+C.+G.+Halfordauthor=J.+A.+Harroldauthor=C.+L.+Lawtonauthor=J.+E.+Blundell&title=Serotonin+%285-HT%29+drugs%3A+effects+on+appetite+expression+and+use+for+the+treatment+of+obesity&doi=10.2174%2F1389450053174550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity</span></div><div class="casAuthors">Halford, Jason C. G.; Harrold, Joanne A.; Lawton, Clare L.; Blundell, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-213</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The pivotal role of 5-HT in the control of appetite was formally proposed nearly 30 years ago.  In particular endogenous hypothalamic 5-HT was implicated in the processes of within meal satiation and the end state of post meal satiety.  Of the numerous 5-HT receptor subtypes currently identified, 5-HT1B and 5-HT2C receptors are believed to mediate the 5-HT induced satiety.  5-HT drugs such as d-fenfluramine, selective serotoninergic reuptake inhibitor (SSRIs) and 5-HT2C receptor agonists have all been shown to significantly attenuate rodent body wt. gain, an effect strongly assocd. with marked hypophagia.  D-Fenfluramine, sibutramine, fluoxetine and the 5-HT2C receptor agonist mCPP have also all been shown to reduce caloric intake by modifying appetite in both lean and obese humans.  Specifically, 5-HT drugs reduce appetite prior to and after the consumption of fixed caloric loads, and reduce pre meal appetite and caloric intake at ad libitum meals.  Clin. significant wt. loss over a year or more can be produced by both d-fenfluramine and sibutramine treatment, but apparently not by the SSRI fluoxetine.  Treatment with the preferential 5-HT2C receptor agonist mCPP and the serotonin precursor 5-HTP was also shown to produce wt. loss in the obese.  Issues around the actual and possible side effects of these compds., and in the case of d-fenfluramine toxicity, have led to a search for drugs that act selectively on the CNS 5-HT receptors crit. to the satiety response.  Currently, a new generation of 5-HT2C selective agonists were developed (including Ro 60-0175, Org 12962, VER-3323, BVT-933 and YM348) and at least one, ADP356, is currently undergoing clin. trials.  Hopefully, such drugs will be as or even more effective at regulating appetite and controlling body wt., and will also be free of their predecessors' side effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMX0O68S7bxLVg90H21EOLACvtfcHk0liO8Oz0jq7p5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVSqu74%253D&md5=ad765430cb2787564d02aad590309068</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1389450053174550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450053174550%26sid%3Dliteratum%253Aachs%26aulast%3DHalford%26aufirst%3DJ.%2BC.%2BG.%26aulast%3DHarrold%26aufirst%3DJ.%2BA.%26aulast%3DLawton%26aufirst%3DC.%2BL.%26aulast%3DBlundell%26aufirst%3DJ.%2BE.%26atitle%3DSerotonin%2520%25285-HT%2529%2520drugs%253A%2520effects%2520on%2520appetite%2520expression%2520and%2520use%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2005%26volume%3D6%26spage%3D201%26epage%3D213%26doi%3D10.2174%2F1389450053174550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Sargent, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, A. J.</span><span> </span><span class="NLM_article-title">Targeting 5-HT receptors for the treatment of obesity</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1016/j.coph.2011.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.coph.2011.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=21330209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1Wqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=52-58&author=B.+J.+Sargentauthor=A.+J.+Henderson&title=Targeting+5-HT+receptors+for+the+treatment+of+obesity&doi=10.1016%2Fj.coph.2011.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting 5-HT receptors for the treatment of obesity</span></div><div class="casAuthors">Sargent, Bruce J.; Henderson, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-58</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin is known to have anorectic properties through centrally acting mechanisms.  Three serotonin receptors have been implicated in mediating these effects: 5-HT1B, 5-HT2C and 5-HT6.  Hypophagic effects are elicited through agonism of the former two receptors, whereas antagonism of the 5-HT6 receptor appears to have an anorectic effect.  All three targets have been validated through extensive studies including knockout mice and selective ligand assessment.  5-HT1B receptor agonists have limited utility due to mechanism-based side effects, whereas 5-HT2C receptor agonists suffer from challenges assocd. with selectivity over the closely related 5-HT2A and 5-HT2B receptors.  5-HT6 receptor antagonists appear to offer great promise, although the mechanisms through which they reduce food intake and body wt. are not fully understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7HpGhwkLC1LVg90H21EOLACvtfcHk0liO8Oz0jq7p5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1Wqs70%253D&md5=6f7344a29e985af4a08d76626dc6d8f9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2011.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2011.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DSargent%26aufirst%3DB.%2BJ.%26aulast%3DHenderson%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%25205-HT%2520receptors%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2011%26volume%3D11%26spage%3D52%26epage%3D58%26doi%3D10.1016%2Fj.coph.2011.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Benhamu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Fontecha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez-Villa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Rodriguez, M. L.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>6</sub> receptor antagonists for the treatment of cognitive deficiency in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7160</span><span class="NLM_x">–</span> <span class="NLM_lpage">7181</span><span class="refDoi"> DOI: 10.1021/jm5003952</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5003952" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVWjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7160-7181&author=B.+Benhamuauthor=M.+Martin-Fontechaauthor=H.+Vazquez-Villaauthor=L.+Pardoauthor=M.+L.+Lopez-Rodriguez&title=Serotonin+5-HT6+receptor+antagonists+for+the+treatment+of+cognitive+deficiency+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm5003952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT6 Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer's Disease</span></div><div class="casAuthors">Benhamu, Bellinda; Martin-Fontecha, Mar; Vazquez-Villa, Henar; Pardo, Leonardo; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7160-7181</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is one of the most frequent causes of death and disability worldwide and has a significant clin. and socioeconomic impact.  In the search for novel therapeutic strategies, serotonin 5-HT6 receptor (5-HT6R) has been proposed as a promising drug target for cognition enhancement in AD.  This manuscript reviews the compelling evidence for the implication of this receptor in learning and memory processes.  We have summarized the current status of the medicinal chem. of 5-HT6R antagonists and the encouraging preclin. findings that demonstrate their significant procognitive behavioral effects in a no. of learning paradigms, probably acting through modulation of multiple neurotransmitter systems and signaling pathways.  The results of the ongoing clin. trials are eagerly awaited to shed some light on the validation of 5-HT6R antagonists as a new drug class for the treatment of symptomatic cognitive impairment in AD, either as stand-alone therapy or in combination with established agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeTO6_2THvaLVg90H21EOLACvtfcHk0ljMwfs3qdQMKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVWjs7c%253D&md5=bf8d2cba73f72e04a5caf8b295647064</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm5003952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5003952%26sid%3Dliteratum%253Aachs%26aulast%3DBenhamu%26aufirst%3DB.%26aulast%3DMartin-Fontecha%26aufirst%3DM.%26aulast%3DVazquez-Villa%26aufirst%3DH.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26atitle%3DSerotonin%25205-HT6%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520cognitive%2520deficiency%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7160%26epage%3D7181%26doi%3D10.1021%2Fjm5003952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fozard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartig, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mylecharane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, P. P. A.,  VII.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology classification of receptors for 5-hydroxytriptamine (serotonin)</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=157-203&author=D.+Hoyerauthor=D.+E.+Clarkeauthor=J.+R.+Fozardauthor=P.+R.+Hartigauthor=G.+R.+Martinauthor=E.+J.+Mylecharaneauthor=P.+R.+Saxenaauthor=P.+P.+A.+Humphrey&title=International+Union+of+Pharmacology+classification+of+receptors+for+5-hydroxytriptamine+%28serotonin%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DD.%2BE.%26aulast%3DFozard%26aufirst%3DJ.%2BR.%26aulast%3DHartig%26aufirst%3DP.%2BR.%26aulast%3DMartin%26aufirst%3DG.%2BR.%26aulast%3DMylecharane%26aufirst%3DE.%2BJ.%26aulast%3DSaxena%26aufirst%3DP.%2BR.%26aulast%3DHumphrey%26aufirst%3DP.%2BP.%2BA.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology%2520classification%2520of%2520receptors%2520for%25205-hydroxytriptamine%2520%2528serotonin%2529%26jtitle%3DPharmacol.%2520Rev.%26date%3D1994%26volume%3D46%26spage%3D157%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Göthert, M.</span><span> </span><span class="NLM_article-title">Serotonin discovery and stepwise disclosure of 5-HT receptor complexity over four decades. Part I. General background and discovery of serotonin as a basis for 5-HT receptor identification</span> <span class="citation_source-journal">Pharmacol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span><span class="refDoi"> DOI: 10.1016/S1734-1140(13)71059-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2FS1734-1140%2813%2971059-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=24145072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FoslSksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=771-786&author=M.+G%C3%B6thert&title=Serotonin+discovery+and+stepwise+disclosure+of+5-HT+receptor+complexity+over+four+decades.+Part+I.+General+background+and+discovery+of+serotonin+as+a+basis+for+5-HT+receptor+identification&doi=10.1016%2FS1734-1140%2813%2971059-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin discovery and stepwise disclosure of 5-HT receptor complexity over four decades. Part I. General background and discovery of serotonin as a basis for 5-HT receptor identification</span></div><div class="casAuthors">Gothert Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological reports : PR</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">771-86</span>
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    </div><div class="casAbstract">This review contains background information on the serotonin system, furthermore the suggestion to introduce the term Contemporary Witness Report (CWR) for a novel type of review and, as the main part, an overview over the history of serotonin discovery as a basis for the identification of its receptor heterogeneity and the increase in complexity by genetic and allosteric variation.  The present article conforms to CWRs in historical and autobiographical elements, in more emphasis on the author's work than in conventional reviews and in aspects neglected in previous reviews, but not in the main feature namely the work of a scientist with comprehensive expertise in a field in which, over long time, he/she continuously performed research and published.  A scientist complying with these requirements is a contemporary witness in that field.  His report on the scientific achievements in that period, a CWR, comprises confirmation and putative re-interpretation of data from a superior viewpoint.  Identification of serotonin's vascular properties (publication year: 1912) as an "adrenaline mimicking substance" (without attempt to isolate it) by O'Connor preceded the discovery of serotonin in the gastrointestinal tract by Erspamer [1937] and in blood by Rapport [1948, 1949], who identified its structure as 5-hydroxytryptamine [1949].  Detection as a neurotransmitter in invertebrates suggested its occurrence in vertebrate CNS as well.  This was verified by finding it in dog, rat and rabbit brain [1953].  The Falck-Hillarp technique [1962] visualized serotonin neurones as fluorescent structures.  The neurotoxin 5,7-dihydroxytryptamine [1972] indirectly proved the involvement of 5-HT in multiple CNS functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8YM4IM1P4MmK_SFaaT9INfW6udTcc2eaUswhpeFO84rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FoslSksw%253D%253D&md5=b0ccd66eefde0739af8f71b433e76126</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1734-1140%2813%2971059-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1734-1140%252813%252971059-4%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6thert%26aufirst%3DM.%26atitle%3DSerotonin%2520discovery%2520and%2520stepwise%2520disclosure%2520of%25205-HT%2520receptor%2520complexity%2520over%2520four%2520decades.%2520Part%2520I.%2520General%2520background%2520and%2520discovery%2520of%2520serotonin%2520as%2520a%2520basis%2520for%25205-HT%2520receptor%2520identification%26jtitle%3DPharmacol.%2520Rep.%26date%3D2013%26volume%3D65%26spage%3D771%26epage%3D786%26doi%3D10.1016%2FS1734-1140%2813%2971059-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">McCorvy, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Structure and function of serotonin G protein-coupled receptors</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.pharmthera.2015.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=25601315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVeisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2015&pages=129-142&author=J.+D.+McCorvyauthor=B.+L.+Roth&title=Structure+and+function+of+serotonin+G+protein-coupled+receptors&doi=10.1016%2Fj.pharmthera.2015.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of serotonin G protein-coupled receptors</span></div><div class="casAuthors">McCorvy, John D.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">129-142</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Serotonin receptors are prevalent throughout the nervous system and the periphery, and remain one of the most lucrative and promising drug discovery targets for disorders ranging from migraine headaches to neuropsychiatric disorders such as schizophrenia and depression.  There are 14 distinct serotonin receptors, of which 13 are G protein-coupled receptors (GPCRs), which are targets for approx. 40% of the approved medicines.  Recent crystallog. and biochem. evidence has provided a converging understanding of the basic structure and functional mechanics of GPCR activation.  Currently, two GPCR crystal structures exist for the serotonin family, the 5-HT1B and 5-HT2B receptor, with the antimigraine and valvulopathic drug ergotamine bound.  The first serotonin crystal structures not only provide the first evidence of serotonin receptor topog. but also provide mechanistic explanations into functional selectivity or biased agonism.  This review will detail the findings of these crystal structures from a mol. and mutagenesis perspective for driving rational drug design for novel therapeutics incorporating biased signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpapliz37oS9bVg90H21EOLACvtfcHk0ljMwfs3qdQMKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVeisbs%253D&md5=0fcfbc57dfb7047f6ffb7c74d437b5b4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure%2520and%2520function%2520of%2520serotonin%2520G%2520protein-coupled%2520receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D150%26spage%3D129%26epage%3D142%26doi%3D10.1016%2Fj.pharmthera.2015.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannon, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G. R.</span><span> </span><span class="NLM_article-title">Molecular, pharmacological and functional diversity of 5-HT receptors</span> <span class="citation_source-journal">Pharmacol. Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span><span class="refDoi"> DOI: 10.1016/S0091-3057(01)00746-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2FS0091-3057%2801%2900746-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=11888546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvVChtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=533-554&author=D.+Hoyerauthor=J.+P.+Hannonauthor=G.+R.+Martin&title=Molecular%2C+pharmacological+and+functional+diversity+of+5-HT+receptors&doi=10.1016%2FS0091-3057%2801%2900746-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular, pharmacological and functional diversity of 5-HT receptors</span></div><div class="casAuthors">Hoyer, Daniel; Hannon, Jason P.; Martin, Graeme R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">533-554</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Serotonin (5-hydroxytryptamine, 5-HT) is probably unique among the monoamines in that its effects are subserved by as many as 13 distinct heptahelical, G-protein-coupled receptors (GPCRs) and one (presumably a family of) ligand-gated ion channel(s).  These receptors are divided into seven distinct classes (5-HT1 to 5-HT7) largely on the basis of their structural and operational characteristics.  While this degree of phys. diversity clearly underscores the physiol. importance of serotonin, evidence for an even greater degree of operational diversity continues to emerge.  The challenge for modern 5-HT research has therefore been to define more precisely the properties of the systems that make this incredible diversity possible.  Much progress in this regard has been made during the last decade with the realization that serotonin is possibly the least conservative monoamine transmitter and the cloning of its many receptors.  Coupled with the actions of an extremely avid and efficient reuptake system, this array of receptor subtypes provides almost limitless signaling capabilities to the extent that one might even question the need for other transmitter systems.  However, the complexity of the system appears endless, since posttranslational modifications, such as alternate splicing and RNA editing, increase the no. of proteins, oligomerization and heteromerization increase the no. of complexes, and multiple G-protein suggest receptor trafficking, allowing phenotypic switching and crosstalk within and possibly between receptor families.  Whether all these possibilities are used in vivo under physiol. or pathol. conditions remains to be firmly established, but in essence, such variety will keep the 5-HT community busy for quite some time.  Those who may have predicted that mol. biol. would largely simplify the life of pharmacologists have missed the point for 5-HT research in particular and, most probably, for many other transmitters.  This chapter is an attempt to summarize very briefly 5-HT receptor diversity.  The reward for unraveling this complex array of serotonin receptor-effector systems may be substantial, the ultimate prize being the development of important new drugs in a range of disease areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3Nndw8IzJXLVg90H21EOLACvtfcHk0lhs-LYQb-UcVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvVChtb4%253D&md5=2fd7e3ea62256c616688b45794a7606a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2801%2900746-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252801%252900746-8%26sid%3Dliteratum%253Aachs%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DHannon%26aufirst%3DJ.%2BP.%26aulast%3DMartin%26aufirst%3DG.%2BR.%26atitle%3DMolecular%252C%2520pharmacological%2520and%2520functional%2520diversity%2520of%25205-HT%2520receptors%26jtitle%3DPharmacol.%2520Biochem.%2520Behav.%26date%3D2002%26volume%3D71%26spage%3D533%26epage%3D554%26doi%3D10.1016%2FS0091-3057%2801%2900746-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cremers, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotty, F.</span><span> </span><span class="NLM_article-title">Therapeutic potential of 5-HT<sub>2C</sub> receptor ligands</span> <span class="citation_source-journal">Sci. World J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1870</span><span class="NLM_x">–</span> <span class="NLM_lpage">1885</span><span class="refDoi"> DOI: 10.1100/tsw.2010.180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1100%2Ftsw.2010.180" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1870-1885&author=N.+H.+Jensenauthor=T.+I.+Cremersauthor=F.+Sotty&title=Therapeutic+potential+of+5-HT2C+receptor+ligands&doi=10.1100%2Ftsw.2010.180"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1100%2Ftsw.2010.180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1100%252Ftsw.2010.180%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DCremers%26aufirst%3DT.%2BI.%26aulast%3DSotty%26aufirst%3DF.%26atitle%3DTherapeutic%2520potential%2520of%25205-HT2C%2520receptor%2520ligands%26jtitle%3DSci.%2520World%2520J.%26date%3D2010%26volume%3D10%26spage%3D1870%26epage%3D1885%26doi%3D10.1100%2Ftsw.2010.180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, P. J.</span><span> </span><span class="NLM_article-title">From obesity to substance abuse: therapeutic opportunities for 5-HT<sub>2C</sub> receptor agonists</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1016/j.tips.2013.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.tips.2013.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=24041919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCltLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=560-570&author=G.+A.+Higginsauthor=E.+M.+Sellersauthor=P.+J.+Fletcher&title=From+obesity+to+substance+abuse%3A+therapeutic+opportunities+for+5-HT2C+receptor+agonists&doi=10.1016%2Fj.tips.2013.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists</span></div><div class="casAuthors">Higgins, Guy A.; Sellers, Edward M.; Fletcher, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">560-570</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent US Food and Drug Administration (FDA) approval of the serotonin (5-hydroxytryptamine, 5-HT) 5-HT2C receptor agonist lorcaserin for the treatment of obesity represents a new therapeutic drug class available to the clinic.  Preclin. evidence supports the potential for this drug class to treat other related conditions such as substance abuse.  In the present article we review this evidence and further suggest that overlapping neurobiol. systems may contribute to an anti-addictive and anti-obesity profile.  The availability of selective 5-HT2C agonists provides an opportunity to evaluate their potential as treatments for nicotine dependence or psychostimulant abuse, conditions for which there is significant medical need but only limited available treatment options.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjiS3n6R_5trVg90H21EOLACvtfcHk0lhs-LYQb-UcVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCltLzK&md5=cf21273e52cb1ba62821886489381717</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DSellers%26aufirst%3DE.%2BM.%26aulast%3DFletcher%26aufirst%3DP.%2BJ.%26atitle%3DFrom%2520obesity%2520to%2520substance%2520abuse%253A%2520therapeutic%2520opportunities%2520for%25205-HT2C%2520receptor%2520agonists%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D560%26epage%3D570%26doi%3D10.1016%2Fj.tips.2013.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Di Giovanni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Deurwaerdere, P.</span><span> </span><span class="NLM_article-title">New therapeutic opportunities for 5-HT<sub>2C</sub> receptor ligands in neuropsychiatric disorders</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.pharmthera.2015.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=26617215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFertbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2016&pages=125-162&author=G.+Di+Giovanniauthor=P.+De+Deurwaerdere&title=New+therapeutic+opportunities+for+5-HT2C+receptor+ligands+in+neuropsychiatric+disorders&doi=10.1016%2Fj.pharmthera.2015.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders</span></div><div class="casAuthors">Di Giovanni, Giuseppe; De Deurwaerdere, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">125-162</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The 5-HT2C receptor (R) displays a widespread distribution in the CNS and is involved in the action of 5-HT in all brain areas.  Knowledge of its functional role in the CNS pathophysiol. has been impaired for many years due to the lack of drugs capable of discriminating among 5-HT2R subtypes, and to a lesser extent to the 5-HT1B, 5-HT5, 5-HT6 and 5-HT7Rs.  The situation has changed since the mid-90s due to the increased availability of new and selective synthesized compds., the creation of 5-HT2C knock out mice, and the progress made in mol. biol.  Many pharmacol. classes of drugs including antipsychotics, antidepressants and anxiolytics display affinities toward 5-HT2CRs and new 5-HT2C ligands have been developed for various neuropsychiatric disorders.  The 5-HT2CR is presumed to mediate tonic/constitutive and phasic controls on the activity of different central neurobiol. networks.  Preclin. data illustrate this complexity to a point that pharmaceutical companies developed either agonists or antagonists for the same disease.In order to better comprehend this complexity, this review will briefly describe the mol. pharmacol. of 5-HT2CRs, as well as their cellular impacts in general, before addressing its central distribution in the mammalian brain.  Thereafter, we review the preclin. efficacy of 5-HT2C ligands in numerous behavioral tests modeling human diseases, highlighting the multiple and competing actions of the 5-HT2CRs in neurobiol. networks and monoaminergic systems.  Notably, we will focus this evidence in the context of the physiopathol. of psychiatric and neurol. disorders including Parkinson's disease, levodopa-induced dyskinesia, and epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf-mGI3WW0GLVg90H21EOLACvtfcHk0lhs-LYQb-UcVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFertbfK&md5=0ba9c76cf2a49eef118e6c46459f11f6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGiovanni%26aufirst%3DG.%26aulast%3DDe%2BDeurwaerdere%26aufirst%3DP.%26atitle%3DNew%2520therapeutic%2520opportunities%2520for%25205-HT2C%2520receptor%2520ligands%2520in%2520neuropsychiatric%2520disorders%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D157%26spage%3D125%26epage%3D162%26doi%3D10.1016%2Fj.pharmthera.2015.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Vickers, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifton, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dourish, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecott, L. H.</span><span> </span><span class="NLM_article-title">Reduced satiating effect of d-fenfluramine in serotonin 5-HT<sub>2C</sub> receptor mutant mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.1007/s002130050952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1007%2Fs002130050952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10353435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVOrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1999&pages=309-314&author=S.+P.+Vickersauthor=P.+G.+Cliftonauthor=C.+T.+Dourishauthor=L.+H.+Tecott&title=Reduced+satiating+effect+of+d-fenfluramine+in+serotonin+5-HT2C+receptor+mutant+mice&doi=10.1007%2Fs002130050952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice</span></div><div class="casAuthors">Vickers, Steven P.; Clifton, Peter G.; Dourish, Colin T.; Tecott, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">309-314</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Rationale: d-Fenfluramine stimulates the release of serotonin (5-HT) and is a potent inhibitor of the re-uptake of 5-HT into nerve terminals.  Administration of d-fenfluramine suppresses food intake in both animals and humans.  Objective: We have investigated the role of the 5-HT2C receptor in mediating the effect of d-fenfluramine on mouse food intake and the behavioral satiety sequence.  Methods: Mutant mice lacking serotonin 5-HT2C receptors and wild-type animals were habituated to a daily presentation of wet mash.  Animals were non-deprived and received d-fenfluramine (3-30 mg/kg) 30 min prior to being assessed for the presence of stereotypy and presented with wet mash.  The behavior of animals was obsd. for the subsequent 40 min and food intake was recorded.  Results: d-Fenfluramine dose-dependently inhibited the consumption of a palatable wet mash by the mice.  D-Fenfluramine (3 mg/kg) significantly reduced the amt. of wet mash consumed by wild-type mice and induced a temporal advance in the behavioral satiety sequence consistent with an enhancement of satiety.  Mutant mice were less sensitive to the satiating effects of 3 mg/kg d-fenfluramine.  Hence, this dose of d-fenfluramine had a reduced effect on both food consumption and the behavioral satiety sequence in the 5-HT2C mutant mice.  In contrast, mutant mice showed an increased sensitivity to the stereotypy induced by high doses of d-fenfluramine (10, 30 mg/kg) compared to that of wild-type littermates.  Conclusion: These data demonstrate a role for the 5-HT2C receptor in mediating d-fenfluramine-induced satiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0bnUdAboMgLVg90H21EOLACvtfcHk0lgNAeIPLVq7Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVOrs7o%253D&md5=e3dcad2d3328797a3516f4ee9c5e10a4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs002130050952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002130050952%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DS.%2BP.%26aulast%3DClifton%26aufirst%3DP.%2BG.%26aulast%3DDourish%26aufirst%3DC.%2BT.%26aulast%3DTecott%26aufirst%3DL.%2BH.%26atitle%3DReduced%2520satiating%2520effect%2520of%2520d-fenfluramine%2520in%2520serotonin%25205-HT2C%2520receptor%2520mutant%2520mice%26jtitle%3DPsychopharmacology%26date%3D1999%26volume%3D143%26spage%3D309%26epage%3D314%26doi%3D10.1007%2Fs002130050952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Vickers, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dourish, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennett, G. A.</span><span> </span><span class="NLM_article-title">Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT<sub>2C</sub> receptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span><span class="refDoi"> DOI: 10.1016/S0028-3908(01)00063-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2FS0028-3908%2801%2900063-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=11489456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslersr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=200-209&author=S.+P.+Vickersauthor=C.+T.+Dourishauthor=G.+A.+Kennett&title=Evidence+that+hypophagia+induced+by+d-fenfluramine+and+d-norfenfluramine+in+the+rat+is+mediated+by+5-HT2C+receptors&doi=10.1016%2FS0028-3908%2801%2900063-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors</span></div><div class="casAuthors">Vickers, S. P.; Dourish, C. T.; Kennett, G. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-209</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The present series of studies is the first to investigate the pharmacol. mechanisms underlying d-fenfluramine- and d-norfenfluramine-induced hypophagia in the rat using highly selective serotonin 5-HT2 receptor antagonists.  Administration of d-fenfluramine, and its major metabolite d-norfenfluramine, suppresses food intake in animals.  Both compds. stimulate the release of serotonin and are potent inhibitors of the re-uptake of 5-HT into nerve terminals.  In addn., d-norfenfluramine also acts as a direct 5-HT2B/2C receptor agonist.  Pre-treatment with the selective 5-HT2C receptor antagonist, SB-242084 (0.3-3 mg/kg), dose-dependently inhibited both d-fenfluramine- (3 mg/kg) and d-norfenfluramine-induced (2 mg/kg) hypophagia.  In contrast, the hypophagic effect of d-fenfluramine and d-norfenfluramine was unaffected by prior treatment with the highly selective 5-HT2B receptor antagonists, SB-215505 (0.3-3 mg/kg) and RS-127445 (1-3 mg/kg) or the 5-HT2A receptor antagonists MDL 100,907 (0.003-0.03 mg/kg) and ketanserin (0.2, 0.5 mg/kg).  In addn., the 5-HT1A receptor antagonist WAY-100635 (0.3, 1 mg/kg) and the 5-HT1B receptor antagonists GR-127935 (1, 2 mg/kg) and SB-224289 (2-10 mg/kg) did not affect d-fenfluramine-induced hypophagia.  These data provide unequivocal evidence for an important role of the 5-HT2C receptor in the mediation of d-fenfluramine and d-norfenfluramine-induced hypophagia in the rat and do not support the involvement of 5-HT1A/1B/2A/2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_6gzP7TyP27Vg90H21EOLACvtfcHk0lgNAeIPLVq7Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslersr8%253D&md5=cf21b67409c141746f0bd6eeeab7d61a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2801%2900063-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252801%252900063-6%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DS.%2BP.%26aulast%3DDourish%26aufirst%3DC.%2BT.%26aulast%3DKennett%26aufirst%3DG.%2BA.%26atitle%3DEvidence%2520that%2520hypophagia%2520induced%2520by%2520d-fenfluramine%2520and%2520d-norfenfluramine%2520in%2520the%2520rat%2520is%2520mediated%2520by%25205-HT2C%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D41%26spage%3D200%26epage%3D209%26doi%3D10.1016%2FS0028-3908%2801%2900063-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Monck, N. J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennett, G. A.</span><span> </span><span class="NLM_article-title">5-HT<sub>2C</sub> Ligands: recent progress</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span><span class="refDoi"> DOI: 10.1016/S0079-6468(07)00006-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2FS0079-6468%2807%2900006-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=18381128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1ynsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=281-390&author=N.+J.+T.+Monckauthor=G.+A.+Kennett&title=5-HT2C+Ligands%3A+recent+progress&doi=10.1016%2FS0079-6468%2807%2900006-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C ligands: recent progress</span></div><div class="casAuthors">Monck, Nathaniel J. T.; Kennett, Guy A.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">281-390</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on the possible therapeutic utilities of selective ligands for the serotonin (5-hydroxytryptamine, 5-HT)2C receptor subtype, side-effect concerns, and medicinal chem. towards 5-HT2C ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVbF-EnQeF4LVg90H21EOLACvtfcHk0lgNAeIPLVq7Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1ynsLk%253D&md5=f15301e46c3c6f77fa806bce3b8ce93e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2807%2900006-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252807%252900006-9%26sid%3Dliteratum%253Aachs%26aulast%3DMonck%26aufirst%3DN.%2BJ.%2BT.%26aulast%3DKennett%26aufirst%3DG.%2BA.%26atitle%3D5-HT2C%2520Ligands%253A%2520recent%2520progress%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D46%26spage%3D281%26epage%3D390%26doi%3D10.1016%2FS0079-6468%2807%2900006-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Garfield, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heisler, L. K.</span><span> </span><span class="NLM_article-title">Pharmacological targeting of the serotonergic system for the treatment of obesity</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">587</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1113/jphysiol.2008.164152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1113%2Fjphysiol.2008.164152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=19029184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=587&publication_year=2009&pages=49-60&author=A.+S.+Garfieldauthor=L.+K.+Heisler&title=Pharmacological+targeting+of+the+serotonergic+system+for+the+treatment+of+obesity&doi=10.1113%2Fjphysiol.2008.164152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological targeting of the serotonergic system for the treatment of obesity</span></div><div class="casAuthors">Garfield, Alastair S.; Heisler, Lora K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">587</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The attenuation of food intake as induced by an increase in serotonergic (5-hydroxytryptamine, 5-HT) efficacy has been a target of antiobesity pharmacotherapies.  However, the induction of tolerance and/or side-effects limited the clin. utility of the earliest serotonin-related medications.  With the global prevalence of obesity rising, there has been renewed interest in the manipulation of the serotonergic system as a point of pharmacol. intervention.  The serotonin2C receptor (5-HT2CR), serotonin1B (rodent)/serotonin1Dβ (human) receptor (5-HT1B/1DβR) and serotonin6 receptor (5-HT6R) represent the most promising serotonin receptor therapeutic targets.  Canonical serotonin receptor compds. have given way to a myriad of novel receptor-selective ligands, many of which have observable anorectic effects.  Here we review serotonergic compds. reducing ingestive behavior and discuss their clin. potential for the treatment of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO3heX7GBmk7Vg90H21EOLACvtfcHk0lhslNi24E8uaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKls70%253D&md5=dc9107028ec848d1fe95cedee7daf5fc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2008.164152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2008.164152%26sid%3Dliteratum%253Aachs%26aulast%3DGarfield%26aufirst%3DA.%2BS.%26aulast%3DHeisler%26aufirst%3DL.%2BK.%26atitle%3DPharmacological%2520targeting%2520of%2520the%2520serotonergic%2520system%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Physiol.%26date%3D2009%26volume%3D587%26spage%3D49%26epage%3D60%26doi%3D10.1113%2Fjphysiol.2008.164152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span> </span><span class="NLM_article-title">5-HT<sub>2C</sub> receptor modulators: a patent survey</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1455</span><span class="refDoi"> DOI: 10.1517/13543776.2010.518956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1517%2F13543776.2010.518956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=20849206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWmtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1429-1455&author=J.+Leeauthor=M.+E.+Jungauthor=J.+Lee&title=5-HT2C+receptor+modulators%3A+a+patent+survey&doi=10.1517%2F13543776.2010.518956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C receptor modulators: a patent survey</span></div><div class="casAuthors">Lee, Junwon; Jung, Myung Eun; Lee, Jinhwa</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1429-1455</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The 5-HT2C receptor is a GPCR and is one of the 14 subtypes that constitute the serotonin receptor family.  The 5-HT2C receptor is exclusively expressed in the CNS where it demonstrates a wide distribution and displays high-affinity interactions with a wide variety of psychiatric medications.  Modulators of 5-HT2C have been implicated as a potential treatment for diseases of significant unmet medical need, including obesity, schizophrenia, depression, anxiety, Parkinson's disease, drug addiction, erectile dysfunction and urinary incontinence.  Thus, there is a great interest in developing potent and selective 5-HT2C receptor modulators.  Areas covered in this review: This review article highlights the research progress in 5-HT2C receptor modulators published in the patent literature between Jan. 2003 and June 2010, giving emphasis to the medicinal chemist's standpoint.  What the reader will gain: Readers will rapidly gain an overview of the various 5-HT2C receptor modulators reported in the patent literature in the past 8 years.  Furthermore, the readers will learn which structure type can interact with the 5-HT2C receptor.  In addn., the readers will be aware of the pharmaceutical companies that have been the main players in the field.  Take home message: There is substantial evidence supporting the concept that a selective 5-HT2C receptor modulator should provide benefit in the treatment of a variety of CNS disorders.  Although research efforts have identified several promising 5-HT2C receptor modulators that display high functional selectivity, further clin. efficacy and safety data are needed to prove their actual clin. utility.  Therefore, the query for selectively acting 5-HT2C receptor modulators is still ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowsaQEKrg_R7Vg90H21EOLACvtfcHk0lhslNi24E8uaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWmtL%252FF&md5=43397f74d27751efdc505165ba96172c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.518956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.518956%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3D5-HT2C%2520receptor%2520modulators%253A%2520a%2520patent%2520survey%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D1429%26epage%3D1455%26doi%3D10.1517%2F13543776.2010.518956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hopkins, C. R.</span><span> </span><span class="NLM_article-title">ACS chemical neuroscience molecule spotlight on lorcaserin</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span><span class="refDoi"> DOI: 10.1021/cn100059u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100059u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSis73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=718-719&author=C.+R.+Hopkins&title=ACS+chemical+neuroscience+molecule+spotlight+on+lorcaserin&doi=10.1021%2Fcn100059u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">ACS Chemical Neuroscience Molecule Spotlight on Lorcaserin</span></div><div class="casAuthors">Hopkins, Corey R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">718-719</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Lorcaserin (APD-356) is the first in a new class of selective serotonin 5-hydroxytryptamine2C (5-HT2C) receptor agonists.  On Dec. 22, 2009, the compd.'s developer (Arena Pharmaceuticals) submitted an NDA to the FDA for approval for wt. management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjgKvE-QA1lLVg90H21EOLACvtfcHk0lhslNi24E8uaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSis73M&md5=5e6686a83195f526726fcbd17b7819db</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcn100059u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100059u%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26atitle%3DACS%2520chemical%2520neuroscience%2520molecule%2520spotlight%2520on%2520lorcaserin%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D718%26epage%3D719%26doi%3D10.1021%2Fcn100059u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span>FY 2012 Innovative Drug Approvals; <span class="NLM_publisher-name">U.S. Food and Drug Administration</span>: <span class="NLM_publisher-loc">Silver Spring, MD</span>, December<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.fda.gov/downloads/aboutfda/reportsmanualsforms/reports/ucm330859.pdf" class="extLink">http://www.fda.gov/downloads/aboutfda/reportsmanualsforms/reports/ucm330859.pdf</a> (Sep 25, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FY+2012+Innovative+Drug+Approvals%3B+U.S.+Food+and+Drug+Administration%3A+Silver+Spring%2C+MD%2C+December+2012%3B+http%3A%2F%2Fwww.fda.gov%2Fdownloads%2Faboutfda%2Freportsmanualsforms%2Freports%2Fucm330859.pdf+%28Sep+25%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DFY%25202012%2520Innovative%2520Drug%2520Approvals%26pub%3DU.S.%2520Food%2520and%2520Drug%2520Administration%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kroeze, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1128</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span><span class="refDoi"> DOI: 10.1016/S0006-3223(98)00132-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2FS0006-3223%2898%2900132-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=9836016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFKqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=1128-1142&author=W.+K.+Kroezeauthor=B.+L.+Roth&title=The+molecular+biology+of+serotonin+receptors%3A+therapeutic+implications+for+the+interface+of+mood+and+psychosis&doi=10.1016%2FS0006-3223%2898%2900132-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis</span></div><div class="casAuthors">Kroeze, Wesley K.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1128-1142</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 152 refs., which summarizes the mol. biol. of serotonin (5-HT; 5-hydroxytryptamine) receptors and indicates the potential relevance of this information for the treatment of mood and psychotic disorders.  At least 15 sep. subtypes of 5-HT receptors have been identified by mol. cloning techniques to be distinct genetic entities.  Subtle differences in the primary amino acid sequences of these receptors can yield large differences in ligand selectivity.  Addnl., it has recently been discovered that drugs such as atypical antipsychotic drugs and serotonin-selective reuptake inhibitors may interact with a large no. of heretofore unknown 5-HT receptors.  Thus clozapine, for instance, has high affinity for at least four sep. 5-HT receptors, and it is unknown which of these receptors is essential for its unique therapeutic efficacy.  One way to approach these questions is to test subtype-selective agents, although there are few of these currently available.  Approaches to the design of subtype-selective ligands are described, including structure-based drug design and combinatorial approaches.  Modes of regulation of 5-HT receptors are also summarized, and it is emphasized that antipsychotic drugs and antidepressants likely exert their effects via nontranscriptional and posttranslational means.  Understanding the cellular mechanisms by which 5-HT receptors are regulated by psychopharmacol. agents is likely to yield novel insights into drug action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBEIwmClT3vbVg90H21EOLACvtfcHk0lhslNi24E8uaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFKqurc%253D&md5=daae7df1a87e737a3cd49d844135a687</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2898%2900132-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252898%252900132-2%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DThe%2520molecular%2520biology%2520of%2520serotonin%2520receptors%253A%2520therapeutic%2520implications%2520for%2520the%2520interface%2520of%2520mood%2520and%2520psychosis%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D44%26spage%3D1128%26epage%3D1142%26doi%3D10.1016%2FS0006-3223%2898%2900132-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauser, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Evidence for possible involvement of 5-HT<sub>2B</sub> receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2836</span><span class="NLM_x">–</span> <span class="NLM_lpage">2841</span><span class="refDoi"> DOI: 10.1161/01.CIR.102.23.2836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1161%2F01.CIR.102.23.2836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=11104741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptVSjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=2836-2841&author=R.+B.+Rothmanauthor=M.+H.+Baumannauthor=J.+E.+Savageauthor=L.+Rauserauthor=A.+McBrideauthor=S.+J.+Hufeisenauthor=B.+L.+Roth&title=Evidence+for+possible+involvement+of+5-HT2B+receptors+in+the+cardiac+valvulopathy+associated+with+fenfluramine+and+other+serotonergic+medications&doi=10.1161%2F01.CIR.102.23.2836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications</span></div><div class="casAuthors">Rothman, Richard B.; Baumann, Michael H.; Savage, Jason E.; Rauser, Laura; McBride, Ace; Hufeisen, Sandra J.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2836-2841</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Serotonergic medications with various mechanisms of action are used to treat psychiatric disorders and are being investigated as treatments for drug dependence.  The occurrence of fenfluramine-assocd. valvular heart disease (VHD) has raised concerns that other serotonergic medications might also increase the risk of developing VHD.  We hypothesized that fenfluramine or its metabolite norfenfluramine and other medications known to produce VHD have preferentially high affinities for a particular serotonin receptor subtype capable of stimulating mitogenesis.  Medications known or suspected to cause VHD (pos. controls) and medications not assocd. with VHD (neg. controls) were screened for activity at 11 cloned serotonin receptor subtypes by use of ligand-binding methods and functional assays.  The pos. control drugs were (±)-fenfluramine; (+)-fenfluramine; (-)-fenfluramine; its metabolites (±)-norfenfluramine, (+)-norfenfluramine, and (-)-norfenfluramine; ergotamine; and methysergide and its metabolite methylergonovine.  The neg. control drugs were phentermine, fluoxetine, its metabolite norfluoxetine, and trazodone and its active metabolite m-chlorophenylpiperazine.  (±)-, (+)-, And (-)-Norfenfluramine, ergotamine, and methylergonovine all had preferentially high affinities for the cloned human serotonin 5-HT2B receptor and were partial to full agonists at the 5-HT2B receptor.  Our data imply that activation of 5-HT2B receptors is necessary to produce VHD and that serotonergic medications that do not activate 5-HT2B receptors are unlikely to produce VHD.  We suggest that all clin. available medications with serotonergic activity and their active metabolites be screened for agonist activity at 5-HT2B receptors and that clinicians should consider suspending their use of medications with significant activity at 5-HT2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6spUXOCLtLrVg90H21EOLACvtfcHk0liuh2SxYXUDHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptVSjtrs%253D&md5=6b8c6059885dd9b058859089914c61b3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.102.23.2836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.102.23.2836%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DSavage%26aufirst%3DJ.%2BE.%26aulast%3DRauser%26aufirst%3DL.%26aulast%3DMcBride%26aufirst%3DA.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DEvidence%2520for%2520possible%2520involvement%2520of%25205-HT2B%2520receptors%2520in%2520the%2520cardiac%2520valvulopathy%2520associated%2520with%2520fenfluramine%2520and%2520other%2520serotonergic%2520medications%26jtitle%3DCirculation%26date%3D2000%26volume%3D102%26spage%3D2836%26epage%3D2841%26doi%3D10.1161%2F01.CIR.102.23.2836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Fitzgerald, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corjay, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbaszade, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Largent, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartig, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D. W.</span><span> </span><span class="NLM_article-title">Possible role of valvular serotonin 5-HT<sub>2B</sub> receptors in the cardiopathy associated with fenfluramine</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10617681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslCltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=75-81&author=L.+W.+Fitzgeraldauthor=T.+C.+Burnauthor=B.+S.+Brownauthor=J.+P.+Pattersonauthor=M.+H.+Corjayauthor=P.+A.+Valentineauthor=J.+H.+Sunauthor=J.+R.+Linkauthor=I.+Abbaszadeauthor=J.+M.+Hollisauthor=B.+L.+Largentauthor=P.+R.+Hartigauthor=G.+F.+Hollisauthor=P.+C.+Meunierauthor=A.+J.+Robichaudauthor=D.+W.+Robertson&title=Possible+role+of+valvular+serotonin+5-HT2B+receptors+in+the+cardiopathy+associated+with+fenfluramine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine</span></div><div class="casAuthors">Fitzgerald, Lawrence W.; Burn, Timothy C.; Brown, Barry S.; Patterson, John P.; Corjay, Martha H.; Valentine, Patricia A.; Sun, Jung-Hui; Link, John R.; Abbaszade, Ilgar; Hollis, Jeannine M.; Largent, Brian L.; Hartig, Paul R.; Hollis, Gregory F.; Meunier, Paul C.; Robichaud, Albert J.; Robertson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-81</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dexfenfluramine was approved in the United States for longterm use as an appetite suppressant until it was reported to be assocd. with valvular heart disease.  The valvular changes (myofibroblast proliferation) are histopathol. indistinguishable from those obsd. in carcinoid disease or after long-term exposure to 5-hydroxytryptamine (5-HT)2-preferring ergot drugs (ergotamine, methysergide).  5-HT2 receptor stimulation is known to cause fibroblast mitogenesis, which could contribute to this lesion.  To elucidate the mechanism of "fenphen"-assocd. valvular lesions, we examd. the interaction of fenfluramine and its metabolite norfenfluramine with 5-HT2 receptor subtypes and examd. the expression of these receptors in human and porcine heart valves.  Fenfluramine binds weakly to 5-HT2A, 5-HT2B, and 5-HT2C receptors.  In contrast, norfenfluramine exhibited high affinity for 5-HT2B and 5-HT2C receptors and more moderate affinity for 5-HT2A receptors.  In cells expressing recombinant 5-HT2B receptors, norfenfluramine potently stimulated the hydrolysis of inositol phosphates, increased intracellular Ca2+, and activated the mitogen-activated protein kinase cascade, the latter of which has been linked to mitogenic actions of the 5-HT2B receptor.  The level of 5-HT2B and 5-HT2A receptor transcripts in heart valves was at least 300-fold higher than the levels of 5-HT2C receptor transcript, which were barely detectable.  We propose that preferential stimulation of valvular 5-HT2B receptors by norfenfluramine, ergot drugs, or 5-HT released from carcinoid tumors (with or without accompanying 5-HT2A receptor activation) may contribute to valvular fibroplasia in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmkbFOXGVxcLVg90H21EOLACvtfcHk0liuh2SxYXUDHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslCltA%253D%253D&md5=b99b778d0de695d377aa4f0006b6dc47</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DL.%2BW.%26aulast%3DBurn%26aufirst%3DT.%2BC.%26aulast%3DBrown%26aufirst%3DB.%2BS.%26aulast%3DPatterson%26aufirst%3DJ.%2BP.%26aulast%3DCorjay%26aufirst%3DM.%2BH.%26aulast%3DValentine%26aufirst%3DP.%2BA.%26aulast%3DSun%26aufirst%3DJ.%2BH.%26aulast%3DLink%26aufirst%3DJ.%2BR.%26aulast%3DAbbaszade%26aufirst%3DI.%26aulast%3DHollis%26aufirst%3DJ.%2BM.%26aulast%3DLargent%26aufirst%3DB.%2BL.%26aulast%3DHartig%26aufirst%3DP.%2BR.%26aulast%3DHollis%26aufirst%3DG.%2BF.%26aulast%3DMeunier%26aufirst%3DP.%2BC.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26aulast%3DRobertson%26aufirst%3DD.%2BW.%26atitle%3DPossible%2520role%2520of%2520valvular%2520serotonin%25205-HT2B%2520receptors%2520in%2520the%2520cardiopathy%2520associated%2520with%2520fenfluramine%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D75%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Astrup, A.</span><span> </span><span class="NLM_article-title">Drug management of obesity - efficacy versus safety</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span><span class="refDoi"> DOI: 10.1056/NEJMe1004076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1056%2FNEJMe1004076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=20647205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVOmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=288-290&author=A.+Astrup&title=Drug+management+of+obesity+-+efficacy+versus+safety&doi=10.1056%2FNEJMe1004076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Drug management of obesity - efficacy versus safety</span></div><div class="casAuthors">Astrup, Arne</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">288-290</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi6IVLWiQAf7Vg90H21EOLACvtfcHk0liuh2SxYXUDHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVOmt78%253D&md5=c7b7c29cb7eeb9b43bfb312a59f42e21</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1056%2FNEJMe1004076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe1004076%26sid%3Dliteratum%253Aachs%26aulast%3DAstrup%26aufirst%3DA.%26atitle%3DDrug%2520management%2520of%2520obesity%2520-%2520efficacy%2520versus%2520safety%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D288%26epage%3D290%26doi%3D10.1056%2FNEJMe1004076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">DiNicolantonio, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, P.</span><span> </span><span class="NLM_article-title">Lorcaserin for the treatment of obesity? A closer look at its side effects</span> <span class="citation_source-journal">Open Heart</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">e000173</span><span class="refDoi"> DOI: 10.1136/openhrt-2014-000173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1136%2Fopenhrt-2014-000173" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=e000173&author=J.+J.+DiNicolantonioauthor=S.+Chatterjeeauthor=J.+H.+O%E2%80%99Keefeauthor=P.+Meier&title=Lorcaserin+for+the+treatment+of+obesity%3F+A+closer+look+at+its+side+effects&doi=10.1136%2Fopenhrt-2014-000173"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1136%2Fopenhrt-2014-000173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fopenhrt-2014-000173%26sid%3Dliteratum%253Aachs%26aulast%3DDiNicolantonio%26aufirst%3DJ.%2BJ.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DJ.%2BH.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DLorcaserin%2520for%2520the%2520treatment%2520of%2520obesity%253F%2520A%2520closer%2520look%2520at%2520its%2520side%2520effects%26jtitle%3DOpen%2520Heart%26date%3D2014%26volume%3D1%26spage%3De000173%26doi%3D10.1136%2Fopenhrt-2014-000173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discov.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1038/nrd2760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1038%2Fnrd2760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=19116626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCkurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=41-54&author=P.+J.+Connauthor=A.+Christopoulosauthor=C.+W.+Lindsley&title=Allosteric+modulators+of+GPCRs%3A+a+novel+approach+for+the+treatment+of+CNS+disorders&doi=10.1038%2Fnrd2760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders</span></div><div class="casAuthors">Conn, P. Jeffrey; Christopoulos, Arthur; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-54</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite G-protein-coupled receptors (GPCRs) being among the most fruitful targets for marketed drugs, intense discovery efforts for several GPCR subtypes have failed to deliver selective drug candidates.  Historically, drug discovery programs for GPCR ligands have been dominated by efforts to develop agonists and antagonists that act at orthosteric sites for endogenous ligands.  However, in recent years, there have been tremendous advances in the discovery of novel ligands for GPCRs that act at allosteric sites to regulate receptor function.  These compds. provide high selectivity, novel modes of efficacy and may lead to novel therapeutic agents for the treatment of multiple psychiatric and neurol. human disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmn5h5XCcPKbVg90H21EOLACvtfcHk0liwPdMhoix9Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCkurfF&md5=e109e94fe3e2c1fcfd480dc84c6609f7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnrd2760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2760%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAllosteric%2520modulators%2520of%2520GPCRs%253A%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2009%26volume%3D8%26spage%3D41%26epage%3D54%26doi%3D10.1038%2Fnrd2760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdul-Ridha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span> </span><span class="NLM_article-title">Regulation of G protein-coupled receptors by allosteric ligands</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span><span class="refDoi"> DOI: 10.1021/cn400005t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400005t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1yhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=527-534&author=J.+R.+Laneauthor=A.+Abdul-Ridhaauthor=M.+Canals&title=Regulation+of+G+protein-coupled+receptors+by+allosteric+ligands&doi=10.1021%2Fcn400005t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of G Protein-Coupled Receptors by Allosteric Ligands</span></div><div class="casAuthors">Lane, J. Robert; Abdul-Ridha, Alaa; Canals, Meritxell</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-534</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topog. distinct, druggable, allosteric sites may be present on all G protein-coupled receptors (GPCRs).  As such, targeting these sites with synthetic small mols. offers an attractive approach to develop receptor-subtype selective chem. leads for the development of novel therapies.  A crucial part of drug development is to understand the acute and chronic effects of such allosteric modulators at their corresponding GPCR target.  Key regulatory processes including cell-surface delivery, endocytosis, recycling, and down-regulation tightly control the no. of receptors at the surface of the cell.  As many GPCR therapeutics will be administered chronically, understanding how such ligands modulate these regulatory pathways forms an essential part of the characterization of novel GPCR ligands.  This is true for both orthosteric and allosteric ligands.  In this Review, we summarize our current understanding of GPCR regulatory processes with a particular focus on the effects and implications of allosteric targeting of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKrOeC3g251bVg90H21EOLACvtfcHk0liwPdMhoix9Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1yhtrY%253D&md5=e95af61d6cdc720069c9d9dd8de8ff5c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn400005t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400005t%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DAbdul-Ridha%26aufirst%3DA.%26aulast%3DCanals%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520G%2520protein-coupled%2520receptors%2520by%2520allosteric%2520ligands%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D527%26epage%3D534%26doi%3D10.1021%2Fcn400005t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Wootten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span> </span><span class="NLM_article-title">Emerging paradigms in GPCR allostery: implications for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discov.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span><span class="refDoi"> DOI: 10.1038/nrd4052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1038%2Fnrd4052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=630-644&author=D.+Woottenauthor=A.+Christopoulosauthor=P.+M.+Sexton&title=Emerging+paradigms+in+GPCR+allostery%3A+implications+for+drug+discovery&doi=10.1038%2Fnrd4052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd4052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4052%26sid%3Dliteratum%253Aachs%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26atitle%3DEmerging%2520paradigms%2520in%2520GPCR%2520allostery%253A%2520implications%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2013%26volume%3D12%26spage%3D630%26epage%3D644%26doi%3D10.1038%2Fnrd4052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Gentry, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Novel allosteric modulators of G protein-coupled receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">19478</span><span class="NLM_x">–</span> <span class="NLM_lpage">19488</span><span class="refDoi"> DOI: 10.1074/jbc.R115.662759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1074%2Fjbc.R115.662759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=26100627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12mt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=19478-19488&author=P.+R.+Gentryauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Novel+allosteric+modulators+of+G+protein-coupled+receptors&doi=10.1074%2Fjbc.R115.662759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Allosteric Modulators of G Protein-coupled Receptors</span></div><div class="casAuthors">Gentry, Patrick R.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">19478-19488</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) are allosteric proteins, because their signal transduction relies on interactions between topog. distinct, yet conformationally linked, domains.  Much of the focus on GPCR allostery in the new millennium, however, has been on modes of targeting GPCR allosteric sites with chem. probes due to the potential for novel therapeutics.  It is now apparent that some GPCRs possess more than one targetable allosteric site, in addn. to a growing list of putative endogenous modulators.  Advances in structural biol. are also shedding new insights into mechanisms of allostery, although the complexities of candidate allosteric drugs necessitate rigorous biol. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-w2L2Z2PwrVg90H21EOLACvtfcHk0ljRND5HgBsJxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12mt7rI&md5=7c3b5c0ddd375e0c05a18b91f2c68e56</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R115.662759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R115.662759%26sid%3Dliteratum%253Aachs%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DNovel%2520allosteric%2520modulators%2520of%2520G%2520protein-coupled%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D19478%26epage%3D19488%26doi%3D10.1074%2Fjbc.R115.662759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Im, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chio, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberts, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D. M.</span><span> </span><span class="NLM_article-title">Positive allosteric modulator of the human 5-HT<sub>2C</sub> receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.1124/mol.64.1.78</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1124%2Fmol.64.1.78" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=12815163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvV2qtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=78-84&author=W.+B.+Imauthor=C.+L.+Chioauthor=G.+L.+Albertsauthor=D.+M.+Dinh&title=Positive+allosteric+modulator+of+the+human+5-HT2C+receptor&doi=10.1124%2Fmol.64.1.78"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Positive allosteric modulator of the human 5-HT2C receptor</span></div><div class="casAuthors">Im, Wha Bin; Chio, Christopher L.; Alberts, Glen L.; Dinh, Dac M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-84</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The human 5-hydroxytryptamine-2C (5-HT2C) receptor has been the target of potential anxiolytics and antiobesity drugs, and its pos. allosteric modulator was discovered to be L-threo-α-D-galacto-octopyranoside, methyl-7-chloro-6,7,8-trideoxy-6-[[(4-undecyl-2-piperidinyl)carbonyl]amino]-1-thiomonohydrochloride (2S-cis) (PNU-69176E).  The drug at low micromolar concns. (<25 μM) markedly enhanced [3H]5-HT binding (more than 300%) by increasing its affinity for low-affinity sites but with no appreciable effect on antagonist ([3H]mesulergine) binding.  Functionally, PNU-69176E alone rendered receptors constitutively active, producing the phenotypes of 5-HT-activated receptors, as measured with mesulergine-sensitive guanosine 5'-O-(3-[35S]thio)triphosphate binding, transient inositol 1,4,5-triphosphate release, and [3H]inositol phosphate accumulation.  These actions of PNU-69176E were obsd. with the human 5-HT2C receptor expressed in several mammalian cell lines (human embryonic kidney 293, NIH3T3, and SH-EP) at variable receptor densities (6 to 45 pmol/mg of protein), but not with analogous 5-HT and dopamine receptors (human 5-HT2A, 5-HT2B, 5-HT6, 5-HT7, and dopamine D2-long and D3 receptors).  Structurally, PNU-69176E consists of a long alkyl chain and a polar moiety, including the α-D-galactopyranoside.  Its analogs with shorter alkyl chains (Me to n-hexyl instead of n-undecyl group) failed to enhance [3H]5-HT binding, and also long alkyl amides are without allosteric modulation.  We propose that PNU-69176E may represent a new class of membrane receptor modulators, which probably need a long alkyl chain as a membrane anchor and target a selective polar head group to receptor modulatory sites near the membrane surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMdPZHNbAJJbVg90H21EOLACvtfcHk0ljRND5HgBsJxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvV2qtrs%253D&md5=26c9f18b3097e2a8921b7803bc836489</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fmol.64.1.78&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.64.1.78%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DW.%2BB.%26aulast%3DChio%26aufirst%3DC.%2BL.%26aulast%3DAlberts%26aufirst%3DG.%2BL.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26atitle%3DPositive%2520allosteric%2520modulator%2520of%2520the%2520human%25205-HT2C%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D78%26epage%3D84%26doi%3D10.1124%2Fmol.64.1.78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ding, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastasio, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span> </span><span class="NLM_article-title">Exploration of synthetic approaches and pharmacological evaluation of PNU-69176E and its stereoisomer as 5-HT<sub>2C</sub> receptor allosteric modulators</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.1021/cn300020x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300020x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=538-545&author=C.+Dingauthor=N.+M.+Bremerauthor=T.+D.+Smithauthor=P.+K.+Seitzauthor=N.+C.+Anastasioauthor=K.+A.+Cunninghamauthor=J.+Zhou&title=Exploration+of+synthetic+approaches+and+pharmacological+evaluation+of+PNU-69176E+and+its+stereoisomer+as+5-HT2C+receptor+allosteric+modulators&doi=10.1021%2Fcn300020x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of Synthetic Approaches and Pharmacological Evaluation of PNU-69176E and Its Stereoisomer as 5-HT2C Receptor Allosteric Modulators</span></div><div class="casAuthors">Ding, Chunyong; Bremer, Nicole M.; Smith, Thressa D.; Seitz, Patricia K.; Anastasio, Noelle C.; Cunningham, Kathryn A.; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">538-545</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Allosteric modulators of the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) present a unique drug design strategy to augment the response to endogenous 5-HT in a site- and event-specific manner with great potential as novel central nervous system probes and therapeutics.  To date, PNU-69176E is the only reported selective pos. allosteric modulator for the 5-HT2CR.  For the first time, an optimized synthetic route to readily access PNU-69176E (1) and its diastereomer 2 has been established in moderate to good overall yields over 10 steps starting from com. available picolinic acid.  This synthetic approach not only enables a feasible prepn. of a sufficient amt. of 1 for use as a ref. compd. for secondary pharmacol. studies, but also provides an efficient synthesis of key intermediates to develop novel and simplified 5-HT2CR allosteric modulators.  Compd. 1 and its diastereomer 2 were functionally characterized in Chinese hamster ovary (CHO) cells stably transfected with the 5-HT2CR using an intracellular calcium (Cai2+) release assay.  Compd. 1 demonstrated efficacy and potency as an allosteric modulator for the 5-HT2CR with no intrinsic agonist activity.  Compd. 1 did not alter 5-HT-evoked Cai2+ in CHO cells stably transfected with the highly homologous 5-HT2AR.  In contrast, the diastereomer 2 did not alter 5-HT-evoked Cai2+ release in 5-HT2AR-CHO or 5-HT2CR-CHO cells or exhibit intrinsic agonist activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-ZC-7cVkBGrVg90H21EOLACvtfcHk0ljRND5HgBsJxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOqsb0%253D&md5=1f635dd7796d2663f1ab08b92c7d7cb9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcn300020x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300020x%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26aulast%3DBremer%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BD.%26aulast%3DSeitz%26aufirst%3DP.%2BK.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DExploration%2520of%2520synthetic%2520approaches%2520and%2520pharmacological%2520evaluation%2520of%2520PNU-69176E%2520and%2520its%2520stereoisomer%2520as%25205-HT2C%2520receptor%2520allosteric%2520modulators%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D538%26epage%3D545%26doi%3D10.1021%2Fcn300020x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">McAllister, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastasio, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, K. A.</span><span> </span><span class="NLM_article-title">In vivo evaluation of novel serotonin 5-HT<sub>2C</sub> receptor positive allosteric modulator CYD-1–79</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">e144</span><span class="refDoi"> DOI: 10.1016/j.drugalcdep.2015.07.394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.drugalcdep.2015.07.394" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2015&pages=e144&author=C.+E.+McAllisterauthor=R.+M.+Hartleyauthor=G.+Zhangauthor=R.+G.+Foxauthor=N.+C.+Anastasioauthor=C.+Wildauthor=J.+Zhouauthor=K.+A.+Cunningham&title=In+vivo+evaluation+of+novel+serotonin+5-HT2C+receptor+positive+allosteric+modulator+CYD-1%E2%80%9379&doi=10.1016%2Fj.drugalcdep.2015.07.394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.drugalcdep.2015.07.394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drugalcdep.2015.07.394%26sid%3Dliteratum%253Aachs%26aulast%3DMcAllister%26aufirst%3DC.%2BE.%26aulast%3DHartley%26aufirst%3DR.%2BM.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DIn%2520vivo%2520evaluation%2520of%2520novel%2520serotonin%25205-HT2C%2520receptor%2520positive%2520allosteric%2520modulator%2520CYD-1%25E2%2580%259379%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2015%26volume%3D156%26spage%3De144%26doi%3D10.1016%2Fj.drugalcdep.2015.07.394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wacker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCorvy, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatakrishnan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schools, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dror, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Crystal structure of an LSD-bound human serotonin receptor</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1016/j.cell.2016.12.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.cell.2016.12.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=28129538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=377-389&author=D.+Wackerauthor=S.+Wangauthor=J.+D.+McCorvyauthor=R.+M.+Betzauthor=A.+J.+Venkatakrishnanauthor=A.+Levitauthor=K.+Lansuauthor=Z.+L.+Schoolsauthor=T.+Cheauthor=D.+E.+Nicholsauthor=B.+K.+Shoichetauthor=R.+O.+Drorauthor=B.+L.+Roth&title=Crystal+structure+of+an+LSD-bound+human+serotonin+receptor&doi=10.1016%2Fj.cell.2016.12.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an LSD-bound human serotonin receptor</span></div><div class="casAuthors">Wacker, Daniel; Wang, Sheng; McCorvy, John D.; Betz, Robin M.; Venkatakrishnan, A. J.; Levit, Anat; Lansu, Katherine; Schools, Zachary L.; Che, Tao; Nichols, David E.; Shoichet, Brian K.; Dror, Ron O.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-389.e12</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The prototypical hallucinogen, LSD, acts via serotonin receptors, and here the authors describe the crystal structure of LSD in complex with human serotonin receptor 5-HT2B.  The complex revealed conformational rearrangements to accommodate LSD, providing a structural explanation for the conformational selectivity of LSD's key diethylamide moiety.  LSD dissocd. exceptionally slow from both 5-HT2BR and 5-HT2AR, a major target for its psychoactivity.  Mol. dynamics (MD) simulations suggested that LSD's slow binding kinetics may be due to a "lid" formed by extracellular loop 2 (EL2) at the entrance to the binding pocket.  A mutation predicted to increase the mobility of this lid greatly accelerated LSD's binding kinetics and selectively dampened LSD-mediated β-arrestin 2 recruitment.  Thus, this study reveals an unexpected binding mode of LSD, illuminates key features of its kinetics, stereochem., and signaling, and provides a mol. explanation for LSD's actions at human serotonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcU-96ccslG7Vg90H21EOLACvtfcHk0lgYxCnr3c2fOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaqs7g%253D&md5=5eee71a2d385d97d9891b669e8c5afa1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.12.033%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DSchools%26aufirst%3DZ.%2BL.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DCrystal%2520structure%2520of%2520an%2520LSD-bound%2520human%2520serotonin%2520receptor%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D377%26epage%3D389%26doi%3D10.1016%2Fj.cell.2016.12.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazandarani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabalski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welmaker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span> </span><span class="NLM_article-title">Antiobesity-like effects of the 5-HT<sub>2C</sub> receptor agonist WAY-161503</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1073–1074</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span><span class="refDoi"> DOI: 10.1016/j.brainres.2005.12.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.brainres.2005.12.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=16430874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Sqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1073%E2%80%931074&publication_year=2006&pages=240-251&author=S.+Rosenzweig-Lipsonauthor=J.+Zhangauthor=H.+Mazandaraniauthor=B.+L.+Harrisonauthor=A.+Sabbauthor=J.+Sabalskiauthor=G.+Stackauthor=G.+Welmakerauthor=J.+E.+Barrettauthor=J.+Dunlop&title=Antiobesity-like+effects+of+the+5-HT2C+receptor+agonist+WAY-161503&doi=10.1016%2Fj.brainres.2005.12.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503</span></div><div class="casAuthors">Rosenzweig-Lipson, Sharon; Zhang, Jean; Mazandarani, Hossein; Harrison, Boyd L.; Sabb, Annmarie; Sabalski, Joan; Stack, Gary; Welmaker, Greg; Barrett, James E.; Dunlop, John</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1073-1074</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">240-251</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">WAY-161503 ((4aR)-8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one), a 5-HT2B/C receptor agonist, was characterized in vitro using stable Chinese hamster ovary cell lines expressing each of the human 5-HT2 receptors and in vivo in animal models of obesity.  WAY-161503 displaced both agonist ([125I]2,5-dimethoxy-4-iodoamphetamine (DOI)) and antagonist ([3H]mesulergine) radioligand binding to the human 5-HT2C receptor with derived Ki values of 3.3 ± 0.9 and 32 ± 6 nM, resp.  Relative to 5-HT2C receptor binding, WAY-161503 was approx. 6-fold less potent at human 5-HT2A receptors ([125I]DOI) with a derived Ki value of 18 nM and 20-fold less potent at human 5-HT2B receptors ([3H]5-HT) with a derived Ki value of 60 nM.  In functional studies, WAY-161503 was a full agonist in stimulating 5-HT2C-receptor-coupled [3H]inositol phosphate (IP) formation and calcium mobilization with EC50 values of 8.5 nM and 0.8 nM, resp.  WAY-161503 was also a 5-HT2B agonist (EC50s of 6.9 and 1.8 nM for IP and calcium, resp.).  In IP studies, WAY-161503 was a weak 5-HT2A partial agonist (EC50, 802 nM) yet potently stimulated calcium mobilization (EC50, 7 nM) in 5-HT2A receptor-expressing cells.  Functionally, WAY-161503 also stimulated the phospholipase A2-coupled arachidonic acid release in 5-HT2C receptor expressing cells albeit with lower potency (EC50, 38 nM) and efficacy (Emax, 77%) compared with activation of the PLC pathway.  In vivo, WAY-161503 produced dose-dependent decreases in 2-h food intake in 24 h fasted normal Sprague-Dawley rats, diet-induced obese mice, and obese Zuker rats with ED50 values of 1.9 mg/kg, 6.8 mg/kg, and 0.73 mg/kg, resp.  The redn. in food intake in normal Sprague-Dawley rats was reversed by administration of the 5-HT2C receptor antagonist SB-242084.  Following chronic administration (10 days) in growing Sprague-Dawley rats, WAY-161503 decreased food intake and attenuated body wt. gain.  Finally, following chronic administration (15 days) of WAY-161503 to obese Zuker rats, the rats maintained a 30% decrease in food intake over the 15-day period combined with a 25 g decrease in body wt. relative to vehicle-treated controls demonstrating a lack of tolerance to its anorectic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq05g9y-g8Sl7Vg90H21EOLACvtfcHk0lgYxCnr3c2fOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Sqt7s%253D&md5=9d33e25899d30c2c9b9840de84469cb2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2005.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2005.12.052%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMazandarani%26aufirst%3DH.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DSabb%26aufirst%3DA.%26aulast%3DSabalski%26aufirst%3DJ.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DWelmaker%26aufirst%3DG.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DDunlop%26aufirst%3DJ.%26atitle%3DAntiobesity-like%2520effects%2520of%2520the%25205-HT2C%2520receptor%2520agonist%2520WAY-161503%26jtitle%3DBrain%2520Res.%26date%3D2006%26volume%3D1073%25E2%2580%25931074%26spage%3D240%26epage%3D251%26doi%3D10.1016%2Fj.brainres.2005.12.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Kennett, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenell, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, T. P.</span><span> </span><span class="NLM_article-title">SB 242084, a selective and brain penetrant 5-HT<sub>2C</sub> receptor antagonist</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span><span class="refDoi"> DOI: 10.1016/S0028-3908(97)00038-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2FS0028-3908%2897%2900038-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=609-620&author=G.+A.+Kennettauthor=M.+D.+Woodauthor=F.+Brightauthor=B.+Trailauthor=G.+Rileyauthor=G.+Hollandauthor=K.+Y.+Avenellauthor=T.+Steanauthor=N.+Uptonauthor=S.+Bromidgeauthor=I.+T.+Forbesauthor=A.+M.+Brownauthor=D.+N.+Middlemissauthor=T.+P.+Blackburn&title=SB+242084%2C+a+selective+and+brain+penetrant+5-HT2C+receptor+antagonist&doi=10.1016%2FS0028-3908%2897%2900038-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2897%2900038-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252897%252900038-5%26sid%3Dliteratum%253Aachs%26aulast%3DKennett%26aufirst%3DG.%2BA.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DBright%26aufirst%3DF.%26aulast%3DTrail%26aufirst%3DB.%26aulast%3DRiley%26aufirst%3DG.%26aulast%3DHolland%26aufirst%3DG.%26aulast%3DAvenell%26aufirst%3DK.%2BY.%26aulast%3DStean%26aufirst%3DT.%26aulast%3DUpton%26aufirst%3DN.%26aulast%3DBromidge%26aufirst%3DS.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DBlackburn%26aufirst%3DT.%2BP.%26atitle%3DSB%2520242084%252C%2520a%2520selective%2520and%2520brain%2520penetrant%25205-HT2C%2520receptor%2520antagonist%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D609%26epage%3D620%26doi%3D10.1016%2FS0028-3908%2897%2900038-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silenieks, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lannoy, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izhakova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, P. J.</span><span> </span><span class="NLM_article-title">Evaluation of chemically diverse 5-HT<sub>2C</sub> receptor agonists on behaviours motivated by food and nicotine and on side effect profiles</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span><span class="refDoi"> DOI: 10.1007/s00213-012-2919-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1007%2Fs00213-012-2919-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=23184281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslekt7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2013&pages=475-490&author=G.+A.+Higginsauthor=L.+B.+Silenieksauthor=W.+Lauauthor=I.+A.+de+Lannoyauthor=D.+K.+Leeauthor=J.+Izhakovaauthor=K.+Coenauthor=A.+D.+Leauthor=P.+J.+Fletcher&title=Evaluation+of+chemically+diverse+5-HT2C+receptor+agonists+on+behaviours+motivated+by+food+and+nicotine+and+on+side+effect+profiles&doi=10.1007%2Fs00213-012-2919-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of chemically diverse 5-HT2C receptor agonists on behaviours motivated by food and nicotine and on side effect profiles</span></div><div class="casAuthors">Higgins, G. A.; Silenieks, L. B.; Lau, W.; de Lannoy, I. A. M.; Lee, D. K. H.; Izhakova, J.; Coen, K.; Le, A. D.; Fletcher, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-490</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Selective 5-HT2C receptor agonists, such as lorcaserin, are being developed for the treatment of obesity.  Studies suggest that they may also have therapeutic potential for addictive behaviors including nicotine dependence, although few drugs of this class have been evaluated.  Objectives: The primary aim was to evaluate the highly selective 5-HT2C agonist, CP-809101, against food-motivated (operant FR5 and progressive ratio schedules, palatability-induced feeding) and nicotine-motivated (i.v. self-administration, drug discrimination) behaviors in rats and to compare with equiv. findings for the structurally distinct 5-HT2C receptor agonists lorcaserin and Ro 60-0175.  The secondary aims were to evaluate the side effect profiles of lorcaserin and CP-809101 and to det. the plasma levels of lorcaserin at a dose (1 mg/kg) that reduces both food and nicotine reinforcement for comparison to plasma concns. reported in human trials.  Results: CP-809101 (0.3-3 mg/kg SC) reduced responding for both nicotine and food and blocked the discriminative stimulus properties of nicotine in a similar manner to lorcaserin and Ro 60-0175.  Behaviors such as hypolocomotion, chewing and ptosis became evident following both CP-809101 and lorcaserin administration at higher doses.  Plasma levels of lorcaserin were of similar range to those reported in obesity trials.  Conclusions: These studies support the utility of 5-HT2C agonists as a therapeutic approach to treat nicotine dependence.  Plasma exposure levels after acute lorcaserin treatment suggest that equiv. dosages could be used to evaluate these drugs in obesity and smoking cessation trials.  Finally, there may be differences in the side effect profiles between lorcaserin and CP-809101, raising the possibility for tolerability differences amongst 5-HT2C agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp_oofEQ4547Vg90H21EOLACvtfcHk0ljrhQE9rJA88Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslekt7fI&md5=e895a2f2a65fca2eb4e70873c2dd8734</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs00213-012-2919-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-012-2919-2%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DSilenieks%26aufirst%3DL.%2BB.%26aulast%3DLau%26aufirst%3DW.%26aulast%3Dde%2BLannoy%26aufirst%3DI.%2BA.%26aulast%3DLee%26aufirst%3DD.%2BK.%26aulast%3DIzhakova%26aufirst%3DJ.%26aulast%3DCoen%26aufirst%3DK.%26aulast%3DLe%26aufirst%3DA.%2BD.%26aulast%3DFletcher%26aufirst%3DP.%2BJ.%26atitle%3DEvaluation%2520of%2520chemically%2520diverse%25205-HT2C%2520receptor%2520agonists%2520on%2520behaviours%2520motivated%2520by%2520food%2520and%2520nicotine%2520and%2520on%2520side%2520effect%2520profiles%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D226%26spage%3D475%26epage%3D490%26doi%3D10.1007%2Fs00213-012-2919-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Dawes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggard-Gibbons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miake-Lye, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroes, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shekelle, P. G.</span><span> </span><span class="NLM_article-title">Mental health conditions among patients seeking and undergoing bariatric surgery. A meta-analysis</span> <span class="citation_source-journal">J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span><span class="refDoi"> DOI: 10.1001/jama.2015.18118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1001%2Fjama.2015.18118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVartbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2016&pages=150-163&author=A.+J.+Dawesauthor=M.+Maggard-Gibbonsauthor=A.+R.+Maherauthor=M.+J.+Boothauthor=I.+Miake-Lyeauthor=J.+M.+Beroesauthor=P.+G.+Shekelle&title=Mental+health+conditions+among+patients+seeking+and+undergoing+bariatric+surgery.+A+meta-analysis&doi=10.1001%2Fjama.2015.18118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Mental health conditions among patients seeking and undergoing bariatric surgery a meta-analysis</span></div><div class="casAuthors">Dawes, Aaron J.; Maggard-Gibbons, Melinda; Maher, Alicia R.; Booth, Marika J.; Miake-Lye, Isomi; Beroes, Jessica M.; Shekelle, Paul G.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">150-163</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">1538-3598</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">IMPORTANCE Bariatric surgery is assocd. with sustained wt. loss and improved phys. health status for severely obese individuals.  Mental health conditions may be common among patients seeking bariatric surgery; however, the prevalence of these conditions and whether they are assocd. with postoperative outcomes remains unknown.  OBJECTIVE To det. the prevalence of mental health conditions among bariatric surgery candidates and recipients, to evaluate the assocn. between preoperative mental health conditions and health outcomes following bariatric surgery, and to evaluate the assocn. between surgery and the clin. course of mental health conditions.  DATA SOURCES We searched PubMed, MEDLINE on OVID, and PsycINFO for studies published between Jan. 1988 and Nov. 2015.  Study quality was assessed using an adapted tool for risk of bias; quality of evidence was rated based on GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria.  FINDINGS We identified 68 publications meeting inclusion criteria: 59 reporting the prevalence of preoperative mental health conditions (65 363 patients) and 27 reporting assocns. between preoperative mental health conditions and postoperative outcomes (50 182 patients).  Among patients seeking and undergoing bariatric surgery, the most common mental health conditions, based on random-effects ests. of prevalence, were depression (19% [95%CI, 14%-25%]) and binge eating disorder (17%[95%CI, 13%-21%]).  There was conflicting evidence regarding the assocn. between preoperative mental health conditions and postoperative wt. loss.  Neither depression nor binge eating disorder was consistently assocd. with differences in wt. outcomes.  Bariatric surgery was, however, consistently assocd. with postoperative decreases in the prevalence of depression (7 studies; 8%-74%decrease) and the severity of depressive symptoms (6 studies; 40%-70%decrease).  CONCLUSIONS AND RELEVANCE Mental health conditions are common among bariatric surgery patients-in particular, depression and binge eating disorder.  There is inconsistent evidence regarding the assocn. between preoperative mental health conditions and postoperative wt. loss.  Moderate-quality evidence supports an assocn. between bariatric surgery and lower rates of depression postoperatively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7MPDh-S6HV7Vg90H21EOLACvtfcHk0ljrhQE9rJA88Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVartbjE&md5=a2ce128eec267c6a34eec593d0b3dc6a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1001%2Fjama.2015.18118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2015.18118%26sid%3Dliteratum%253Aachs%26aulast%3DDawes%26aufirst%3DA.%2BJ.%26aulast%3DMaggard-Gibbons%26aufirst%3DM.%26aulast%3DMaher%26aufirst%3DA.%2BR.%26aulast%3DBooth%26aufirst%3DM.%2BJ.%26aulast%3DMiake-Lye%26aufirst%3DI.%26aulast%3DBeroes%26aufirst%3DJ.%2BM.%26aulast%3DShekelle%26aufirst%3DP.%2BG.%26atitle%3DMental%2520health%2520conditions%2520among%2520patients%2520seeking%2520and%2520undergoing%2520bariatric%2520surgery.%2520A%2520meta-analysis%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2016%26volume%3D315%26spage%3D150%26epage%3D163%26doi%3D10.1001%2Fjama.2015.18118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Crespillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavón, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero-Zerbo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Llebrez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Valero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bermúdez-Silva, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suárez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fonseca, F. R.</span><span> </span><span class="NLM_article-title">Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">1899</span><span class="NLM_x">–</span> <span class="NLM_lpage">1915</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01477.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1111%2Fj.1476-5381.2011.01477.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=21557739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2011&pages=1899-1915&author=A.+Crespilloauthor=M.+Alonsoauthor=M.+Vidaauthor=F.+J.+Pav%C3%B3nauthor=A.+Serranoauthor=P.+Riveraauthor=Y.+Romero-Zerboauthor=P.+Fern%C3%A1ndez-Llebrezauthor=A.+Mart%C3%ADnezauthor=V.+P%C3%A9rez-Valeroauthor=F.+J.+Berm%C3%BAdez-Silvaauthor=J.+Su%C3%A1rezauthor=F.+R.+de+Fonseca&title=Reduction+of+body+weight%2C+liver+steatosis+and+expression+of+stearoyl-CoA+desaturase+1+by+the+isoflavone+daidzein+in+diet-induced+obesity&doi=10.1111%2Fj.1476-5381.2011.01477.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity</span></div><div class="casAuthors">Crespillo, A.; Alonso, M.; Vida, M.; Pavon, F. J.; Serrano, A.; Rivera, P.; Romero-Zerbo, Y.; Fernandez-Llebrez, P.; Martinez, A.; Perez-Valero, V.; Bermudez-Silva, F. J.; Suarez, J.; de Fonseca, F. R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1899-1915</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: The lack of safe and effective treatments for obesity has increased interest in natural products that may serve as alternative therapies.  From this perspective, we have analyzed the effects of daidzein, one of the main soy isoflavones, on diet-induced obesity in rats.  Exptl. Approach: Rats made obese after exposure to a very (60%) high fat-content diet were treated with daidzein (50 mg·kg-1) for 14 days.  The dose was selected on the basis of the acute effects of this isoflavone on a feeding test.  After 14 days, animals were killed and plasma, white and brown adipose tissue, muscle and liver studied for the levels and expression of metabolites, proteins and genes relevant to lipid metab.  Key Results: A single treatment (acute) with daidzein dose-dependently reduced food intake.  Chronic treatment (daily for 14 days) reduced wt. gain and fat content in liver, accompanied by high leptin and low adiponectin levels in plasma.  While skeletal muscle was weakly affected by treatment, both adipose tissue and liver displayed marked changes after treatment with daidzein, affecting transcription factors and lipogenic enzymes, particularly stearoyl CoA desaturase 1, a pivotal enzyme in obesity.  Expression of uncoupling protein 1, an important enzyme for thermogenesis, was increased in brown adipose tissue after daidzein treatment.  Conclusions and Implications: These results support the use of isoflavones in diet-induced obesity, esp. when hepatic steatosis is present and open a new field of use for these natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAaEqrubpdQLVg90H21EOLACvtfcHk0ljfwpV94vl2HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsLzF&md5=e7eb04760b40ceeea2d07cb9f99419d3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01477.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01477.x%26sid%3Dliteratum%253Aachs%26aulast%3DCrespillo%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DVida%26aufirst%3DM.%26aulast%3DPav%25C3%25B3n%26aufirst%3DF.%2BJ.%26aulast%3DSerrano%26aufirst%3DA.%26aulast%3DRivera%26aufirst%3DP.%26aulast%3DRomero-Zerbo%26aufirst%3DY.%26aulast%3DFern%25C3%25A1ndez-Llebrez%26aufirst%3DP.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez-Valero%26aufirst%3DV.%26aulast%3DBerm%25C3%25BAdez-Silva%26aufirst%3DF.%2BJ.%26aulast%3DSu%25C3%25A1rez%26aufirst%3DJ.%26aulast%3Dde%2BFonseca%26aufirst%3DF.%2BR.%26atitle%3DReduction%2520of%2520body%2520weight%252C%2520liver%2520steatosis%2520and%2520expression%2520of%2520stearoyl-CoA%2520desaturase%25201%2520by%2520the%2520isoflavone%2520daidzein%2520in%2520diet-induced%2520obesity%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D164%26spage%3D1899%26epage%3D1915%26doi%3D10.1111%2Fj.1476-5381.2011.01477.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Gomez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trigo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Arco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cippitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nava, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fonseca, F. R.</span><span> </span><span class="NLM_article-title">A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">9612</span><span class="NLM_x">–</span> <span class="NLM_lpage">9617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=12417686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVGmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=9612-9617&author=R.+Gomezauthor=M.+Navarroauthor=B.+Ferrerauthor=J.+M.+Trigoauthor=A.+Bilbaoauthor=I.+Del+Arcoauthor=A.+Cippitelliauthor=F.+Navaauthor=D.+Piomelliauthor=F.+R.+de+Fonseca&title=A+peripheral+mechanism+for+CB1+cannabinoid+receptor-dependent+modulation+of+feeding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding</span></div><div class="casAuthors">Gomez, Raquel; Navarro, Miguel; Ferrer, Belen; Trigo, Jose M.; Bilbao, Ainhoa; Del Arco, Ignacio; Cippitelli, Andrea; Nava, Felice; Piomelli, Daniele; Rodriguez de Fonseca, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9612-9617</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies suggest that the endocannabinoid system modulates feeding.  Despite the existence of central mechanisms for the regulation of food intake by endocannabinoids, evidence indicates that peripheral mechanisms may also exist.  To test this hypothesis, the authors investigated (1) the effects of feeding on intestinal anandamide accumulation; (2) the effects of central (intracerebroventricular) and peripheral (i.p.) administration of the endocannabinoid agonist anandamide, the synthetic cannabinoid agonist R-(+)-(2,3-dihydro-5-methyl-3-[(4-morpholinyl)methyl]pyrol[1,2,3-de]-1,4-benzoxazin-6-yl)(1-naphthalenyl) methanone monomethanesulfonate (WIN55,212-2), and the CB1-selective antagonist N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR141716A) on food intake in rats; and (3) the effects of sensory deafferentation on the modulation of feeding by cannabinoids.  Food deprivation produced a sevenfold increase in anandamide content in the small intestine but not in the brain or stomach.  Refeeding normalized intestinal anandamide levels.  Peripheral but not central administration of anandamide or WIN55,212-2 promoted hyperphagia in partially satiated rats.  Similarly, peripheral but not central administration of SR141716A reduced food intake.  Capsaicin deafferentation abolished the peripheral effects of both cannabinoid agonists and antagonists, suggesting that these agents modulate food intake by acting on CB1 receptors located on capsaicin-sensitive sensory terminals.  Oleoylethanolamide, a noncannabinoid fatty ethanolamide that acts peripherally, prevented hyperphagia induced by the endogenous cannabinoid anandamide.  Pretreatment with SR141716A enhanced the inhibition of feeding induced by i.p. administration of oleoylethanolamide.  The results reveal an unexpected role for peripheral CB1 receptors in the regulation of feeding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9nrazAFzXBbVg90H21EOLACvtfcHk0ljfwpV94vl2HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVGmtrY%253D&md5=fc4d9c4d6e02f99a5554187ece898b85</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DFerrer%26aufirst%3DB.%26aulast%3DTrigo%26aufirst%3DJ.%2BM.%26aulast%3DBilbao%26aufirst%3DA.%26aulast%3DDel%2BArco%26aufirst%3DI.%26aulast%3DCippitelli%26aufirst%3DA.%26aulast%3DNava%26aufirst%3DF.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3Dde%2BFonseca%26aufirst%3DF.%2BR.%26atitle%3DA%2520peripheral%2520mechanism%2520for%2520CB1%2520cannabinoid%2520receptor-dependent%2520modulation%2520of%2520feeding%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D9612%26epage%3D9617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Rodríguez de Fonseca, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escuredo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nava, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murillo-Rodriguez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffrida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoVerme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaetani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kathuria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">An anorexic lipid mediator regulated by feeding</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><span class="refDoi"> DOI: 10.1038/35102582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1038%2F35102582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=11700558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFahs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=209-212&author=F.+R.+Rodr%C3%ADguez+de+Fonsecaauthor=M.+Navarroauthor=R.+Gomezauthor=L.+Escuredoauthor=F.+Navaauthor=J.+Fuauthor=E.+Murillo-Rodriguezauthor=A.+Giuffridaauthor=J.+LoVermeauthor=S.+Gaetaniauthor=S.+Kathuriaauthor=C.+Gallauthor=D.+Piomelli&title=An+anorexic+lipid+mediator+regulated+by+feeding&doi=10.1038%2F35102582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An anorexic lipid mediator regulated by feeding</span></div><div class="casAuthors">Rodriguez de Fonseca, F.; Navarro, M.; Gomez, R.; Escuredo, L.; Nava, F.; Fu, J.; Murillo-Rodriguez, E.; Gluffrida, A.; Lo Verme, J.; Gaetani, S.; Kathurla, S.; Gall, C.; Piomell, D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue">6860</span>),
    <span class="NLM_cas:pages">209-212</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors show that, in rats, food deprivation markedly reduces oleylethanolamide (OEA) biosynthesis in the small intestine.  Administration of OEA causes a potent and persistent decrease in food intake and gain in body mass.  This anorexic effect is behaviorally selective and is assocd. with the discrete activation of brain regions (the paraventricular hypothalamic nucleus and the nucleus of the solitary tract) involved in the control of satiety.  OEA does not affect food intake when injected into the brain ventricles, and its anorexic actions are prevented when peripheral sensory fibers are removed by treatment with capsaicin.  These results indicate that OEA is a lipid mediator involved in the peripheral regulation of feeding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40Gb0kaK8SLVg90H21EOLACvtfcHk0ljfwpV94vl2HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFahs7c%253D&md5=07430859a5e7cd93d0ce5d79364c4b6e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2F35102582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35102582%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%2Bde%2BFonseca%26aufirst%3DF.%2BR.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DEscuredo%26aufirst%3DL.%26aulast%3DNava%26aufirst%3DF.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DMurillo-Rodriguez%26aufirst%3DE.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DLoVerme%26aufirst%3DJ.%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DKathuria%26aufirst%3DS.%26aulast%3DGall%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAn%2520anorexic%2520lipid%2520mediator%2520regulated%2520by%2520feeding%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D209%26epage%3D212%26doi%3D10.1038%2F35102582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Eric A. Wold, Erik J. Garcia, Christopher T. Wild, Joanna M. Miszkiel, Claudia A. Soto, Jianping Chen, Konrad Pazdrak, Robert G. Fox, Noelle C. Anastasio, Kathryn A. Cunningham, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT2C Receptor-Positive Allosteric Modulators with Enhanced Drug-like Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7529-7544. <a href="https://doi.org/10.1021/acs.jmedchem.9b01953" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01953%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-Phenylpiperidine-2-Carboxamide%252BAnalogues%252Bas%252BSerotonin%252B5-HT2C%252BReceptor-Positive%252BAllosteric%252BModulators%252Bwith%252BEnhanced%252BDrug-like%252BProperties%26aulast%3DWold%26aufirst%3DEric%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D16122019%26date%3D07072020%26date%3D22062020%26volume%3D63%26issue%3D14%26spage%3D7529%26epage%3D7544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher
T. Wild, Joanna M. Miszkiel, Eric A. Wold, Claudia A. Soto, Chunyong Ding, Rachel M. Hartley, Mark A. White, Noelle C. Anastasio, Kathryn A. Cunningham, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 288-305. <a href="https://doi.org/10.1021/acs.jmedchem.8b00401" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00401%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BCharacterization%252Bof%252B4-Undecylpiperidine-2-carboxamides%252Bas%252BPositive%252BAllosteric%252BModulators%252Bof%252Bthe%252BSerotonin%252B%2525285-HT%252529%252B5-HT2C%252BReceptor%26aulast%3DWild%26aufirst%3DChristopher%2BT.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D12032018%26date%3D13042018%26date%3D05042018%26volume%3D62%26issue%3D1%26spage%3D288%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 88-127. <a href="https://doi.org/10.1021/acs.jmedchem.8b00875" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BModulation%252Bof%252BClass%252BA%252BGPCRs%25253A%252BTargets%25252C%252BAgents%25252C%252Band%252BEmerging%252BConcepts%26aulast%3DWold%26aufirst%3DEric%2BA.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D02062018%26date%3D28082018%26date%3D14082018%26volume%3D62%26issue%3D1%26spage%3D88%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael L.  Mathai</span>. </span><span class="cited-content_cbyCitation_article-title">Has the bloom gone out of lorcaserin following the CAMELLIA-TIMI61 trial?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2021,</strong> <em>22 </em>
                                    (3)
                                     , 261-264. <a href="https://doi.org/10.1080/14656566.2020.1858795" title="DOI URL">https://doi.org/10.1080/14656566.2020.1858795</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2020.1858795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2020.1858795%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DHas%252Bthe%252Bbloom%252Bgone%252Bout%252Bof%252Blorcaserin%252Bfollowing%252Bthe%252BCAMELLIA-TIMI61%252Btrial%25253F%26aulast%3DMathai%26aufirst%3DMichael%2BL.%26date%3D2021%26date%3D2020%26volume%3D22%26issue%3D3%26spage%3D261%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang-Yu  Ye</span>, <span class="hlFld-ContribAuthor ">Zhi-Qin  Liang</span>, <span class="hlFld-ContribAuthor ">Cong  Jin</span>, <span class="hlFld-ContribAuthor ">Qi-Wei  Lang</span>, <span class="hlFld-ContribAuthor ">Gen-Qiang  Chen</span>, <span class="hlFld-ContribAuthor ">Xumu  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design of oxa-spirocyclic PHOX ligands for the asymmetric synthesis of lorcaserin
              via
              iridium-catalyzed asymmetric hydrogenation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (2)
                                     , 195-198. <a href="https://doi.org/10.1039/D0CC06311H" title="DOI URL">https://doi.org/10.1039/D0CC06311H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC06311H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC06311H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DDesign%252Bof%252Boxa-spirocyclic%252BPHOX%252Bligands%252Bfor%252Bthe%252Basymmetric%252Bsynthesis%252Bof%252Blorcaserin%252Bvia%252Biridium-catalyzed%252Basymmetric%252Bhydrogenation%26aulast%3DYe%26aufirst%3DXiang-Yu%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D2%26spage%3D195%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary  Chinigo</span>, <span class="hlFld-ContribAuthor ">Yiqing  Feng</span>, <span class="hlFld-ContribAuthor ">Susan  Hoy</span>, <span class="hlFld-ContribAuthor ">Ricardo  Lira</span>, <span class="hlFld-ContribAuthor ">Matthew  Perry</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridazines and Their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00082-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00082-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00082-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00082-2%26sid%3Dliteratum%253Aachs%26atitle%3DPyridazines%252Band%252BTheir%252BBenzo%252BDerivatives%26aulast%3DChinigo%26aufirst%3DGary%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Fasciani</span>, <span class="hlFld-ContribAuthor ">Francesco  Petragnano</span>, <span class="hlFld-ContribAuthor ">Gabriella  Aloisi</span>, <span class="hlFld-ContribAuthor ">Francesco  Marampon</span>, <span class="hlFld-ContribAuthor ">Marco  Carli</span>, <span class="hlFld-ContribAuthor ">Marco  Scarselli</span>, <span class="hlFld-ContribAuthor ">Roberto  Maggio</span>, <span class="hlFld-ContribAuthor ">Mario  Rossi</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (11)
                                     , 388. <a href="https://doi.org/10.3390/ph13110388" title="DOI URL">https://doi.org/10.3390/ph13110388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13110388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13110388%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DAllosteric%252BModulators%252Bof%252BG%252BProtein-Coupled%252BDopamine%252Band%252BSerotonin%252BReceptors%25253A%252BA%252BNew%252BClass%252Bof%252BAtypical%252BAntipsychotics%26aulast%3DFasciani%26aufirst%3DIrene%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D11%26spage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lu  Xu</span>, <span class="hlFld-ContribAuthor ">Wenze  Li</span>, <span class="hlFld-ContribAuthor ">Venkatakaushik  Voleti</span>, <span class="hlFld-ContribAuthor ">Dong-Jing  Zou</span>, <span class="hlFld-ContribAuthor ">Elizabeth M. C.  Hillman</span>, <span class="hlFld-ContribAuthor ">Stuart  Firestein</span>. </span><span class="cited-content_cbyCitation_article-title">Widespread receptor-driven modulation in peripheral olfactory coding. </span><span class="cited-content_cbyCitation_journal-name">Science</span><span> <strong>2020,</strong> <em>368 </em>
                                    (6487)
                                     , eaaz5390. <a href="https://doi.org/10.1126/science.aaz5390" title="DOI URL">https://doi.org/10.1126/science.aaz5390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/science.aaz5390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscience.aaz5390%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%26atitle%3DWidespread%252Breceptor-driven%252Bmodulation%252Bin%252Bperipheral%252Bolfactory%252Bcoding%26aulast%3DXu%26aufirst%3DLu%26date%3D2020%26date%3D2020%26volume%3D368%26issue%3D6487%26spage%3Deaaz5390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María L.  López-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Bellinda  Benhamú</span>, <span class="hlFld-ContribAuthor ">Henar  Vázquez-Villa</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric modulators targeting GPCRs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 195-241. <a href="https://doi.org/10.1016/B978-0-12-816228-6.00011-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-816228-6.00011-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816228-6.00011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816228-6.00011-8%26sid%3Dliteratum%253Aachs%26atitle%3DAllosteric%252Bmodulators%252Btargeting%252BGPCRs%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DMar%25C3%25ADa%2BL.%26date%3D2020%26spage%3D195%26epage%3D241%26pub%3DElsevier%26atitle%3DGPCRs%26date%3D2020%26volume%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathryn A.  Cunningham</span>, <span class="hlFld-ContribAuthor ">Leonard L.  Howell</span>, <span class="hlFld-ContribAuthor ">Noelle C.  Anastasio</span>. </span><span class="cited-content_cbyCitation_article-title">Serotonin neurobiology in cocaine use disorder. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 745-802. <a href="https://doi.org/10.1016/B978-0-444-64125-0.00040-2" title="DOI URL">https://doi.org/10.1016/B978-0-444-64125-0.00040-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-64125-0.00040-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-64125-0.00040-2%26sid%3Dliteratum%253Aachs%26atitle%3DSerotonin%252Bneurobiology%252Bin%252Bcocaine%252Buse%252Bdisorder%26aulast%3DCunningham%26aufirst%3DKathryn%2BA.%26date%3D2020%26spage%3D745%26epage%3D802%26pub%3DElsevier%26atitle%3DHandbook%252Bof%252Bthe%252BBehavioral%252BNeurobiology%252Bof%252BSerotonin%26date%3D2020%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ganesh S.  Ghotekar</span>, <span class="hlFld-ContribAuthor ">Devidas A.  More</span>, <span class="hlFld-ContribAuthor ">Viswanadh  Nalla</span>, <span class="hlFld-ContribAuthor ">M.  Muthukrishnan</span>. </span><span class="cited-content_cbyCitation_article-title">A new enantioselective synthesis of antiobesity drug lorcaserin. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2019,</strong> <em>43 </em>
                                    (43)
                                     , 16876-16880. <a href="https://doi.org/10.1039/C9NJ04234B" title="DOI URL">https://doi.org/10.1039/C9NJ04234B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ04234B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ04234B%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DA%252Bnew%252Benantioselective%252Bsynthesis%252Bof%252Bantiobesity%252Bdrug%252Blorcaserin%26aulast%3DGhotekar%26aufirst%3DGanesh%2BS.%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D43%26spage%3D16876%26epage%3D16880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric A.  Wold</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Wild</span>, <span class="hlFld-ContribAuthor ">Kathryn A.  Cunningham</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (16)
                                     , 1381-1398. <a href="https://doi.org/10.2174/1568026619666190709101449" title="DOI URL">https://doi.org/10.2174/1568026619666190709101449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190709101449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190709101449%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bthe%252B5-HT2C%252BReceptor%252Bin%252BBiological%252BContext%252Band%252Bthe%252BCurrent%252BState%252Bof%252B5-HT2C%252BReceptor%252BLigand%252BDevelopment%26aulast%3DWold%26aufirst%3DEric%2BA.%26date%3D2019%26volume%3D19%26issue%3D16%26spage%3D1381%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kartikey  Singh</span>, <span class="hlFld-ContribAuthor ">Chandan  Sona</span>, <span class="hlFld-ContribAuthor ">Vikash  Ojha</span>, <span class="hlFld-ContribAuthor ">Maninder  Singh</span>, <span class="hlFld-ContribAuthor ">Ankita  Mishra</span>, <span class="hlFld-ContribAuthor ">Ajeet  Kumar</span>, <span class="hlFld-ContribAuthor ">Mohammad Imran  Siddiqi</span>, <span class="hlFld-ContribAuthor ">Rama P.  Tripathi</span>, <span class="hlFld-ContribAuthor ">Prem N.  Yadav</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of dual role of piperazine-linked phenyl cyclopropyl methanone as positive allosteric modulator of 5-HT2C and negative allosteric modulator of 5-HT2B receptors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 499-516. <a href="https://doi.org/10.1016/j.ejmech.2018.12.070" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.070%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bdual%252Brole%252Bof%252Bpiperazine-linked%252Bphenyl%252Bcyclopropyl%252Bmethanone%252Bas%252Bpositive%252Ballosteric%252Bmodulator%252Bof%252B5-HT2C%252Band%252Bnegative%252Ballosteric%252Bmodulator%252Bof%252B5-HT2B%252Breceptors%26aulast%3DSingh%26aufirst%3DKartikey%26date%3D2019%26volume%3D164%26spage%3D499%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui Li  Heng</span>, <span class="hlFld-ContribAuthor ">Chin Fei  Chee</span>, <span class="hlFld-ContribAuthor ">Chun Keng  Thy</span>, <span class="hlFld-ContribAuthor ">Jia Ti  Tee</span>, <span class="hlFld-ContribAuthor ">Sek Peng  Chin</span>, <span class="hlFld-ContribAuthor ">Deron R.  Herr</span>, <span class="hlFld-ContribAuthor ">Michael J. C.  Buckle</span>, <span class="hlFld-ContribAuthor ">Ian C.  Paterson</span>, <span class="hlFld-ContribAuthor ">Stephen W.  Doughty</span>, <span class="hlFld-ContribAuthor ">Noorsaadah  Abd. Rahman</span>, <span class="hlFld-ContribAuthor ">Lip Yong  Chung</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro functional evaluation of isolaureline, dicentrine and glaucine enantiomers at 5-HT
              2
              and α
              1
              receptors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2019,</strong> <em>93 </em>
                                    (2)
                                     , 132-138. <a href="https://doi.org/10.1111/cbdd.13390" title="DOI URL">https://doi.org/10.1111/cbdd.13390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13390%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DIn%252Bvitro%252Bfunctional%252Bevaluation%252Bof%252Bisolaureline%25252C%252Bdicentrine%252Band%252Bglaucine%252Benantiomers%252Bat%252B5-HT%252B2%252Band%252B%2525CE%2525B1%252B1%252Breceptors%26aulast%3DHeng%26aufirst%3DHui%2BLi%26date%3D2019%26date%3D2018%26volume%3D93%26issue%3D2%26spage%3D132%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Zhou</span>, <span class="hlFld-ContribAuthor ">Kathryn A.  Cunningham</span>. </span><span class="cited-content_cbyCitation_article-title">Positive-allosteric modulation of the 5-HT2C receptor: implications for neuropsychopharmacology and neurotherapeutics. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2019,</strong> <em>44 </em>
                                    (1)
                                     , 230-231. <a href="https://doi.org/10.1038/s41386-018-0190-x" title="DOI URL">https://doi.org/10.1038/s41386-018-0190-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-018-0190-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-018-0190-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DPositive-allosteric%252Bmodulation%252Bof%252Bthe%252B5-HT2C%252Breceptor%25253A%252Bimplications%252Bfor%252Bneuropsychopharmacology%252Band%252Bneurotherapeutics%26aulast%3DZhou%26aufirst%3DJia%26date%3D2019%26date%3D2018%26volume%3D44%26issue%3D1%26spage%3D230%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Classical serotoninergic antiobesity agents. (B) 5-HT<sub>2C</sub>R ligands: agonist <b>3</b> clinically used for obesity and positive allosteric modulator <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. High-throughput screening of Vivia Biotech chemical library and subsequent functional validation allowed to identify hit compound <b>5</b>, which entered a medicinal chemistry program for the search of allosteric modulators of the 5-HT<sub>2C</sub>R.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Compounds <b>6</b>–<b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amino <i>N</i>-heterocycle, NaBH(OAc)<sub>3</sub>, 1,2-dichloroethane, Δ, 8–15 h, 11–21% (<b>6</b>–<b>9</b>, <b>13</b>); (b) (i) amino <i>N</i>-heterocycle, <i>p</i>-TSA, toluene, Δ, 5–18 h, (ii) NaBH<sub>4</sub>, MeOH, 0 °C to rt, 1–2 h, 33–73% (<b>10</b>–<b>12</b>, <b>14</b>).</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Target Compounds <b>15</b>–<b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) pyridin-3-amine, <i>p</i>-TSA, toluene, Δ, 1–6 h, (ii) NaBH<sub>4</sub>, MeOH, 0 °C to rt, 15–60 min, 26–91%; (b) benzyl bromide derivative, NaH, DMF, rt, 15 min, 30–87%; (c) 2-, 3-, or 4-(bromomethyl)pyridine hydrobromide, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 2 h, 86–94%; (d) (bromomethyl)cyclopropane, NaH, DMF, rt, 1 h, 97%.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vitro characterization of compound <b>11</b>. (A) 5-HT curves in the presence of increasing concentrations of the compound. (B) Effect of the compound in the absence of serotonin. (C) Allosteric effect of the compound at the 5-HT<sub>2A</sub>R. (D) Agonist effect of the compound at the 5-HT<sub>2A</sub>R. (E) Allosteric effect of the compound at the 5-HT<sub>2B</sub>R. (F) Agonist effect of the compound at the 5-HT<sub>2B</sub>R. (G) Binding displacements of orthosteric ligands of the 5-HT<sub>2C</sub>R by 10 μM <b>11</b>. Points represent the mean ± SD (vertical bars) of triplicate measurements.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo behavior of the new 5-HT<sub>2C</sub>R PAM <b>11</b>. (A) The 5-HT<sub>2C</sub>R agonist <b>47</b> reduced feeding in food deprived animals. (B) In a similar model, compound <b>11</b> has a more potent and prolonged action. (C) When administered in animals with restricted food access (4 h/day), <b>11</b> reduced daily feeding. (D) This effect was also observed when the compound was given to animals with continuous access to food. (E,F) In both models, food restriction and continuous access, repeated administration of <b>11</b> reduced net body weight gain. (G) Compound <b>11</b> induced hypolocomotion in the elevated plus maze. (H) Compound <b>11</b> did not result in conditioned taste aversion. * denotes statistical significance (<i>P</i> < 0.01) when compared to control. <i>N</i> = at least 8 animals per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/medium/jm-2017-00994u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo allosteric modulation of serotonin-induced feeding suppression by compound <b>11</b>. (A) Selective serotonin reuptake inhibitor sertraline induced a mild feeding suppression in rats. (B,C) When the extracellular concentration of serotonin increased upon administration of sertraline, the anorectic effect of <b>11</b> was potentiated. * denotes statistical significance (<i>P</i> < 0.01) when compared to control. <i>N</i> = at least 8 animals per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00994/20171215/images/large/jm-2017-00994u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00994&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i34">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span> </span><span class="NLM_article-title">Overweight and obesity</span>. Global Health Observatory (GHO) Data; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span><a href="http://www.who.int/gho/ncd/risk_factors/overweight_text/en/" class="extLink">http://www.who.int/gho/ncd/risk_factors/overweight_text/en/</a> (Sep 25, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Overweight+and+obesity.+Global+Health+Observatory+%28GHO%29+Data%3B+World+Health+Organization%3A+Geneva%2C+2017%3B+http%3A%2F%2Fwww.who.int%2Fgho%2Fncd%2Frisk_factors%2Foverweight_text%2Fen%2F+%28Sep+25%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DOverweight%2520and%2520obesity%26jtitle%3DGlobal%2520Health%2520Observatory%2520%2528GHO%2529%2520Data%26pub%3DWorld%2520Health%2520Organization%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Marseglia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Angelo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicotera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Rosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigo, T.</span><span> </span><span class="NLM_article-title">Oxidative Stress in Obesity: A critical component in human diseases</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.3390/ijms16010378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.3390%2Fijms16010378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlKiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=378-400&author=L.+Marsegliaauthor=S.+Mantiauthor=G.+D%E2%80%99Angeloauthor=A.+Nicoteraauthor=E.+Parisiauthor=G.+Di+Rosaauthor=E.+Gittoauthor=T.+Arrigo&title=Oxidative+Stress+in+Obesity%3A+A+critical+component+in+human+diseases&doi=10.3390%2Fijms16010378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress in obesity: a critical component in human diseases</span></div><div class="casAuthors">Marseglia, Lucia; Manti, Sara; D'Angelo, Gabriella; Nicotera, Antonio; Parisi, Eleonora; Di Rosa, Gabriella; Gitto, Eloisa; Arrigo, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">378-400, 23 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Obesity, a social problem worldwide, is characterized by an increase in body wt. that results in excessive fat accumulation.  Obesity is a major cause of morbidity and mortality and leads to several diseases, including metabolic syndrome, diabetes mellitus, cardiovascular, fatty liver diseases, and cancer.  Growing evidence allows us to understand the crit. role of adipose tissue in controlling the physic-pathol. mechanisms of obesity and related comorbidities.  Recently, adipose tissue, esp. in the visceral compartment, has been considered not only as a simple energy depository tissue, but also as an active endocrine organ releasing a variety of biol. active mols. known as adipocytokines or adipokines.  Based on the complex interplay between adipokines, obesity is also characterized by chronic low grade inflammation with permanently increased oxidative stress (OS).  Over-expression of oxidative stress damages cellular structures together with under-prodn. of anti-oxidant mechanisms, leading to the development of obesity-related complications.  The aim of this review is to summarize what is known in the relationship between OS in obesity and obesity-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSjsR0zOPwTLVg90H21EOLACvtfcHk0lia6_Zzxvhq5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlKiug%253D%253D&md5=47a74f93ffd527c3f910745104a69937</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3390%2Fijms16010378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms16010378%26sid%3Dliteratum%253Aachs%26aulast%3DMarseglia%26aufirst%3DL.%26aulast%3DManti%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DG.%26aulast%3DNicotera%26aufirst%3DA.%26aulast%3DParisi%26aufirst%3DE.%26aulast%3DDi%2BRosa%26aufirst%3DG.%26aulast%3DGitto%26aufirst%3DE.%26aulast%3DArrigo%26aufirst%3DT.%26atitle%3DOxidative%2520Stress%2520in%2520Obesity%253A%2520A%2520critical%2520component%2520in%2520human%2520diseases%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2015%26volume%3D16%26spage%3D378%26epage%3D400%26doi%3D10.3390%2Fijms16010378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Colman, E.</span><span> </span><span class="NLM_article-title">Food and Drug Administration’s obesity drug guidance document: a short history</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">2156</span><span class="NLM_x">–</span> <span class="NLM_lpage">2164</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.111.028381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1161%2FCIRCULATIONAHA.111.028381" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=2156-2164&author=E.+Colman&title=Food+and+Drug+Administration%E2%80%99s+obesity+drug+guidance+document%3A+a+short+history&doi=10.1161%2FCIRCULATIONAHA.111.028381"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.111.028381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.111.028381%26sid%3Dliteratum%253Aachs%26aulast%3DColman%26aufirst%3DE.%26atitle%3DFood%2520and%2520Drug%2520Administration%25E2%2580%2599s%2520obesity%2520drug%2520guidance%2520document%253A%2520a%2520short%2520history%26jtitle%3DCirculation%26date%3D2012%26volume%3D125%26spage%3D2156%26epage%3D2164%26doi%3D10.1161%2FCIRCULATIONAHA.111.028381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Rodríguez, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, K. M.</span><span> </span><span class="NLM_article-title">Past, present, and future of pharmacologic therapy in obesity</span> <span class="citation_source-journal">Prim. Care Clin. Office Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1016/j.pop.2015.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.pop.2015.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=26896200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A280%3ADC%252BC28jis12qtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2016&pages=61-67&author=J.+E.+Rodr%C3%ADguezauthor=K.+M.+Campbell&title=Past%2C+present%2C+and+future+of+pharmacologic+therapy+in+obesity&doi=10.1016%2Fj.pop.2015.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Past, Present, and Future of Pharmacologic Therapy in Obesity</span></div><div class="casAuthors">Rodriguez Jose E; Campbell Kendall M</div><div class="citationInfo"><span class="NLM_cas:title">Primary care</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-7, viii</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Medications for obesity management can be divided into 4 groups: antidepressants (naltrexone/bupropion), stimulants (phentermine, phendimetrazine, diethylpropion, phentermine/topiramate), fat blockers (orlistat), and diabetes medications (liraglutide).  Each group has specific therapeutic effects, adverse effects, and costs.  Two medications are indicated for long-term use in obesity: lorcaserin and orlistat.  Other available medications are for short-term use.  High cost makes many of these medications inaccessible for underserved and poor patients.  Because of misuse potential, many obesity medications are also classified as controlled substances.  There are no medications currently approved for use in pregnant or lactating women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFDeXC2zSiSENHe_gFldTbfW6udTcc2eajkrB7JQ1ALbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jis12qtQ%253D%253D&md5=8cea992350a28916c2f2e31fc24eb535</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pop.2015.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pop.2015.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DJ.%2BE.%26aulast%3DCampbell%26aufirst%3DK.%2BM.%26atitle%3DPast%252C%2520present%252C%2520and%2520future%2520of%2520pharmacologic%2520therapy%2520in%2520obesity%26jtitle%3DPrim.%2520Care%2520Clin.%2520Office%2520Pract.%26date%3D2016%26volume%3D43%26spage%3D61%26epage%3D67%26doi%3D10.1016%2Fj.pop.2015.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Narayanaswami, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwoskin, L. P.</span><span> </span><span class="NLM_article-title">Obesity: Current and potential pharmacotherapeutics and targets</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.pharmthera.2016.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=27773782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslelsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2017&pages=116-147&author=V.+Narayanaswamiauthor=L.+P.+Dwoskin&title=Obesity%3A+Current+and+potential+pharmacotherapeutics+and+targets&doi=10.1016%2Fj.pharmthera.2016.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Obesity: Current and potential pharmacotherapeutics and targets</span></div><div class="casAuthors">Narayanaswami, Vidya; Dwoskin, Linda P.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">116-147</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Obesity is a global epidemic that contributes to a no. of health complications including cardiovascular disease, type 2 diabetes, cancer and neuropsychiatric disorders.  Pharmacotherapeutic strategies to treat obesity are urgently needed.  Research over the past two decades has increased substantially our knowledge of central and peripheral mechanisms underlying homeostatic energy balance.  Homeostatic mechanisms involve multiple components including neuronal circuits, some originating in hypothalamus and brain stem, as well as peripherally-derived satiety, hunger and adiposity signals that modulate neural activity and regulate eating behavior.  Dysregulation of one or more of these homeostatic components results in obesity.  Coincident with obesity, reward mechanisms that regulate hedonic aspects of food intake override the homeostatic regulation of eating.  In addn. to functional interactions between homeostatic and reward systems in the regulation of food intake, homeostatic signals have the ability to alter vulnerability to drug abuse.  Regarding the treatment of obesity, pharmacol. monotherapies primarily focus on a single protein target.  FDA-approved monotherapy options include phentermine (Adipex-P), orlistat (Xenical), lorcaserin (Belviq) and liraglutide (Saxenda).  However, monotherapies have limited efficacy, in part due to the recruitment of alternate and counter-regulatory pathways.  Consequently, a multi-target approach may provide greater benefit.  Recently, two combination products have been approved by the FDA to treat obesity, including phentermine/topiramate (Qsymia) and naltrexone/bupropion (Contrave).  The current review provides an overview of homeostatic and reward mechanisms that regulate energy balance, potential therapeutic targets for obesity and current treatment options, including some candidate therapeutics in clin. development.  Finally, challenges in anti-obesity drug development are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpId6VccvHlSrVg90H21EOLACvtfcHk0lia6_Zzxvhq5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslelsL7M&md5=f634c2c8f018cdbbcbf5c016221ef751</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DNarayanaswami%26aufirst%3DV.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DObesity%253A%2520Current%2520and%2520potential%2520pharmacotherapeutics%2520and%2520targets%26jtitle%3DPharmacol.%2520Ther.%26date%3D2017%26volume%3D170%26spage%3D116%26epage%3D147%26doi%3D10.1016%2Fj.pharmthera.2016.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Halford, J. C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrold, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, J. E.</span><span> </span><span class="NLM_article-title">Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.2174/1389450053174550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.2174%2F1389450053174550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=15777190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVSqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=201-213&author=J.+C.+G.+Halfordauthor=J.+A.+Harroldauthor=C.+L.+Lawtonauthor=J.+E.+Blundell&title=Serotonin+%285-HT%29+drugs%3A+effects+on+appetite+expression+and+use+for+the+treatment+of+obesity&doi=10.2174%2F1389450053174550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity</span></div><div class="casAuthors">Halford, Jason C. G.; Harrold, Joanne A.; Lawton, Clare L.; Blundell, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-213</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The pivotal role of 5-HT in the control of appetite was formally proposed nearly 30 years ago.  In particular endogenous hypothalamic 5-HT was implicated in the processes of within meal satiation and the end state of post meal satiety.  Of the numerous 5-HT receptor subtypes currently identified, 5-HT1B and 5-HT2C receptors are believed to mediate the 5-HT induced satiety.  5-HT drugs such as d-fenfluramine, selective serotoninergic reuptake inhibitor (SSRIs) and 5-HT2C receptor agonists have all been shown to significantly attenuate rodent body wt. gain, an effect strongly assocd. with marked hypophagia.  D-Fenfluramine, sibutramine, fluoxetine and the 5-HT2C receptor agonist mCPP have also all been shown to reduce caloric intake by modifying appetite in both lean and obese humans.  Specifically, 5-HT drugs reduce appetite prior to and after the consumption of fixed caloric loads, and reduce pre meal appetite and caloric intake at ad libitum meals.  Clin. significant wt. loss over a year or more can be produced by both d-fenfluramine and sibutramine treatment, but apparently not by the SSRI fluoxetine.  Treatment with the preferential 5-HT2C receptor agonist mCPP and the serotonin precursor 5-HTP was also shown to produce wt. loss in the obese.  Issues around the actual and possible side effects of these compds., and in the case of d-fenfluramine toxicity, have led to a search for drugs that act selectively on the CNS 5-HT receptors crit. to the satiety response.  Currently, a new generation of 5-HT2C selective agonists were developed (including Ro 60-0175, Org 12962, VER-3323, BVT-933 and YM348) and at least one, ADP356, is currently undergoing clin. trials.  Hopefully, such drugs will be as or even more effective at regulating appetite and controlling body wt., and will also be free of their predecessors' side effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMX0O68S7bxLVg90H21EOLACvtfcHk0lhtV6ccZCgkMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVSqu74%253D&md5=ad765430cb2787564d02aad590309068</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1389450053174550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450053174550%26sid%3Dliteratum%253Aachs%26aulast%3DHalford%26aufirst%3DJ.%2BC.%2BG.%26aulast%3DHarrold%26aufirst%3DJ.%2BA.%26aulast%3DLawton%26aufirst%3DC.%2BL.%26aulast%3DBlundell%26aufirst%3DJ.%2BE.%26atitle%3DSerotonin%2520%25285-HT%2529%2520drugs%253A%2520effects%2520on%2520appetite%2520expression%2520and%2520use%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2005%26volume%3D6%26spage%3D201%26epage%3D213%26doi%3D10.2174%2F1389450053174550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Sargent, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, A. J.</span><span> </span><span class="NLM_article-title">Targeting 5-HT receptors for the treatment of obesity</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1016/j.coph.2011.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.coph.2011.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=21330209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1Wqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=52-58&author=B.+J.+Sargentauthor=A.+J.+Henderson&title=Targeting+5-HT+receptors+for+the+treatment+of+obesity&doi=10.1016%2Fj.coph.2011.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting 5-HT receptors for the treatment of obesity</span></div><div class="casAuthors">Sargent, Bruce J.; Henderson, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-58</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin is known to have anorectic properties through centrally acting mechanisms.  Three serotonin receptors have been implicated in mediating these effects: 5-HT1B, 5-HT2C and 5-HT6.  Hypophagic effects are elicited through agonism of the former two receptors, whereas antagonism of the 5-HT6 receptor appears to have an anorectic effect.  All three targets have been validated through extensive studies including knockout mice and selective ligand assessment.  5-HT1B receptor agonists have limited utility due to mechanism-based side effects, whereas 5-HT2C receptor agonists suffer from challenges assocd. with selectivity over the closely related 5-HT2A and 5-HT2B receptors.  5-HT6 receptor antagonists appear to offer great promise, although the mechanisms through which they reduce food intake and body wt. are not fully understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7HpGhwkLC1LVg90H21EOLACvtfcHk0lhtV6ccZCgkMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1Wqs70%253D&md5=6f7344a29e985af4a08d76626dc6d8f9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2011.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2011.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DSargent%26aufirst%3DB.%2BJ.%26aulast%3DHenderson%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%25205-HT%2520receptors%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2011%26volume%3D11%26spage%3D52%26epage%3D58%26doi%3D10.1016%2Fj.coph.2011.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Benhamu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Fontecha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez-Villa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Rodriguez, M. L.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>6</sub> receptor antagonists for the treatment of cognitive deficiency in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7160</span><span class="NLM_x">–</span> <span class="NLM_lpage">7181</span><span class="refDoi"> DOI: 10.1021/jm5003952</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5003952" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVWjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7160-7181&author=B.+Benhamuauthor=M.+Martin-Fontechaauthor=H.+Vazquez-Villaauthor=L.+Pardoauthor=M.+L.+Lopez-Rodriguez&title=Serotonin+5-HT6+receptor+antagonists+for+the+treatment+of+cognitive+deficiency+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm5003952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT6 Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer's Disease</span></div><div class="casAuthors">Benhamu, Bellinda; Martin-Fontecha, Mar; Vazquez-Villa, Henar; Pardo, Leonardo; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7160-7181</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is one of the most frequent causes of death and disability worldwide and has a significant clin. and socioeconomic impact.  In the search for novel therapeutic strategies, serotonin 5-HT6 receptor (5-HT6R) has been proposed as a promising drug target for cognition enhancement in AD.  This manuscript reviews the compelling evidence for the implication of this receptor in learning and memory processes.  We have summarized the current status of the medicinal chem. of 5-HT6R antagonists and the encouraging preclin. findings that demonstrate their significant procognitive behavioral effects in a no. of learning paradigms, probably acting through modulation of multiple neurotransmitter systems and signaling pathways.  The results of the ongoing clin. trials are eagerly awaited to shed some light on the validation of 5-HT6R antagonists as a new drug class for the treatment of symptomatic cognitive impairment in AD, either as stand-alone therapy or in combination with established agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeTO6_2THvaLVg90H21EOLACvtfcHk0lhtV6ccZCgkMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVWjs7c%253D&md5=bf8d2cba73f72e04a5caf8b295647064</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm5003952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5003952%26sid%3Dliteratum%253Aachs%26aulast%3DBenhamu%26aufirst%3DB.%26aulast%3DMartin-Fontecha%26aufirst%3DM.%26aulast%3DVazquez-Villa%26aufirst%3DH.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%2BL.%26atitle%3DSerotonin%25205-HT6%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520cognitive%2520deficiency%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7160%26epage%3D7181%26doi%3D10.1021%2Fjm5003952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fozard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartig, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mylecharane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, P. P. A.,  VII.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology classification of receptors for 5-hydroxytriptamine (serotonin)</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=157-203&author=D.+Hoyerauthor=D.+E.+Clarkeauthor=J.+R.+Fozardauthor=P.+R.+Hartigauthor=G.+R.+Martinauthor=E.+J.+Mylecharaneauthor=P.+R.+Saxenaauthor=P.+P.+A.+Humphrey&title=International+Union+of+Pharmacology+classification+of+receptors+for+5-hydroxytriptamine+%28serotonin%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DD.%2BE.%26aulast%3DFozard%26aufirst%3DJ.%2BR.%26aulast%3DHartig%26aufirst%3DP.%2BR.%26aulast%3DMartin%26aufirst%3DG.%2BR.%26aulast%3DMylecharane%26aufirst%3DE.%2BJ.%26aulast%3DSaxena%26aufirst%3DP.%2BR.%26aulast%3DHumphrey%26aufirst%3DP.%2BP.%2BA.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology%2520classification%2520of%2520receptors%2520for%25205-hydroxytriptamine%2520%2528serotonin%2529%26jtitle%3DPharmacol.%2520Rev.%26date%3D1994%26volume%3D46%26spage%3D157%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Göthert, M.</span><span> </span><span class="NLM_article-title">Serotonin discovery and stepwise disclosure of 5-HT receptor complexity over four decades. Part I. General background and discovery of serotonin as a basis for 5-HT receptor identification</span> <span class="citation_source-journal">Pharmacol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span><span class="refDoi"> DOI: 10.1016/S1734-1140(13)71059-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2FS1734-1140%2813%2971059-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=24145072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FoslSksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=771-786&author=M.+G%C3%B6thert&title=Serotonin+discovery+and+stepwise+disclosure+of+5-HT+receptor+complexity+over+four+decades.+Part+I.+General+background+and+discovery+of+serotonin+as+a+basis+for+5-HT+receptor+identification&doi=10.1016%2FS1734-1140%2813%2971059-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin discovery and stepwise disclosure of 5-HT receptor complexity over four decades. Part I. General background and discovery of serotonin as a basis for 5-HT receptor identification</span></div><div class="casAuthors">Gothert Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological reports : PR</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">771-86</span>
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    </div><div class="casAbstract">This review contains background information on the serotonin system, furthermore the suggestion to introduce the term Contemporary Witness Report (CWR) for a novel type of review and, as the main part, an overview over the history of serotonin discovery as a basis for the identification of its receptor heterogeneity and the increase in complexity by genetic and allosteric variation.  The present article conforms to CWRs in historical and autobiographical elements, in more emphasis on the author's work than in conventional reviews and in aspects neglected in previous reviews, but not in the main feature namely the work of a scientist with comprehensive expertise in a field in which, over long time, he/she continuously performed research and published.  A scientist complying with these requirements is a contemporary witness in that field.  His report on the scientific achievements in that period, a CWR, comprises confirmation and putative re-interpretation of data from a superior viewpoint.  Identification of serotonin's vascular properties (publication year: 1912) as an "adrenaline mimicking substance" (without attempt to isolate it) by O'Connor preceded the discovery of serotonin in the gastrointestinal tract by Erspamer [1937] and in blood by Rapport [1948, 1949], who identified its structure as 5-hydroxytryptamine [1949].  Detection as a neurotransmitter in invertebrates suggested its occurrence in vertebrate CNS as well.  This was verified by finding it in dog, rat and rabbit brain [1953].  The Falck-Hillarp technique [1962] visualized serotonin neurones as fluorescent structures.  The neurotoxin 5,7-dihydroxytryptamine [1972] indirectly proved the involvement of 5-HT in multiple CNS functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8YM4IM1P4MmK_SFaaT9INfW6udTcc2eZAU-axqUngBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FoslSksw%253D%253D&md5=b0ccd66eefde0739af8f71b433e76126</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1734-1140%2813%2971059-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1734-1140%252813%252971059-4%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6thert%26aufirst%3DM.%26atitle%3DSerotonin%2520discovery%2520and%2520stepwise%2520disclosure%2520of%25205-HT%2520receptor%2520complexity%2520over%2520four%2520decades.%2520Part%2520I.%2520General%2520background%2520and%2520discovery%2520of%2520serotonin%2520as%2520a%2520basis%2520for%25205-HT%2520receptor%2520identification%26jtitle%3DPharmacol.%2520Rep.%26date%3D2013%26volume%3D65%26spage%3D771%26epage%3D786%26doi%3D10.1016%2FS1734-1140%2813%2971059-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">McCorvy, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Structure and function of serotonin G protein-coupled receptors</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.pharmthera.2015.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=25601315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVeisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2015&pages=129-142&author=J.+D.+McCorvyauthor=B.+L.+Roth&title=Structure+and+function+of+serotonin+G+protein-coupled+receptors&doi=10.1016%2Fj.pharmthera.2015.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of serotonin G protein-coupled receptors</span></div><div class="casAuthors">McCorvy, John D.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">129-142</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Serotonin receptors are prevalent throughout the nervous system and the periphery, and remain one of the most lucrative and promising drug discovery targets for disorders ranging from migraine headaches to neuropsychiatric disorders such as schizophrenia and depression.  There are 14 distinct serotonin receptors, of which 13 are G protein-coupled receptors (GPCRs), which are targets for approx. 40% of the approved medicines.  Recent crystallog. and biochem. evidence has provided a converging understanding of the basic structure and functional mechanics of GPCR activation.  Currently, two GPCR crystal structures exist for the serotonin family, the 5-HT1B and 5-HT2B receptor, with the antimigraine and valvulopathic drug ergotamine bound.  The first serotonin crystal structures not only provide the first evidence of serotonin receptor topog. but also provide mechanistic explanations into functional selectivity or biased agonism.  This review will detail the findings of these crystal structures from a mol. and mutagenesis perspective for driving rational drug design for novel therapeutics incorporating biased signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpapliz37oS9bVg90H21EOLACvtfcHk0lhP-I9t0Fosqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVeisbs%253D&md5=0fcfbc57dfb7047f6ffb7c74d437b5b4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DStructure%2520and%2520function%2520of%2520serotonin%2520G%2520protein-coupled%2520receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D150%26spage%3D129%26epage%3D142%26doi%3D10.1016%2Fj.pharmthera.2015.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannon, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G. R.</span><span> </span><span class="NLM_article-title">Molecular, pharmacological and functional diversity of 5-HT receptors</span> <span class="citation_source-journal">Pharmacol. Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span><span class="refDoi"> DOI: 10.1016/S0091-3057(01)00746-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2FS0091-3057%2801%2900746-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=11888546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvVChtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=533-554&author=D.+Hoyerauthor=J.+P.+Hannonauthor=G.+R.+Martin&title=Molecular%2C+pharmacological+and+functional+diversity+of+5-HT+receptors&doi=10.1016%2FS0091-3057%2801%2900746-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular, pharmacological and functional diversity of 5-HT receptors</span></div><div class="casAuthors">Hoyer, Daniel; Hannon, Jason P.; Martin, Graeme R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">533-554</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Serotonin (5-hydroxytryptamine, 5-HT) is probably unique among the monoamines in that its effects are subserved by as many as 13 distinct heptahelical, G-protein-coupled receptors (GPCRs) and one (presumably a family of) ligand-gated ion channel(s).  These receptors are divided into seven distinct classes (5-HT1 to 5-HT7) largely on the basis of their structural and operational characteristics.  While this degree of phys. diversity clearly underscores the physiol. importance of serotonin, evidence for an even greater degree of operational diversity continues to emerge.  The challenge for modern 5-HT research has therefore been to define more precisely the properties of the systems that make this incredible diversity possible.  Much progress in this regard has been made during the last decade with the realization that serotonin is possibly the least conservative monoamine transmitter and the cloning of its many receptors.  Coupled with the actions of an extremely avid and efficient reuptake system, this array of receptor subtypes provides almost limitless signaling capabilities to the extent that one might even question the need for other transmitter systems.  However, the complexity of the system appears endless, since posttranslational modifications, such as alternate splicing and RNA editing, increase the no. of proteins, oligomerization and heteromerization increase the no. of complexes, and multiple G-protein suggest receptor trafficking, allowing phenotypic switching and crosstalk within and possibly between receptor families.  Whether all these possibilities are used in vivo under physiol. or pathol. conditions remains to be firmly established, but in essence, such variety will keep the 5-HT community busy for quite some time.  Those who may have predicted that mol. biol. would largely simplify the life of pharmacologists have missed the point for 5-HT research in particular and, most probably, for many other transmitters.  This chapter is an attempt to summarize very briefly 5-HT receptor diversity.  The reward for unraveling this complex array of serotonin receptor-effector systems may be substantial, the ultimate prize being the development of important new drugs in a range of disease areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3Nndw8IzJXLVg90H21EOLACvtfcHk0lhP-I9t0Fosqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvVChtb4%253D&md5=2fd7e3ea62256c616688b45794a7606a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2801%2900746-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252801%252900746-8%26sid%3Dliteratum%253Aachs%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DHannon%26aufirst%3DJ.%2BP.%26aulast%3DMartin%26aufirst%3DG.%2BR.%26atitle%3DMolecular%252C%2520pharmacological%2520and%2520functional%2520diversity%2520of%25205-HT%2520receptors%26jtitle%3DPharmacol.%2520Biochem.%2520Behav.%26date%3D2002%26volume%3D71%26spage%3D533%26epage%3D554%26doi%3D10.1016%2FS0091-3057%2801%2900746-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cremers, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotty, F.</span><span> </span><span class="NLM_article-title">Therapeutic potential of 5-HT<sub>2C</sub> receptor ligands</span> <span class="citation_source-journal">Sci. World J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1870</span><span class="NLM_x">–</span> <span class="NLM_lpage">1885</span><span class="refDoi"> DOI: 10.1100/tsw.2010.180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1100%2Ftsw.2010.180" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1870-1885&author=N.+H.+Jensenauthor=T.+I.+Cremersauthor=F.+Sotty&title=Therapeutic+potential+of+5-HT2C+receptor+ligands&doi=10.1100%2Ftsw.2010.180"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1100%2Ftsw.2010.180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1100%252Ftsw.2010.180%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DCremers%26aufirst%3DT.%2BI.%26aulast%3DSotty%26aufirst%3DF.%26atitle%3DTherapeutic%2520potential%2520of%25205-HT2C%2520receptor%2520ligands%26jtitle%3DSci.%2520World%2520J.%26date%3D2010%26volume%3D10%26spage%3D1870%26epage%3D1885%26doi%3D10.1100%2Ftsw.2010.180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, P. J.</span><span> </span><span class="NLM_article-title">From obesity to substance abuse: therapeutic opportunities for 5-HT<sub>2C</sub> receptor agonists</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1016/j.tips.2013.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.tips.2013.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=24041919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCltLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=560-570&author=G.+A.+Higginsauthor=E.+M.+Sellersauthor=P.+J.+Fletcher&title=From+obesity+to+substance+abuse%3A+therapeutic+opportunities+for+5-HT2C+receptor+agonists&doi=10.1016%2Fj.tips.2013.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists</span></div><div class="casAuthors">Higgins, Guy A.; Sellers, Edward M.; Fletcher, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">560-570</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent US Food and Drug Administration (FDA) approval of the serotonin (5-hydroxytryptamine, 5-HT) 5-HT2C receptor agonist lorcaserin for the treatment of obesity represents a new therapeutic drug class available to the clinic.  Preclin. evidence supports the potential for this drug class to treat other related conditions such as substance abuse.  In the present article we review this evidence and further suggest that overlapping neurobiol. systems may contribute to an anti-addictive and anti-obesity profile.  The availability of selective 5-HT2C agonists provides an opportunity to evaluate their potential as treatments for nicotine dependence or psychostimulant abuse, conditions for which there is significant medical need but only limited available treatment options.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjiS3n6R_5trVg90H21EOLACvtfcHk0lj672hrHX-SEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCltLzK&md5=cf21273e52cb1ba62821886489381717</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DSellers%26aufirst%3DE.%2BM.%26aulast%3DFletcher%26aufirst%3DP.%2BJ.%26atitle%3DFrom%2520obesity%2520to%2520substance%2520abuse%253A%2520therapeutic%2520opportunities%2520for%25205-HT2C%2520receptor%2520agonists%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D560%26epage%3D570%26doi%3D10.1016%2Fj.tips.2013.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Di Giovanni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Deurwaerdere, P.</span><span> </span><span class="NLM_article-title">New therapeutic opportunities for 5-HT<sub>2C</sub> receptor ligands in neuropsychiatric disorders</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.pharmthera.2015.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=26617215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFertbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2016&pages=125-162&author=G.+Di+Giovanniauthor=P.+De+Deurwaerdere&title=New+therapeutic+opportunities+for+5-HT2C+receptor+ligands+in+neuropsychiatric+disorders&doi=10.1016%2Fj.pharmthera.2015.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders</span></div><div class="casAuthors">Di Giovanni, Giuseppe; De Deurwaerdere, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">125-162</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The 5-HT2C receptor (R) displays a widespread distribution in the CNS and is involved in the action of 5-HT in all brain areas.  Knowledge of its functional role in the CNS pathophysiol. has been impaired for many years due to the lack of drugs capable of discriminating among 5-HT2R subtypes, and to a lesser extent to the 5-HT1B, 5-HT5, 5-HT6 and 5-HT7Rs.  The situation has changed since the mid-90s due to the increased availability of new and selective synthesized compds., the creation of 5-HT2C knock out mice, and the progress made in mol. biol.  Many pharmacol. classes of drugs including antipsychotics, antidepressants and anxiolytics display affinities toward 5-HT2CRs and new 5-HT2C ligands have been developed for various neuropsychiatric disorders.  The 5-HT2CR is presumed to mediate tonic/constitutive and phasic controls on the activity of different central neurobiol. networks.  Preclin. data illustrate this complexity to a point that pharmaceutical companies developed either agonists or antagonists for the same disease.In order to better comprehend this complexity, this review will briefly describe the mol. pharmacol. of 5-HT2CRs, as well as their cellular impacts in general, before addressing its central distribution in the mammalian brain.  Thereafter, we review the preclin. efficacy of 5-HT2C ligands in numerous behavioral tests modeling human diseases, highlighting the multiple and competing actions of the 5-HT2CRs in neurobiol. networks and monoaminergic systems.  Notably, we will focus this evidence in the context of the physiopathol. of psychiatric and neurol. disorders including Parkinson's disease, levodopa-induced dyskinesia, and epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf-mGI3WW0GLVg90H21EOLACvtfcHk0lj672hrHX-SEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFertbfK&md5=0ba9c76cf2a49eef118e6c46459f11f6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGiovanni%26aufirst%3DG.%26aulast%3DDe%2BDeurwaerdere%26aufirst%3DP.%26atitle%3DNew%2520therapeutic%2520opportunities%2520for%25205-HT2C%2520receptor%2520ligands%2520in%2520neuropsychiatric%2520disorders%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D157%26spage%3D125%26epage%3D162%26doi%3D10.1016%2Fj.pharmthera.2015.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Vickers, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifton, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dourish, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecott, L. H.</span><span> </span><span class="NLM_article-title">Reduced satiating effect of d-fenfluramine in serotonin 5-HT<sub>2C</sub> receptor mutant mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.1007/s002130050952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1007%2Fs002130050952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10353435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVOrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1999&pages=309-314&author=S.+P.+Vickersauthor=P.+G.+Cliftonauthor=C.+T.+Dourishauthor=L.+H.+Tecott&title=Reduced+satiating+effect+of+d-fenfluramine+in+serotonin+5-HT2C+receptor+mutant+mice&doi=10.1007%2Fs002130050952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice</span></div><div class="casAuthors">Vickers, Steven P.; Clifton, Peter G.; Dourish, Colin T.; Tecott, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">309-314</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Rationale: d-Fenfluramine stimulates the release of serotonin (5-HT) and is a potent inhibitor of the re-uptake of 5-HT into nerve terminals.  Administration of d-fenfluramine suppresses food intake in both animals and humans.  Objective: We have investigated the role of the 5-HT2C receptor in mediating the effect of d-fenfluramine on mouse food intake and the behavioral satiety sequence.  Methods: Mutant mice lacking serotonin 5-HT2C receptors and wild-type animals were habituated to a daily presentation of wet mash.  Animals were non-deprived and received d-fenfluramine (3-30 mg/kg) 30 min prior to being assessed for the presence of stereotypy and presented with wet mash.  The behavior of animals was obsd. for the subsequent 40 min and food intake was recorded.  Results: d-Fenfluramine dose-dependently inhibited the consumption of a palatable wet mash by the mice.  D-Fenfluramine (3 mg/kg) significantly reduced the amt. of wet mash consumed by wild-type mice and induced a temporal advance in the behavioral satiety sequence consistent with an enhancement of satiety.  Mutant mice were less sensitive to the satiating effects of 3 mg/kg d-fenfluramine.  Hence, this dose of d-fenfluramine had a reduced effect on both food consumption and the behavioral satiety sequence in the 5-HT2C mutant mice.  In contrast, mutant mice showed an increased sensitivity to the stereotypy induced by high doses of d-fenfluramine (10, 30 mg/kg) compared to that of wild-type littermates.  Conclusion: These data demonstrate a role for the 5-HT2C receptor in mediating d-fenfluramine-induced satiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0bnUdAboMgLVg90H21EOLACvtfcHk0lj672hrHX-SEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVOrs7o%253D&md5=e3dcad2d3328797a3516f4ee9c5e10a4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs002130050952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002130050952%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DS.%2BP.%26aulast%3DClifton%26aufirst%3DP.%2BG.%26aulast%3DDourish%26aufirst%3DC.%2BT.%26aulast%3DTecott%26aufirst%3DL.%2BH.%26atitle%3DReduced%2520satiating%2520effect%2520of%2520d-fenfluramine%2520in%2520serotonin%25205-HT2C%2520receptor%2520mutant%2520mice%26jtitle%3DPsychopharmacology%26date%3D1999%26volume%3D143%26spage%3D309%26epage%3D314%26doi%3D10.1007%2Fs002130050952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Vickers, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dourish, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennett, G. A.</span><span> </span><span class="NLM_article-title">Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT<sub>2C</sub> receptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span><span class="refDoi"> DOI: 10.1016/S0028-3908(01)00063-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2FS0028-3908%2801%2900063-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=11489456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslersr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=200-209&author=S.+P.+Vickersauthor=C.+T.+Dourishauthor=G.+A.+Kennett&title=Evidence+that+hypophagia+induced+by+d-fenfluramine+and+d-norfenfluramine+in+the+rat+is+mediated+by+5-HT2C+receptors&doi=10.1016%2FS0028-3908%2801%2900063-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors</span></div><div class="casAuthors">Vickers, S. P.; Dourish, C. T.; Kennett, G. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-209</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The present series of studies is the first to investigate the pharmacol. mechanisms underlying d-fenfluramine- and d-norfenfluramine-induced hypophagia in the rat using highly selective serotonin 5-HT2 receptor antagonists.  Administration of d-fenfluramine, and its major metabolite d-norfenfluramine, suppresses food intake in animals.  Both compds. stimulate the release of serotonin and are potent inhibitors of the re-uptake of 5-HT into nerve terminals.  In addn., d-norfenfluramine also acts as a direct 5-HT2B/2C receptor agonist.  Pre-treatment with the selective 5-HT2C receptor antagonist, SB-242084 (0.3-3 mg/kg), dose-dependently inhibited both d-fenfluramine- (3 mg/kg) and d-norfenfluramine-induced (2 mg/kg) hypophagia.  In contrast, the hypophagic effect of d-fenfluramine and d-norfenfluramine was unaffected by prior treatment with the highly selective 5-HT2B receptor antagonists, SB-215505 (0.3-3 mg/kg) and RS-127445 (1-3 mg/kg) or the 5-HT2A receptor antagonists MDL 100,907 (0.003-0.03 mg/kg) and ketanserin (0.2, 0.5 mg/kg).  In addn., the 5-HT1A receptor antagonist WAY-100635 (0.3, 1 mg/kg) and the 5-HT1B receptor antagonists GR-127935 (1, 2 mg/kg) and SB-224289 (2-10 mg/kg) did not affect d-fenfluramine-induced hypophagia.  These data provide unequivocal evidence for an important role of the 5-HT2C receptor in the mediation of d-fenfluramine and d-norfenfluramine-induced hypophagia in the rat and do not support the involvement of 5-HT1A/1B/2A/2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_6gzP7TyP27Vg90H21EOLACvtfcHk0li90_4qXZ9lHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslersr8%253D&md5=cf21b67409c141746f0bd6eeeab7d61a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2801%2900063-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252801%252900063-6%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DS.%2BP.%26aulast%3DDourish%26aufirst%3DC.%2BT.%26aulast%3DKennett%26aufirst%3DG.%2BA.%26atitle%3DEvidence%2520that%2520hypophagia%2520induced%2520by%2520d-fenfluramine%2520and%2520d-norfenfluramine%2520in%2520the%2520rat%2520is%2520mediated%2520by%25205-HT2C%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D41%26spage%3D200%26epage%3D209%26doi%3D10.1016%2FS0028-3908%2801%2900063-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Monck, N. J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennett, G. A.</span><span> </span><span class="NLM_article-title">5-HT<sub>2C</sub> Ligands: recent progress</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span><span class="refDoi"> DOI: 10.1016/S0079-6468(07)00006-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2FS0079-6468%2807%2900006-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=18381128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1ynsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=281-390&author=N.+J.+T.+Monckauthor=G.+A.+Kennett&title=5-HT2C+Ligands%3A+recent+progress&doi=10.1016%2FS0079-6468%2807%2900006-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C ligands: recent progress</span></div><div class="casAuthors">Monck, Nathaniel J. T.; Kennett, Guy A.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">281-390</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on the possible therapeutic utilities of selective ligands for the serotonin (5-hydroxytryptamine, 5-HT)2C receptor subtype, side-effect concerns, and medicinal chem. towards 5-HT2C ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVbF-EnQeF4LVg90H21EOLACvtfcHk0li90_4qXZ9lHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1ynsLk%253D&md5=f15301e46c3c6f77fa806bce3b8ce93e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2807%2900006-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252807%252900006-9%26sid%3Dliteratum%253Aachs%26aulast%3DMonck%26aufirst%3DN.%2BJ.%2BT.%26aulast%3DKennett%26aufirst%3DG.%2BA.%26atitle%3D5-HT2C%2520Ligands%253A%2520recent%2520progress%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D46%26spage%3D281%26epage%3D390%26doi%3D10.1016%2FS0079-6468%2807%2900006-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Garfield, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heisler, L. K.</span><span> </span><span class="NLM_article-title">Pharmacological targeting of the serotonergic system for the treatment of obesity</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">587</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1113/jphysiol.2008.164152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1113%2Fjphysiol.2008.164152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=19029184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=587&publication_year=2009&pages=49-60&author=A.+S.+Garfieldauthor=L.+K.+Heisler&title=Pharmacological+targeting+of+the+serotonergic+system+for+the+treatment+of+obesity&doi=10.1113%2Fjphysiol.2008.164152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological targeting of the serotonergic system for the treatment of obesity</span></div><div class="casAuthors">Garfield, Alastair S.; Heisler, Lora K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">587</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The attenuation of food intake as induced by an increase in serotonergic (5-hydroxytryptamine, 5-HT) efficacy has been a target of antiobesity pharmacotherapies.  However, the induction of tolerance and/or side-effects limited the clin. utility of the earliest serotonin-related medications.  With the global prevalence of obesity rising, there has been renewed interest in the manipulation of the serotonergic system as a point of pharmacol. intervention.  The serotonin2C receptor (5-HT2CR), serotonin1B (rodent)/serotonin1Dβ (human) receptor (5-HT1B/1DβR) and serotonin6 receptor (5-HT6R) represent the most promising serotonin receptor therapeutic targets.  Canonical serotonin receptor compds. have given way to a myriad of novel receptor-selective ligands, many of which have observable anorectic effects.  Here we review serotonergic compds. reducing ingestive behavior and discuss their clin. potential for the treatment of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO3heX7GBmk7Vg90H21EOLACvtfcHk0li90_4qXZ9lHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKls70%253D&md5=dc9107028ec848d1fe95cedee7daf5fc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2008.164152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2008.164152%26sid%3Dliteratum%253Aachs%26aulast%3DGarfield%26aufirst%3DA.%2BS.%26aulast%3DHeisler%26aufirst%3DL.%2BK.%26atitle%3DPharmacological%2520targeting%2520of%2520the%2520serotonergic%2520system%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Physiol.%26date%3D2009%26volume%3D587%26spage%3D49%26epage%3D60%26doi%3D10.1113%2Fjphysiol.2008.164152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span> </span><span class="NLM_article-title">5-HT<sub>2C</sub> receptor modulators: a patent survey</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1455</span><span class="refDoi"> DOI: 10.1517/13543776.2010.518956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1517%2F13543776.2010.518956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=20849206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWmtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1429-1455&author=J.+Leeauthor=M.+E.+Jungauthor=J.+Lee&title=5-HT2C+receptor+modulators%3A+a+patent+survey&doi=10.1517%2F13543776.2010.518956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C receptor modulators: a patent survey</span></div><div class="casAuthors">Lee, Junwon; Jung, Myung Eun; Lee, Jinhwa</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1429-1455</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The 5-HT2C receptor is a GPCR and is one of the 14 subtypes that constitute the serotonin receptor family.  The 5-HT2C receptor is exclusively expressed in the CNS where it demonstrates a wide distribution and displays high-affinity interactions with a wide variety of psychiatric medications.  Modulators of 5-HT2C have been implicated as a potential treatment for diseases of significant unmet medical need, including obesity, schizophrenia, depression, anxiety, Parkinson's disease, drug addiction, erectile dysfunction and urinary incontinence.  Thus, there is a great interest in developing potent and selective 5-HT2C receptor modulators.  Areas covered in this review: This review article highlights the research progress in 5-HT2C receptor modulators published in the patent literature between Jan. 2003 and June 2010, giving emphasis to the medicinal chemist's standpoint.  What the reader will gain: Readers will rapidly gain an overview of the various 5-HT2C receptor modulators reported in the patent literature in the past 8 years.  Furthermore, the readers will learn which structure type can interact with the 5-HT2C receptor.  In addn., the readers will be aware of the pharmaceutical companies that have been the main players in the field.  Take home message: There is substantial evidence supporting the concept that a selective 5-HT2C receptor modulator should provide benefit in the treatment of a variety of CNS disorders.  Although research efforts have identified several promising 5-HT2C receptor modulators that display high functional selectivity, further clin. efficacy and safety data are needed to prove their actual clin. utility.  Therefore, the query for selectively acting 5-HT2C receptor modulators is still ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowsaQEKrg_R7Vg90H21EOLACvtfcHk0li90_4qXZ9lHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWmtL%252FF&md5=43397f74d27751efdc505165ba96172c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.518956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.518956%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3D5-HT2C%2520receptor%2520modulators%253A%2520a%2520patent%2520survey%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D1429%26epage%3D1455%26doi%3D10.1517%2F13543776.2010.518956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hopkins, C. R.</span><span> </span><span class="NLM_article-title">ACS chemical neuroscience molecule spotlight on lorcaserin</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span><span class="refDoi"> DOI: 10.1021/cn100059u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100059u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSis73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=718-719&author=C.+R.+Hopkins&title=ACS+chemical+neuroscience+molecule+spotlight+on+lorcaserin&doi=10.1021%2Fcn100059u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">ACS Chemical Neuroscience Molecule Spotlight on Lorcaserin</span></div><div class="casAuthors">Hopkins, Corey R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">718-719</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Lorcaserin (APD-356) is the first in a new class of selective serotonin 5-hydroxytryptamine2C (5-HT2C) receptor agonists.  On Dec. 22, 2009, the compd.'s developer (Arena Pharmaceuticals) submitted an NDA to the FDA for approval for wt. management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjgKvE-QA1lLVg90H21EOLACvtfcHk0lhpLxLi7kos9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSis73M&md5=5e6686a83195f526726fcbd17b7819db</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcn100059u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100059u%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26atitle%3DACS%2520chemical%2520neuroscience%2520molecule%2520spotlight%2520on%2520lorcaserin%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D718%26epage%3D719%26doi%3D10.1021%2Fcn100059u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span>FY 2012 Innovative Drug Approvals; <span class="NLM_publisher-name">U.S. Food and Drug Administration</span>: <span class="NLM_publisher-loc">Silver Spring, MD</span>, December<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.fda.gov/downloads/aboutfda/reportsmanualsforms/reports/ucm330859.pdf" class="extLink">http://www.fda.gov/downloads/aboutfda/reportsmanualsforms/reports/ucm330859.pdf</a> (Sep 25, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FY+2012+Innovative+Drug+Approvals%3B+U.S.+Food+and+Drug+Administration%3A+Silver+Spring%2C+MD%2C+December+2012%3B+http%3A%2F%2Fwww.fda.gov%2Fdownloads%2Faboutfda%2Freportsmanualsforms%2Freports%2Fucm330859.pdf+%28Sep+25%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DFY%25202012%2520Innovative%2520Drug%2520Approvals%26pub%3DU.S.%2520Food%2520and%2520Drug%2520Administration%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kroeze, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1128</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span><span class="refDoi"> DOI: 10.1016/S0006-3223(98)00132-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2FS0006-3223%2898%2900132-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=9836016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFKqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=1128-1142&author=W.+K.+Kroezeauthor=B.+L.+Roth&title=The+molecular+biology+of+serotonin+receptors%3A+therapeutic+implications+for+the+interface+of+mood+and+psychosis&doi=10.1016%2FS0006-3223%2898%2900132-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis</span></div><div class="casAuthors">Kroeze, Wesley K.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1128-1142</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 152 refs., which summarizes the mol. biol. of serotonin (5-HT; 5-hydroxytryptamine) receptors and indicates the potential relevance of this information for the treatment of mood and psychotic disorders.  At least 15 sep. subtypes of 5-HT receptors have been identified by mol. cloning techniques to be distinct genetic entities.  Subtle differences in the primary amino acid sequences of these receptors can yield large differences in ligand selectivity.  Addnl., it has recently been discovered that drugs such as atypical antipsychotic drugs and serotonin-selective reuptake inhibitors may interact with a large no. of heretofore unknown 5-HT receptors.  Thus clozapine, for instance, has high affinity for at least four sep. 5-HT receptors, and it is unknown which of these receptors is essential for its unique therapeutic efficacy.  One way to approach these questions is to test subtype-selective agents, although there are few of these currently available.  Approaches to the design of subtype-selective ligands are described, including structure-based drug design and combinatorial approaches.  Modes of regulation of 5-HT receptors are also summarized, and it is emphasized that antipsychotic drugs and antidepressants likely exert their effects via nontranscriptional and posttranslational means.  Understanding the cellular mechanisms by which 5-HT receptors are regulated by psychopharmacol. agents is likely to yield novel insights into drug action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBEIwmClT3vbVg90H21EOLACvtfcHk0lhpLxLi7kos9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFKqurc%253D&md5=daae7df1a87e737a3cd49d844135a687</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2898%2900132-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252898%252900132-2%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DThe%2520molecular%2520biology%2520of%2520serotonin%2520receptors%253A%2520therapeutic%2520implications%2520for%2520the%2520interface%2520of%2520mood%2520and%2520psychosis%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D44%26spage%3D1128%26epage%3D1142%26doi%3D10.1016%2FS0006-3223%2898%2900132-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauser, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Evidence for possible involvement of 5-HT<sub>2B</sub> receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2836</span><span class="NLM_x">–</span> <span class="NLM_lpage">2841</span><span class="refDoi"> DOI: 10.1161/01.CIR.102.23.2836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1161%2F01.CIR.102.23.2836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=11104741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptVSjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=2836-2841&author=R.+B.+Rothmanauthor=M.+H.+Baumannauthor=J.+E.+Savageauthor=L.+Rauserauthor=A.+McBrideauthor=S.+J.+Hufeisenauthor=B.+L.+Roth&title=Evidence+for+possible+involvement+of+5-HT2B+receptors+in+the+cardiac+valvulopathy+associated+with+fenfluramine+and+other+serotonergic+medications&doi=10.1161%2F01.CIR.102.23.2836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications</span></div><div class="casAuthors">Rothman, Richard B.; Baumann, Michael H.; Savage, Jason E.; Rauser, Laura; McBride, Ace; Hufeisen, Sandra J.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2836-2841</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Serotonergic medications with various mechanisms of action are used to treat psychiatric disorders and are being investigated as treatments for drug dependence.  The occurrence of fenfluramine-assocd. valvular heart disease (VHD) has raised concerns that other serotonergic medications might also increase the risk of developing VHD.  We hypothesized that fenfluramine or its metabolite norfenfluramine and other medications known to produce VHD have preferentially high affinities for a particular serotonin receptor subtype capable of stimulating mitogenesis.  Medications known or suspected to cause VHD (pos. controls) and medications not assocd. with VHD (neg. controls) were screened for activity at 11 cloned serotonin receptor subtypes by use of ligand-binding methods and functional assays.  The pos. control drugs were (±)-fenfluramine; (+)-fenfluramine; (-)-fenfluramine; its metabolites (±)-norfenfluramine, (+)-norfenfluramine, and (-)-norfenfluramine; ergotamine; and methysergide and its metabolite methylergonovine.  The neg. control drugs were phentermine, fluoxetine, its metabolite norfluoxetine, and trazodone and its active metabolite m-chlorophenylpiperazine.  (±)-, (+)-, And (-)-Norfenfluramine, ergotamine, and methylergonovine all had preferentially high affinities for the cloned human serotonin 5-HT2B receptor and were partial to full agonists at the 5-HT2B receptor.  Our data imply that activation of 5-HT2B receptors is necessary to produce VHD and that serotonergic medications that do not activate 5-HT2B receptors are unlikely to produce VHD.  We suggest that all clin. available medications with serotonergic activity and their active metabolites be screened for agonist activity at 5-HT2B receptors and that clinicians should consider suspending their use of medications with significant activity at 5-HT2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6spUXOCLtLrVg90H21EOLACvtfcHk0lhpLxLi7kos9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptVSjtrs%253D&md5=6b8c6059885dd9b058859089914c61b3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.102.23.2836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.102.23.2836%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DSavage%26aufirst%3DJ.%2BE.%26aulast%3DRauser%26aufirst%3DL.%26aulast%3DMcBride%26aufirst%3DA.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DEvidence%2520for%2520possible%2520involvement%2520of%25205-HT2B%2520receptors%2520in%2520the%2520cardiac%2520valvulopathy%2520associated%2520with%2520fenfluramine%2520and%2520other%2520serotonergic%2520medications%26jtitle%3DCirculation%26date%3D2000%26volume%3D102%26spage%3D2836%26epage%3D2841%26doi%3D10.1161%2F01.CIR.102.23.2836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Fitzgerald, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corjay, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbaszade, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Largent, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartig, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D. W.</span><span> </span><span class="NLM_article-title">Possible role of valvular serotonin 5-HT<sub>2B</sub> receptors in the cardiopathy associated with fenfluramine</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10617681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslCltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=75-81&author=L.+W.+Fitzgeraldauthor=T.+C.+Burnauthor=B.+S.+Brownauthor=J.+P.+Pattersonauthor=M.+H.+Corjayauthor=P.+A.+Valentineauthor=J.+H.+Sunauthor=J.+R.+Linkauthor=I.+Abbaszadeauthor=J.+M.+Hollisauthor=B.+L.+Largentauthor=P.+R.+Hartigauthor=G.+F.+Hollisauthor=P.+C.+Meunierauthor=A.+J.+Robichaudauthor=D.+W.+Robertson&title=Possible+role+of+valvular+serotonin+5-HT2B+receptors+in+the+cardiopathy+associated+with+fenfluramine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine</span></div><div class="casAuthors">Fitzgerald, Lawrence W.; Burn, Timothy C.; Brown, Barry S.; Patterson, John P.; Corjay, Martha H.; Valentine, Patricia A.; Sun, Jung-Hui; Link, John R.; Abbaszade, Ilgar; Hollis, Jeannine M.; Largent, Brian L.; Hartig, Paul R.; Hollis, Gregory F.; Meunier, Paul C.; Robichaud, Albert J.; Robertson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-81</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dexfenfluramine was approved in the United States for longterm use as an appetite suppressant until it was reported to be assocd. with valvular heart disease.  The valvular changes (myofibroblast proliferation) are histopathol. indistinguishable from those obsd. in carcinoid disease or after long-term exposure to 5-hydroxytryptamine (5-HT)2-preferring ergot drugs (ergotamine, methysergide).  5-HT2 receptor stimulation is known to cause fibroblast mitogenesis, which could contribute to this lesion.  To elucidate the mechanism of "fenphen"-assocd. valvular lesions, we examd. the interaction of fenfluramine and its metabolite norfenfluramine with 5-HT2 receptor subtypes and examd. the expression of these receptors in human and porcine heart valves.  Fenfluramine binds weakly to 5-HT2A, 5-HT2B, and 5-HT2C receptors.  In contrast, norfenfluramine exhibited high affinity for 5-HT2B and 5-HT2C receptors and more moderate affinity for 5-HT2A receptors.  In cells expressing recombinant 5-HT2B receptors, norfenfluramine potently stimulated the hydrolysis of inositol phosphates, increased intracellular Ca2+, and activated the mitogen-activated protein kinase cascade, the latter of which has been linked to mitogenic actions of the 5-HT2B receptor.  The level of 5-HT2B and 5-HT2A receptor transcripts in heart valves was at least 300-fold higher than the levels of 5-HT2C receptor transcript, which were barely detectable.  We propose that preferential stimulation of valvular 5-HT2B receptors by norfenfluramine, ergot drugs, or 5-HT released from carcinoid tumors (with or without accompanying 5-HT2A receptor activation) may contribute to valvular fibroplasia in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmkbFOXGVxcLVg90H21EOLACvtfcHk0lgECDEeUYAyGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslCltA%253D%253D&md5=b99b778d0de695d377aa4f0006b6dc47</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DL.%2BW.%26aulast%3DBurn%26aufirst%3DT.%2BC.%26aulast%3DBrown%26aufirst%3DB.%2BS.%26aulast%3DPatterson%26aufirst%3DJ.%2BP.%26aulast%3DCorjay%26aufirst%3DM.%2BH.%26aulast%3DValentine%26aufirst%3DP.%2BA.%26aulast%3DSun%26aufirst%3DJ.%2BH.%26aulast%3DLink%26aufirst%3DJ.%2BR.%26aulast%3DAbbaszade%26aufirst%3DI.%26aulast%3DHollis%26aufirst%3DJ.%2BM.%26aulast%3DLargent%26aufirst%3DB.%2BL.%26aulast%3DHartig%26aufirst%3DP.%2BR.%26aulast%3DHollis%26aufirst%3DG.%2BF.%26aulast%3DMeunier%26aufirst%3DP.%2BC.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26aulast%3DRobertson%26aufirst%3DD.%2BW.%26atitle%3DPossible%2520role%2520of%2520valvular%2520serotonin%25205-HT2B%2520receptors%2520in%2520the%2520cardiopathy%2520associated%2520with%2520fenfluramine%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D75%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Astrup, A.</span><span> </span><span class="NLM_article-title">Drug management of obesity - efficacy versus safety</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span><span class="refDoi"> DOI: 10.1056/NEJMe1004076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1056%2FNEJMe1004076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=20647205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVOmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=288-290&author=A.+Astrup&title=Drug+management+of+obesity+-+efficacy+versus+safety&doi=10.1056%2FNEJMe1004076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Drug management of obesity - efficacy versus safety</span></div><div class="casAuthors">Astrup, Arne</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">288-290</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi6IVLWiQAf7Vg90H21EOLACvtfcHk0lgECDEeUYAyGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVOmt78%253D&md5=c7b7c29cb7eeb9b43bfb312a59f42e21</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1056%2FNEJMe1004076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe1004076%26sid%3Dliteratum%253Aachs%26aulast%3DAstrup%26aufirst%3DA.%26atitle%3DDrug%2520management%2520of%2520obesity%2520-%2520efficacy%2520versus%2520safety%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D288%26epage%3D290%26doi%3D10.1056%2FNEJMe1004076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">DiNicolantonio, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, P.</span><span> </span><span class="NLM_article-title">Lorcaserin for the treatment of obesity? A closer look at its side effects</span> <span class="citation_source-journal">Open Heart</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">e000173</span><span class="refDoi"> DOI: 10.1136/openhrt-2014-000173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1136%2Fopenhrt-2014-000173" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=e000173&author=J.+J.+DiNicolantonioauthor=S.+Chatterjeeauthor=J.+H.+O%E2%80%99Keefeauthor=P.+Meier&title=Lorcaserin+for+the+treatment+of+obesity%3F+A+closer+look+at+its+side+effects&doi=10.1136%2Fopenhrt-2014-000173"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1136%2Fopenhrt-2014-000173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fopenhrt-2014-000173%26sid%3Dliteratum%253Aachs%26aulast%3DDiNicolantonio%26aufirst%3DJ.%2BJ.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DJ.%2BH.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DLorcaserin%2520for%2520the%2520treatment%2520of%2520obesity%253F%2520A%2520closer%2520look%2520at%2520its%2520side%2520effects%26jtitle%3DOpen%2520Heart%26date%3D2014%26volume%3D1%26spage%3De000173%26doi%3D10.1136%2Fopenhrt-2014-000173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discov.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1038/nrd2760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1038%2Fnrd2760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=19116626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCkurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=41-54&author=P.+J.+Connauthor=A.+Christopoulosauthor=C.+W.+Lindsley&title=Allosteric+modulators+of+GPCRs%3A+a+novel+approach+for+the+treatment+of+CNS+disorders&doi=10.1038%2Fnrd2760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders</span></div><div class="casAuthors">Conn, P. Jeffrey; Christopoulos, Arthur; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-54</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite G-protein-coupled receptors (GPCRs) being among the most fruitful targets for marketed drugs, intense discovery efforts for several GPCR subtypes have failed to deliver selective drug candidates.  Historically, drug discovery programs for GPCR ligands have been dominated by efforts to develop agonists and antagonists that act at orthosteric sites for endogenous ligands.  However, in recent years, there have been tremendous advances in the discovery of novel ligands for GPCRs that act at allosteric sites to regulate receptor function.  These compds. provide high selectivity, novel modes of efficacy and may lead to novel therapeutic agents for the treatment of multiple psychiatric and neurol. human disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmn5h5XCcPKbVg90H21EOLACvtfcHk0lgECDEeUYAyGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCkurfF&md5=e109e94fe3e2c1fcfd480dc84c6609f7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnrd2760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2760%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAllosteric%2520modulators%2520of%2520GPCRs%253A%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2009%26volume%3D8%26spage%3D41%26epage%3D54%26doi%3D10.1038%2Fnrd2760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdul-Ridha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span> </span><span class="NLM_article-title">Regulation of G protein-coupled receptors by allosteric ligands</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span><span class="refDoi"> DOI: 10.1021/cn400005t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400005t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1yhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=527-534&author=J.+R.+Laneauthor=A.+Abdul-Ridhaauthor=M.+Canals&title=Regulation+of+G+protein-coupled+receptors+by+allosteric+ligands&doi=10.1021%2Fcn400005t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of G Protein-Coupled Receptors by Allosteric Ligands</span></div><div class="casAuthors">Lane, J. Robert; Abdul-Ridha, Alaa; Canals, Meritxell</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-534</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topog. distinct, druggable, allosteric sites may be present on all G protein-coupled receptors (GPCRs).  As such, targeting these sites with synthetic small mols. offers an attractive approach to develop receptor-subtype selective chem. leads for the development of novel therapies.  A crucial part of drug development is to understand the acute and chronic effects of such allosteric modulators at their corresponding GPCR target.  Key regulatory processes including cell-surface delivery, endocytosis, recycling, and down-regulation tightly control the no. of receptors at the surface of the cell.  As many GPCR therapeutics will be administered chronically, understanding how such ligands modulate these regulatory pathways forms an essential part of the characterization of novel GPCR ligands.  This is true for both orthosteric and allosteric ligands.  In this Review, we summarize our current understanding of GPCR regulatory processes with a particular focus on the effects and implications of allosteric targeting of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKrOeC3g251bVg90H21EOLACvtfcHk0lg2uH3oHZt2vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1yhtrY%253D&md5=e95af61d6cdc720069c9d9dd8de8ff5c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn400005t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400005t%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DAbdul-Ridha%26aufirst%3DA.%26aulast%3DCanals%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520G%2520protein-coupled%2520receptors%2520by%2520allosteric%2520ligands%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D527%26epage%3D534%26doi%3D10.1021%2Fcn400005t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Wootten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span> </span><span class="NLM_article-title">Emerging paradigms in GPCR allostery: implications for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discov.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span><span class="refDoi"> DOI: 10.1038/nrd4052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1038%2Fnrd4052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=630-644&author=D.+Woottenauthor=A.+Christopoulosauthor=P.+M.+Sexton&title=Emerging+paradigms+in+GPCR+allostery%3A+implications+for+drug+discovery&doi=10.1038%2Fnrd4052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd4052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4052%26sid%3Dliteratum%253Aachs%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26atitle%3DEmerging%2520paradigms%2520in%2520GPCR%2520allostery%253A%2520implications%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2013%26volume%3D12%26spage%3D630%26epage%3D644%26doi%3D10.1038%2Fnrd4052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Gentry, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Novel allosteric modulators of G protein-coupled receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">19478</span><span class="NLM_x">–</span> <span class="NLM_lpage">19488</span><span class="refDoi"> DOI: 10.1074/jbc.R115.662759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1074%2Fjbc.R115.662759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=26100627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12mt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=19478-19488&author=P.+R.+Gentryauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Novel+allosteric+modulators+of+G+protein-coupled+receptors&doi=10.1074%2Fjbc.R115.662759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Allosteric Modulators of G Protein-coupled Receptors</span></div><div class="casAuthors">Gentry, Patrick R.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">19478-19488</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) are allosteric proteins, because their signal transduction relies on interactions between topog. distinct, yet conformationally linked, domains.  Much of the focus on GPCR allostery in the new millennium, however, has been on modes of targeting GPCR allosteric sites with chem. probes due to the potential for novel therapeutics.  It is now apparent that some GPCRs possess more than one targetable allosteric site, in addn. to a growing list of putative endogenous modulators.  Advances in structural biol. are also shedding new insights into mechanisms of allostery, although the complexities of candidate allosteric drugs necessitate rigorous biol. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-w2L2Z2PwrVg90H21EOLACvtfcHk0lg2uH3oHZt2vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12mt7rI&md5=7c3b5c0ddd375e0c05a18b91f2c68e56</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R115.662759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R115.662759%26sid%3Dliteratum%253Aachs%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DNovel%2520allosteric%2520modulators%2520of%2520G%2520protein-coupled%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D19478%26epage%3D19488%26doi%3D10.1074%2Fjbc.R115.662759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Im, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chio, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberts, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D. M.</span><span> </span><span class="NLM_article-title">Positive allosteric modulator of the human 5-HT<sub>2C</sub> receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.1124/mol.64.1.78</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1124%2Fmol.64.1.78" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=12815163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvV2qtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=78-84&author=W.+B.+Imauthor=C.+L.+Chioauthor=G.+L.+Albertsauthor=D.+M.+Dinh&title=Positive+allosteric+modulator+of+the+human+5-HT2C+receptor&doi=10.1124%2Fmol.64.1.78"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Positive allosteric modulator of the human 5-HT2C receptor</span></div><div class="casAuthors">Im, Wha Bin; Chio, Christopher L.; Alberts, Glen L.; Dinh, Dac M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-84</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The human 5-hydroxytryptamine-2C (5-HT2C) receptor has been the target of potential anxiolytics and antiobesity drugs, and its pos. allosteric modulator was discovered to be L-threo-α-D-galacto-octopyranoside, methyl-7-chloro-6,7,8-trideoxy-6-[[(4-undecyl-2-piperidinyl)carbonyl]amino]-1-thiomonohydrochloride (2S-cis) (PNU-69176E).  The drug at low micromolar concns. (<25 μM) markedly enhanced [3H]5-HT binding (more than 300%) by increasing its affinity for low-affinity sites but with no appreciable effect on antagonist ([3H]mesulergine) binding.  Functionally, PNU-69176E alone rendered receptors constitutively active, producing the phenotypes of 5-HT-activated receptors, as measured with mesulergine-sensitive guanosine 5'-O-(3-[35S]thio)triphosphate binding, transient inositol 1,4,5-triphosphate release, and [3H]inositol phosphate accumulation.  These actions of PNU-69176E were obsd. with the human 5-HT2C receptor expressed in several mammalian cell lines (human embryonic kidney 293, NIH3T3, and SH-EP) at variable receptor densities (6 to 45 pmol/mg of protein), but not with analogous 5-HT and dopamine receptors (human 5-HT2A, 5-HT2B, 5-HT6, 5-HT7, and dopamine D2-long and D3 receptors).  Structurally, PNU-69176E consists of a long alkyl chain and a polar moiety, including the α-D-galactopyranoside.  Its analogs with shorter alkyl chains (Me to n-hexyl instead of n-undecyl group) failed to enhance [3H]5-HT binding, and also long alkyl amides are without allosteric modulation.  We propose that PNU-69176E may represent a new class of membrane receptor modulators, which probably need a long alkyl chain as a membrane anchor and target a selective polar head group to receptor modulatory sites near the membrane surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMdPZHNbAJJbVg90H21EOLACvtfcHk0lg2uH3oHZt2vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvV2qtrs%253D&md5=26c9f18b3097e2a8921b7803bc836489</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fmol.64.1.78&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.64.1.78%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DW.%2BB.%26aulast%3DChio%26aufirst%3DC.%2BL.%26aulast%3DAlberts%26aufirst%3DG.%2BL.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26atitle%3DPositive%2520allosteric%2520modulator%2520of%2520the%2520human%25205-HT2C%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D78%26epage%3D84%26doi%3D10.1124%2Fmol.64.1.78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ding, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastasio, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span> </span><span class="NLM_article-title">Exploration of synthetic approaches and pharmacological evaluation of PNU-69176E and its stereoisomer as 5-HT<sub>2C</sub> receptor allosteric modulators</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.1021/cn300020x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300020x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=538-545&author=C.+Dingauthor=N.+M.+Bremerauthor=T.+D.+Smithauthor=P.+K.+Seitzauthor=N.+C.+Anastasioauthor=K.+A.+Cunninghamauthor=J.+Zhou&title=Exploration+of+synthetic+approaches+and+pharmacological+evaluation+of+PNU-69176E+and+its+stereoisomer+as+5-HT2C+receptor+allosteric+modulators&doi=10.1021%2Fcn300020x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of Synthetic Approaches and Pharmacological Evaluation of PNU-69176E and Its Stereoisomer as 5-HT2C Receptor Allosteric Modulators</span></div><div class="casAuthors">Ding, Chunyong; Bremer, Nicole M.; Smith, Thressa D.; Seitz, Patricia K.; Anastasio, Noelle C.; Cunningham, Kathryn A.; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">538-545</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Allosteric modulators of the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) present a unique drug design strategy to augment the response to endogenous 5-HT in a site- and event-specific manner with great potential as novel central nervous system probes and therapeutics.  To date, PNU-69176E is the only reported selective pos. allosteric modulator for the 5-HT2CR.  For the first time, an optimized synthetic route to readily access PNU-69176E (1) and its diastereomer 2 has been established in moderate to good overall yields over 10 steps starting from com. available picolinic acid.  This synthetic approach not only enables a feasible prepn. of a sufficient amt. of 1 for use as a ref. compd. for secondary pharmacol. studies, but also provides an efficient synthesis of key intermediates to develop novel and simplified 5-HT2CR allosteric modulators.  Compd. 1 and its diastereomer 2 were functionally characterized in Chinese hamster ovary (CHO) cells stably transfected with the 5-HT2CR using an intracellular calcium (Cai2+) release assay.  Compd. 1 demonstrated efficacy and potency as an allosteric modulator for the 5-HT2CR with no intrinsic agonist activity.  Compd. 1 did not alter 5-HT-evoked Cai2+ in CHO cells stably transfected with the highly homologous 5-HT2AR.  In contrast, the diastereomer 2 did not alter 5-HT-evoked Cai2+ release in 5-HT2AR-CHO or 5-HT2CR-CHO cells or exhibit intrinsic agonist activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-ZC-7cVkBGrVg90H21EOLACvtfcHk0lhxje22OxGsOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOqsb0%253D&md5=1f635dd7796d2663f1ab08b92c7d7cb9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcn300020x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300020x%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26aulast%3DBremer%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BD.%26aulast%3DSeitz%26aufirst%3DP.%2BK.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DExploration%2520of%2520synthetic%2520approaches%2520and%2520pharmacological%2520evaluation%2520of%2520PNU-69176E%2520and%2520its%2520stereoisomer%2520as%25205-HT2C%2520receptor%2520allosteric%2520modulators%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D538%26epage%3D545%26doi%3D10.1021%2Fcn300020x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">McAllister, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastasio, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, K. A.</span><span> </span><span class="NLM_article-title">In vivo evaluation of novel serotonin 5-HT<sub>2C</sub> receptor positive allosteric modulator CYD-1–79</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">e144</span><span class="refDoi"> DOI: 10.1016/j.drugalcdep.2015.07.394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.drugalcdep.2015.07.394" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2015&pages=e144&author=C.+E.+McAllisterauthor=R.+M.+Hartleyauthor=G.+Zhangauthor=R.+G.+Foxauthor=N.+C.+Anastasioauthor=C.+Wildauthor=J.+Zhouauthor=K.+A.+Cunningham&title=In+vivo+evaluation+of+novel+serotonin+5-HT2C+receptor+positive+allosteric+modulator+CYD-1%E2%80%9379&doi=10.1016%2Fj.drugalcdep.2015.07.394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.drugalcdep.2015.07.394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drugalcdep.2015.07.394%26sid%3Dliteratum%253Aachs%26aulast%3DMcAllister%26aufirst%3DC.%2BE.%26aulast%3DHartley%26aufirst%3DR.%2BM.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DIn%2520vivo%2520evaluation%2520of%2520novel%2520serotonin%25205-HT2C%2520receptor%2520positive%2520allosteric%2520modulator%2520CYD-1%25E2%2580%259379%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2015%26volume%3D156%26spage%3De144%26doi%3D10.1016%2Fj.drugalcdep.2015.07.394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wacker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCorvy, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatakrishnan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schools, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dror, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Crystal structure of an LSD-bound human serotonin receptor</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1016/j.cell.2016.12.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.cell.2016.12.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=28129538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=377-389&author=D.+Wackerauthor=S.+Wangauthor=J.+D.+McCorvyauthor=R.+M.+Betzauthor=A.+J.+Venkatakrishnanauthor=A.+Levitauthor=K.+Lansuauthor=Z.+L.+Schoolsauthor=T.+Cheauthor=D.+E.+Nicholsauthor=B.+K.+Shoichetauthor=R.+O.+Drorauthor=B.+L.+Roth&title=Crystal+structure+of+an+LSD-bound+human+serotonin+receptor&doi=10.1016%2Fj.cell.2016.12.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an LSD-bound human serotonin receptor</span></div><div class="casAuthors">Wacker, Daniel; Wang, Sheng; McCorvy, John D.; Betz, Robin M.; Venkatakrishnan, A. J.; Levit, Anat; Lansu, Katherine; Schools, Zachary L.; Che, Tao; Nichols, David E.; Shoichet, Brian K.; Dror, Ron O.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-389.e12</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The prototypical hallucinogen, LSD, acts via serotonin receptors, and here the authors describe the crystal structure of LSD in complex with human serotonin receptor 5-HT2B.  The complex revealed conformational rearrangements to accommodate LSD, providing a structural explanation for the conformational selectivity of LSD's key diethylamide moiety.  LSD dissocd. exceptionally slow from both 5-HT2BR and 5-HT2AR, a major target for its psychoactivity.  Mol. dynamics (MD) simulations suggested that LSD's slow binding kinetics may be due to a "lid" formed by extracellular loop 2 (EL2) at the entrance to the binding pocket.  A mutation predicted to increase the mobility of this lid greatly accelerated LSD's binding kinetics and selectively dampened LSD-mediated β-arrestin 2 recruitment.  Thus, this study reveals an unexpected binding mode of LSD, illuminates key features of its kinetics, stereochem., and signaling, and provides a mol. explanation for LSD's actions at human serotonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcU-96ccslG7Vg90H21EOLACvtfcHk0lhxje22OxGsOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaqs7g%253D&md5=5eee71a2d385d97d9891b669e8c5afa1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.12.033%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DSchools%26aufirst%3DZ.%2BL.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DCrystal%2520structure%2520of%2520an%2520LSD-bound%2520human%2520serotonin%2520receptor%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D377%26epage%3D389%26doi%3D10.1016%2Fj.cell.2016.12.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazandarani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabalski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welmaker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span> </span><span class="NLM_article-title">Antiobesity-like effects of the 5-HT<sub>2C</sub> receptor agonist WAY-161503</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1073–1074</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span><span class="refDoi"> DOI: 10.1016/j.brainres.2005.12.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2Fj.brainres.2005.12.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=16430874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Sqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1073%E2%80%931074&publication_year=2006&pages=240-251&author=S.+Rosenzweig-Lipsonauthor=J.+Zhangauthor=H.+Mazandaraniauthor=B.+L.+Harrisonauthor=A.+Sabbauthor=J.+Sabalskiauthor=G.+Stackauthor=G.+Welmakerauthor=J.+E.+Barrettauthor=J.+Dunlop&title=Antiobesity-like+effects+of+the+5-HT2C+receptor+agonist+WAY-161503&doi=10.1016%2Fj.brainres.2005.12.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503</span></div><div class="casAuthors">Rosenzweig-Lipson, Sharon; Zhang, Jean; Mazandarani, Hossein; Harrison, Boyd L.; Sabb, Annmarie; Sabalski, Joan; Stack, Gary; Welmaker, Greg; Barrett, James E.; Dunlop, John</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1073-1074</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">240-251</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">WAY-161503 ((4aR)-8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one), a 5-HT2B/C receptor agonist, was characterized in vitro using stable Chinese hamster ovary cell lines expressing each of the human 5-HT2 receptors and in vivo in animal models of obesity.  WAY-161503 displaced both agonist ([125I]2,5-dimethoxy-4-iodoamphetamine (DOI)) and antagonist ([3H]mesulergine) radioligand binding to the human 5-HT2C receptor with derived Ki values of 3.3 ± 0.9 and 32 ± 6 nM, resp.  Relative to 5-HT2C receptor binding, WAY-161503 was approx. 6-fold less potent at human 5-HT2A receptors ([125I]DOI) with a derived Ki value of 18 nM and 20-fold less potent at human 5-HT2B receptors ([3H]5-HT) with a derived Ki value of 60 nM.  In functional studies, WAY-161503 was a full agonist in stimulating 5-HT2C-receptor-coupled [3H]inositol phosphate (IP) formation and calcium mobilization with EC50 values of 8.5 nM and 0.8 nM, resp.  WAY-161503 was also a 5-HT2B agonist (EC50s of 6.9 and 1.8 nM for IP and calcium, resp.).  In IP studies, WAY-161503 was a weak 5-HT2A partial agonist (EC50, 802 nM) yet potently stimulated calcium mobilization (EC50, 7 nM) in 5-HT2A receptor-expressing cells.  Functionally, WAY-161503 also stimulated the phospholipase A2-coupled arachidonic acid release in 5-HT2C receptor expressing cells albeit with lower potency (EC50, 38 nM) and efficacy (Emax, 77%) compared with activation of the PLC pathway.  In vivo, WAY-161503 produced dose-dependent decreases in 2-h food intake in 24 h fasted normal Sprague-Dawley rats, diet-induced obese mice, and obese Zuker rats with ED50 values of 1.9 mg/kg, 6.8 mg/kg, and 0.73 mg/kg, resp.  The redn. in food intake in normal Sprague-Dawley rats was reversed by administration of the 5-HT2C receptor antagonist SB-242084.  Following chronic administration (10 days) in growing Sprague-Dawley rats, WAY-161503 decreased food intake and attenuated body wt. gain.  Finally, following chronic administration (15 days) of WAY-161503 to obese Zuker rats, the rats maintained a 30% decrease in food intake over the 15-day period combined with a 25 g decrease in body wt. relative to vehicle-treated controls demonstrating a lack of tolerance to its anorectic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq05g9y-g8Sl7Vg90H21EOLACvtfcHk0linjTA3o-NTbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Sqt7s%253D&md5=9d33e25899d30c2c9b9840de84469cb2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2005.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2005.12.052%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMazandarani%26aufirst%3DH.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DSabb%26aufirst%3DA.%26aulast%3DSabalski%26aufirst%3DJ.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DWelmaker%26aufirst%3DG.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DDunlop%26aufirst%3DJ.%26atitle%3DAntiobesity-like%2520effects%2520of%2520the%25205-HT2C%2520receptor%2520agonist%2520WAY-161503%26jtitle%3DBrain%2520Res.%26date%3D2006%26volume%3D1073%25E2%2580%25931074%26spage%3D240%26epage%3D251%26doi%3D10.1016%2Fj.brainres.2005.12.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Kennett, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenell, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, T. P.</span><span> </span><span class="NLM_article-title">SB 242084, a selective and brain penetrant 5-HT<sub>2C</sub> receptor antagonist</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span><span class="refDoi"> DOI: 10.1016/S0028-3908(97)00038-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1016%2FS0028-3908%2897%2900038-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=609-620&author=G.+A.+Kennettauthor=M.+D.+Woodauthor=F.+Brightauthor=B.+Trailauthor=G.+Rileyauthor=G.+Hollandauthor=K.+Y.+Avenellauthor=T.+Steanauthor=N.+Uptonauthor=S.+Bromidgeauthor=I.+T.+Forbesauthor=A.+M.+Brownauthor=D.+N.+Middlemissauthor=T.+P.+Blackburn&title=SB+242084%2C+a+selective+and+brain+penetrant+5-HT2C+receptor+antagonist&doi=10.1016%2FS0028-3908%2897%2900038-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2897%2900038-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252897%252900038-5%26sid%3Dliteratum%253Aachs%26aulast%3DKennett%26aufirst%3DG.%2BA.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DBright%26aufirst%3DF.%26aulast%3DTrail%26aufirst%3DB.%26aulast%3DRiley%26aufirst%3DG.%26aulast%3DHolland%26aufirst%3DG.%26aulast%3DAvenell%26aufirst%3DK.%2BY.%26aulast%3DStean%26aufirst%3DT.%26aulast%3DUpton%26aufirst%3DN.%26aulast%3DBromidge%26aufirst%3DS.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DBlackburn%26aufirst%3DT.%2BP.%26atitle%3DSB%2520242084%252C%2520a%2520selective%2520and%2520brain%2520penetrant%25205-HT2C%2520receptor%2520antagonist%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D609%26epage%3D620%26doi%3D10.1016%2FS0028-3908%2897%2900038-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silenieks, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lannoy, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izhakova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, P. J.</span><span> </span><span class="NLM_article-title">Evaluation of chemically diverse 5-HT<sub>2C</sub> receptor agonists on behaviours motivated by food and nicotine and on side effect profiles</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span><span class="refDoi"> DOI: 10.1007/s00213-012-2919-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1007%2Fs00213-012-2919-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=23184281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslekt7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2013&pages=475-490&author=G.+A.+Higginsauthor=L.+B.+Silenieksauthor=W.+Lauauthor=I.+A.+de+Lannoyauthor=D.+K.+Leeauthor=J.+Izhakovaauthor=K.+Coenauthor=A.+D.+Leauthor=P.+J.+Fletcher&title=Evaluation+of+chemically+diverse+5-HT2C+receptor+agonists+on+behaviours+motivated+by+food+and+nicotine+and+on+side+effect+profiles&doi=10.1007%2Fs00213-012-2919-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of chemically diverse 5-HT2C receptor agonists on behaviours motivated by food and nicotine and on side effect profiles</span></div><div class="casAuthors">Higgins, G. A.; Silenieks, L. B.; Lau, W.; de Lannoy, I. A. M.; Lee, D. K. H.; Izhakova, J.; Coen, K.; Le, A. D.; Fletcher, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-490</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Selective 5-HT2C receptor agonists, such as lorcaserin, are being developed for the treatment of obesity.  Studies suggest that they may also have therapeutic potential for addictive behaviors including nicotine dependence, although few drugs of this class have been evaluated.  Objectives: The primary aim was to evaluate the highly selective 5-HT2C agonist, CP-809101, against food-motivated (operant FR5 and progressive ratio schedules, palatability-induced feeding) and nicotine-motivated (i.v. self-administration, drug discrimination) behaviors in rats and to compare with equiv. findings for the structurally distinct 5-HT2C receptor agonists lorcaserin and Ro 60-0175.  The secondary aims were to evaluate the side effect profiles of lorcaserin and CP-809101 and to det. the plasma levels of lorcaserin at a dose (1 mg/kg) that reduces both food and nicotine reinforcement for comparison to plasma concns. reported in human trials.  Results: CP-809101 (0.3-3 mg/kg SC) reduced responding for both nicotine and food and blocked the discriminative stimulus properties of nicotine in a similar manner to lorcaserin and Ro 60-0175.  Behaviors such as hypolocomotion, chewing and ptosis became evident following both CP-809101 and lorcaserin administration at higher doses.  Plasma levels of lorcaserin were of similar range to those reported in obesity trials.  Conclusions: These studies support the utility of 5-HT2C agonists as a therapeutic approach to treat nicotine dependence.  Plasma exposure levels after acute lorcaserin treatment suggest that equiv. dosages could be used to evaluate these drugs in obesity and smoking cessation trials.  Finally, there may be differences in the side effect profiles between lorcaserin and CP-809101, raising the possibility for tolerability differences amongst 5-HT2C agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp_oofEQ4547Vg90H21EOLACvtfcHk0linjTA3o-NTbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslekt7fI&md5=e895a2f2a65fca2eb4e70873c2dd8734</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs00213-012-2919-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-012-2919-2%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DSilenieks%26aufirst%3DL.%2BB.%26aulast%3DLau%26aufirst%3DW.%26aulast%3Dde%2BLannoy%26aufirst%3DI.%2BA.%26aulast%3DLee%26aufirst%3DD.%2BK.%26aulast%3DIzhakova%26aufirst%3DJ.%26aulast%3DCoen%26aufirst%3DK.%26aulast%3DLe%26aufirst%3DA.%2BD.%26aulast%3DFletcher%26aufirst%3DP.%2BJ.%26atitle%3DEvaluation%2520of%2520chemically%2520diverse%25205-HT2C%2520receptor%2520agonists%2520on%2520behaviours%2520motivated%2520by%2520food%2520and%2520nicotine%2520and%2520on%2520side%2520effect%2520profiles%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D226%26spage%3D475%26epage%3D490%26doi%3D10.1007%2Fs00213-012-2919-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Dawes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggard-Gibbons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miake-Lye, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroes, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shekelle, P. G.</span><span> </span><span class="NLM_article-title">Mental health conditions among patients seeking and undergoing bariatric surgery. A meta-analysis</span> <span class="citation_source-journal">J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span><span class="refDoi"> DOI: 10.1001/jama.2015.18118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1001%2Fjama.2015.18118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVartbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2016&pages=150-163&author=A.+J.+Dawesauthor=M.+Maggard-Gibbonsauthor=A.+R.+Maherauthor=M.+J.+Boothauthor=I.+Miake-Lyeauthor=J.+M.+Beroesauthor=P.+G.+Shekelle&title=Mental+health+conditions+among+patients+seeking+and+undergoing+bariatric+surgery.+A+meta-analysis&doi=10.1001%2Fjama.2015.18118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Mental health conditions among patients seeking and undergoing bariatric surgery a meta-analysis</span></div><div class="casAuthors">Dawes, Aaron J.; Maggard-Gibbons, Melinda; Maher, Alicia R.; Booth, Marika J.; Miake-Lye, Isomi; Beroes, Jessica M.; Shekelle, Paul G.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">150-163</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">1538-3598</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">IMPORTANCE Bariatric surgery is assocd. with sustained wt. loss and improved phys. health status for severely obese individuals.  Mental health conditions may be common among patients seeking bariatric surgery; however, the prevalence of these conditions and whether they are assocd. with postoperative outcomes remains unknown.  OBJECTIVE To det. the prevalence of mental health conditions among bariatric surgery candidates and recipients, to evaluate the assocn. between preoperative mental health conditions and health outcomes following bariatric surgery, and to evaluate the assocn. between surgery and the clin. course of mental health conditions.  DATA SOURCES We searched PubMed, MEDLINE on OVID, and PsycINFO for studies published between Jan. 1988 and Nov. 2015.  Study quality was assessed using an adapted tool for risk of bias; quality of evidence was rated based on GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria.  FINDINGS We identified 68 publications meeting inclusion criteria: 59 reporting the prevalence of preoperative mental health conditions (65 363 patients) and 27 reporting assocns. between preoperative mental health conditions and postoperative outcomes (50 182 patients).  Among patients seeking and undergoing bariatric surgery, the most common mental health conditions, based on random-effects ests. of prevalence, were depression (19% [95%CI, 14%-25%]) and binge eating disorder (17%[95%CI, 13%-21%]).  There was conflicting evidence regarding the assocn. between preoperative mental health conditions and postoperative wt. loss.  Neither depression nor binge eating disorder was consistently assocd. with differences in wt. outcomes.  Bariatric surgery was, however, consistently assocd. with postoperative decreases in the prevalence of depression (7 studies; 8%-74%decrease) and the severity of depressive symptoms (6 studies; 40%-70%decrease).  CONCLUSIONS AND RELEVANCE Mental health conditions are common among bariatric surgery patients-in particular, depression and binge eating disorder.  There is inconsistent evidence regarding the assocn. between preoperative mental health conditions and postoperative wt. loss.  Moderate-quality evidence supports an assocn. between bariatric surgery and lower rates of depression postoperatively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7MPDh-S6HV7Vg90H21EOLACvtfcHk0linjTA3o-NTbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVartbjE&md5=a2ce128eec267c6a34eec593d0b3dc6a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1001%2Fjama.2015.18118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2015.18118%26sid%3Dliteratum%253Aachs%26aulast%3DDawes%26aufirst%3DA.%2BJ.%26aulast%3DMaggard-Gibbons%26aufirst%3DM.%26aulast%3DMaher%26aufirst%3DA.%2BR.%26aulast%3DBooth%26aufirst%3DM.%2BJ.%26aulast%3DMiake-Lye%26aufirst%3DI.%26aulast%3DBeroes%26aufirst%3DJ.%2BM.%26aulast%3DShekelle%26aufirst%3DP.%2BG.%26atitle%3DMental%2520health%2520conditions%2520among%2520patients%2520seeking%2520and%2520undergoing%2520bariatric%2520surgery.%2520A%2520meta-analysis%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2016%26volume%3D315%26spage%3D150%26epage%3D163%26doi%3D10.1001%2Fjama.2015.18118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Crespillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavón, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero-Zerbo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Llebrez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Valero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bermúdez-Silva, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suárez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fonseca, F. R.</span><span> </span><span class="NLM_article-title">Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">1899</span><span class="NLM_x">–</span> <span class="NLM_lpage">1915</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01477.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1111%2Fj.1476-5381.2011.01477.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=21557739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2011&pages=1899-1915&author=A.+Crespilloauthor=M.+Alonsoauthor=M.+Vidaauthor=F.+J.+Pav%C3%B3nauthor=A.+Serranoauthor=P.+Riveraauthor=Y.+Romero-Zerboauthor=P.+Fern%C3%A1ndez-Llebrezauthor=A.+Mart%C3%ADnezauthor=V.+P%C3%A9rez-Valeroauthor=F.+J.+Berm%C3%BAdez-Silvaauthor=J.+Su%C3%A1rezauthor=F.+R.+de+Fonseca&title=Reduction+of+body+weight%2C+liver+steatosis+and+expression+of+stearoyl-CoA+desaturase+1+by+the+isoflavone+daidzein+in+diet-induced+obesity&doi=10.1111%2Fj.1476-5381.2011.01477.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity</span></div><div class="casAuthors">Crespillo, A.; Alonso, M.; Vida, M.; Pavon, F. J.; Serrano, A.; Rivera, P.; Romero-Zerbo, Y.; Fernandez-Llebrez, P.; Martinez, A.; Perez-Valero, V.; Bermudez-Silva, F. J.; Suarez, J.; de Fonseca, F. R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1899-1915</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: The lack of safe and effective treatments for obesity has increased interest in natural products that may serve as alternative therapies.  From this perspective, we have analyzed the effects of daidzein, one of the main soy isoflavones, on diet-induced obesity in rats.  Exptl. Approach: Rats made obese after exposure to a very (60%) high fat-content diet were treated with daidzein (50 mg·kg-1) for 14 days.  The dose was selected on the basis of the acute effects of this isoflavone on a feeding test.  After 14 days, animals were killed and plasma, white and brown adipose tissue, muscle and liver studied for the levels and expression of metabolites, proteins and genes relevant to lipid metab.  Key Results: A single treatment (acute) with daidzein dose-dependently reduced food intake.  Chronic treatment (daily for 14 days) reduced wt. gain and fat content in liver, accompanied by high leptin and low adiponectin levels in plasma.  While skeletal muscle was weakly affected by treatment, both adipose tissue and liver displayed marked changes after treatment with daidzein, affecting transcription factors and lipogenic enzymes, particularly stearoyl CoA desaturase 1, a pivotal enzyme in obesity.  Expression of uncoupling protein 1, an important enzyme for thermogenesis, was increased in brown adipose tissue after daidzein treatment.  Conclusions and Implications: These results support the use of isoflavones in diet-induced obesity, esp. when hepatic steatosis is present and open a new field of use for these natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAaEqrubpdQLVg90H21EOLACvtfcHk0lhIPypNj-Z9wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsLzF&md5=e7eb04760b40ceeea2d07cb9f99419d3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01477.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01477.x%26sid%3Dliteratum%253Aachs%26aulast%3DCrespillo%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DVida%26aufirst%3DM.%26aulast%3DPav%25C3%25B3n%26aufirst%3DF.%2BJ.%26aulast%3DSerrano%26aufirst%3DA.%26aulast%3DRivera%26aufirst%3DP.%26aulast%3DRomero-Zerbo%26aufirst%3DY.%26aulast%3DFern%25C3%25A1ndez-Llebrez%26aufirst%3DP.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez-Valero%26aufirst%3DV.%26aulast%3DBerm%25C3%25BAdez-Silva%26aufirst%3DF.%2BJ.%26aulast%3DSu%25C3%25A1rez%26aufirst%3DJ.%26aulast%3Dde%2BFonseca%26aufirst%3DF.%2BR.%26atitle%3DReduction%2520of%2520body%2520weight%252C%2520liver%2520steatosis%2520and%2520expression%2520of%2520stearoyl-CoA%2520desaturase%25201%2520by%2520the%2520isoflavone%2520daidzein%2520in%2520diet-induced%2520obesity%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D164%26spage%3D1899%26epage%3D1915%26doi%3D10.1111%2Fj.1476-5381.2011.01477.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Gomez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trigo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Arco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cippitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nava, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fonseca, F. R.</span><span> </span><span class="NLM_article-title">A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">9612</span><span class="NLM_x">–</span> <span class="NLM_lpage">9617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=12417686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVGmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=9612-9617&author=R.+Gomezauthor=M.+Navarroauthor=B.+Ferrerauthor=J.+M.+Trigoauthor=A.+Bilbaoauthor=I.+Del+Arcoauthor=A.+Cippitelliauthor=F.+Navaauthor=D.+Piomelliauthor=F.+R.+de+Fonseca&title=A+peripheral+mechanism+for+CB1+cannabinoid+receptor-dependent+modulation+of+feeding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding</span></div><div class="casAuthors">Gomez, Raquel; Navarro, Miguel; Ferrer, Belen; Trigo, Jose M.; Bilbao, Ainhoa; Del Arco, Ignacio; Cippitelli, Andrea; Nava, Felice; Piomelli, Daniele; Rodriguez de Fonseca, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9612-9617</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies suggest that the endocannabinoid system modulates feeding.  Despite the existence of central mechanisms for the regulation of food intake by endocannabinoids, evidence indicates that peripheral mechanisms may also exist.  To test this hypothesis, the authors investigated (1) the effects of feeding on intestinal anandamide accumulation; (2) the effects of central (intracerebroventricular) and peripheral (i.p.) administration of the endocannabinoid agonist anandamide, the synthetic cannabinoid agonist R-(+)-(2,3-dihydro-5-methyl-3-[(4-morpholinyl)methyl]pyrol[1,2,3-de]-1,4-benzoxazin-6-yl)(1-naphthalenyl) methanone monomethanesulfonate (WIN55,212-2), and the CB1-selective antagonist N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR141716A) on food intake in rats; and (3) the effects of sensory deafferentation on the modulation of feeding by cannabinoids.  Food deprivation produced a sevenfold increase in anandamide content in the small intestine but not in the brain or stomach.  Refeeding normalized intestinal anandamide levels.  Peripheral but not central administration of anandamide or WIN55,212-2 promoted hyperphagia in partially satiated rats.  Similarly, peripheral but not central administration of SR141716A reduced food intake.  Capsaicin deafferentation abolished the peripheral effects of both cannabinoid agonists and antagonists, suggesting that these agents modulate food intake by acting on CB1 receptors located on capsaicin-sensitive sensory terminals.  Oleoylethanolamide, a noncannabinoid fatty ethanolamide that acts peripherally, prevented hyperphagia induced by the endogenous cannabinoid anandamide.  Pretreatment with SR141716A enhanced the inhibition of feeding induced by i.p. administration of oleoylethanolamide.  The results reveal an unexpected role for peripheral CB1 receptors in the regulation of feeding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9nrazAFzXBbVg90H21EOLACvtfcHk0licbIfc9ejE8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVGmtrY%253D&md5=fc4d9c4d6e02f99a5554187ece898b85</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DFerrer%26aufirst%3DB.%26aulast%3DTrigo%26aufirst%3DJ.%2BM.%26aulast%3DBilbao%26aufirst%3DA.%26aulast%3DDel%2BArco%26aufirst%3DI.%26aulast%3DCippitelli%26aufirst%3DA.%26aulast%3DNava%26aufirst%3DF.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3Dde%2BFonseca%26aufirst%3DF.%2BR.%26atitle%3DA%2520peripheral%2520mechanism%2520for%2520CB1%2520cannabinoid%2520receptor-dependent%2520modulation%2520of%2520feeding%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D9612%26epage%3D9617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Rodríguez de Fonseca, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escuredo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nava, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murillo-Rodriguez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffrida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoVerme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaetani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kathuria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">An anorexic lipid mediator regulated by feeding</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><span class="refDoi"> DOI: 10.1038/35102582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=10.1038%2F35102582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=11700558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFahs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=209-212&author=F.+R.+Rodr%C3%ADguez+de+Fonsecaauthor=M.+Navarroauthor=R.+Gomezauthor=L.+Escuredoauthor=F.+Navaauthor=J.+Fuauthor=E.+Murillo-Rodriguezauthor=A.+Giuffridaauthor=J.+LoVermeauthor=S.+Gaetaniauthor=S.+Kathuriaauthor=C.+Gallauthor=D.+Piomelli&title=An+anorexic+lipid+mediator+regulated+by+feeding&doi=10.1038%2F35102582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An anorexic lipid mediator regulated by feeding</span></div><div class="casAuthors">Rodriguez de Fonseca, F.; Navarro, M.; Gomez, R.; Escuredo, L.; Nava, F.; Fu, J.; Murillo-Rodriguez, E.; Gluffrida, A.; Lo Verme, J.; Gaetani, S.; Kathurla, S.; Gall, C.; Piomell, D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue">6860</span>),
    <span class="NLM_cas:pages">209-212</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors show that, in rats, food deprivation markedly reduces oleylethanolamide (OEA) biosynthesis in the small intestine.  Administration of OEA causes a potent and persistent decrease in food intake and gain in body mass.  This anorexic effect is behaviorally selective and is assocd. with the discrete activation of brain regions (the paraventricular hypothalamic nucleus and the nucleus of the solitary tract) involved in the control of satiety.  OEA does not affect food intake when injected into the brain ventricles, and its anorexic actions are prevented when peripheral sensory fibers are removed by treatment with capsaicin.  These results indicate that OEA is a lipid mediator involved in the peripheral regulation of feeding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40Gb0kaK8SLVg90H21EOLACvtfcHk0licbIfc9ejE8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFahs7c%253D&md5=07430859a5e7cd93d0ce5d79364c4b6e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2F35102582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35102582%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%2Bde%2BFonseca%26aufirst%3DF.%2BR.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DEscuredo%26aufirst%3DL.%26aulast%3DNava%26aufirst%3DF.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DMurillo-Rodriguez%26aufirst%3DE.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DLoVerme%26aufirst%3DJ.%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DKathuria%26aufirst%3DS.%26aulast%3DGall%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAn%2520anorexic%2520lipid%2520mediator%2520regulated%2520by%2520feeding%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D209%26epage%3D212%26doi%3D10.1038%2F35102582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i29"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00994">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_51668"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00994">10.1021/acs.jmedchem.7b00994</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthesis and characterization data of compounds <b>6</b>–<b>8</b>, <b>10</b>, <b>12</b>–<b>18</b>, and <b>20</b>–<b>42</b>; HPLC-MS purity analyses of final compounds <b>6</b>–<b>41</b>; molecular formula strings for compounds <b>1</b>–<b>48</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00994/suppl_file/jm7b00994_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00994/suppl_file/jm7b00994_si_001.pdf">jm7b00994_si_001.pdf (649.38 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00994%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00994" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679973641d873c7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
